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Abstract
Mutations in ATRX, a Snf2-type chromatin remodeler, frequently lead to intellectual disability.
However, the function of ATRX within the brain in cognition and synaptic transmission are
incompletely understood. The aim of this study was to investigate the role of ATRX in the
adult mouse brain. While complete loss of ATRX in the embryonic mouse brain results in
perinatal lethality, mosaic expression of ATRX stunted growth and perturbed circulating IGF1 levels. Mosaic expression of ATRX also impaired adult cognition, specifically recognition
memory and spatial learning and memory. However, there were confounding factors that led
me to a new model in which I deleted the gene in postnatal mouse glutamatergic neurons.
Magnetic resonance imaging of these mice revealed increased hippocampal CA1 and CA3
layers, and behaviour analysis indicated deficiencies in hippocampal-dependent learning and
memory in the contextual fear task, Morris water maze, and paired-associate learning task.
These behavioural abnormalities were not present in the female counterparts. Transmission
electron microscopy of male hippocampal CA1 synapses revealed decreased number of total
and docked vesicles and increased cleft width and post-synaptic density size. Hippocampal
RNA-sequencing followed by sex-interaction analysis of male and female knockout transcripts
highlighted potential impairments in the synaptic vesicle cycle. miR-137, a known regulator
of presynaptic vesicle cycle and plasticity, was upregulated in the male knockout hippocampi
but downregulated in the female knockouts. These results demonstrate sexually-dimorphic
regulation of miR-137 and learning and memory by ATRX in forebrain glutamatergic neurons,
indicating potential miRNA-targeting therapies for cognitive disorders by ATRX mutations.
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Summary for Lay Audience
The ATRX gene is required for the ATRX protein which modifies how the genetic material,
DNA, is packaged and regulated in brain cells. When there is no ATRX present in the cell,
there is deregulation of many different genes. Mutations during development that decrease the
function of ATRX result in an intellectual disability disorder known as ATR-X syndrome. This
syndrome is characterized by intellectual disability, developmental delay, abnormalities in
facial structure, and small brain size. Therefore, ATRX is important in our nervous system
and loss is directly related to many mental health disorders. My project focuses on the role of
ATRX in learning and memory. I hypothesize that ATRX plays a very important role in the
control of genes required for learning and memory by altering expression of genes involved in
this process. In order to look at the effects that ATRX has on epigenetics in the adult brain, I
generated two mouse models that deletes ATRX in the brain – one in the whole brain, and one
in areas important for learning and memory. These mice underwent various behaviour tests to
determine if they were able to learn and remember different tasks. I found that the mutant mice
were unable to form two distinct types of memories: spatial memories and fear memories. I
also found that loss of ATRX causes abnormal brain size in areas required for learning and
memory. Additionally, ATRX may be required to regulate a particular microRNA, which in
turn can regulate many different genes involved in proper neuron function. In summary, my
work demonstrates a role for ATRX in learning and memory, thereby providing another link
between chromatin remodeling proteins and cognition.
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Chapter 1

1

Introduction

1.1 Intellectual disability
Disorders of intellectual development vary from mild to profound and are classified by the
World Health Organization International Classification of Disease, Version 11 (ID:6A00)
by below average intellectual capabilities and adaptive functioning, at least two standard
deviations below the mean. The most recent estimate of intellectual disability (ID)
prevalence in Canada ranges from 1-3% (Ouellette-Kuntz et al., 2005). Patients with ID
will require lifelong treatments and services and so the economic costs of ID are quite high
with over 36% of ID patients in Canada incurring health-care related costs of $2610 or
more per year which includes physician services, medications, continuing care, and
hospitalizations (Lunsky, De Oliveira, Wilton, & Wodchis, 2019).
ID disorders can further be classified as syndromic if accompanied by other symptoms
(e.g. Down Syndrome, Fragile-X Syndrome), or non-syndromic if other symptoms are
absent. ID can be caused by environmental, genetic, or a combination of environmental
and genetic factors. Environmental factors include exposure to drugs in utero (e.g. Fetal
alcohol spectrum disorder) or postnatal exposure to lead (Lidsky & Schneider, 2003; West,
Chen, & Pantazis, 1994). There are a number of single-gene disorders that result in ID,
such as Fragile-X or Cornelia de Lange syndrome (Krantz et al., 2004; McConkie-Rosell
et al., 1993), but genetic factors leading to ID can also include chromosomal abnormalities,
such as trisomy 21 leading to Down syndrome or the presence of an extra X chromosome
(XXY) resulting in Klinefelter’s (Antonarakis, Lyle, Dermitzakis, Reymond, & Deutsch,
2004; Lanfranco, Kamischke, Zitzmann, & Nieschlag, 2004). In 2011, approximately 500
genes had been identified that contribute to intellectual disability, but by 2016 that number
had grown to over 700 due to the advent of next-generation sequencing techniques,
indicating a high prevalence of genetic contribution to intellectual disability (reviewed in
van Bokhoven (2011), Vissers, Gilissen, and Veltman (2016)).
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1.2 Genes and pathways linked to ID
The proteins coded by ID genes are thought to be linked by different pathways, with either
shared functions, binding partners, or other complex interactions. Indeed, multiple
pathways linked to cognition have started to emerge. One such pathway is the RAS-MAPK
cell signaling pathway, where extracellular stimuli activate receptor tyrosine kinases,
triggering downstream targets including Ras-guanine exchange factors that convert RasGDP to Ras-GTP to signal to the Mitogen-activated protein kinase (MAPK),
Phosphoinositide 3-kinase (PI3K), and c-Jun N-terminal kinase (JNK) pathways (reviewed
in Borrie, Brems, Legius, and Bagni (2017)). Mutations in many Ras-MAPK pathway
genes result in ID disorders with overlapping symptoms, termed Rasopothies. These
diseases include Neurofibromatosis Type 1, caused by mutations in a Ras-GAP, which
normally acts to negatively regulate Ras (Wallace et al., 1990) as well as Legius syndrome
by mutations in SPRED1, a negative regulator of Ras-activated BRAF and CRAF (Brems
et al., 2007). Patients of Neurofibromatosis Type 1 have motor abnormalities, cognitive
and executive function impairments, and an increased risk for autism-spectrum disorder
(ASD) (Debrabant et al., 2014; Lehtonen, Howie, Trump, & Huson, 2013; Morris et al.,
2016). Legius syndrome is typically milder compared to Neurofibromatosis, but still causes
learning impairments, attention problems, and ADHD (Brems et al., 2012).
Another pathway often implicated in ID is the Rho-GTPase pathway. Rho-GTPases are
signaling proteins necessary for cytoskeleton remodeling, a process critical for axonal
outgrowth, dendritic branching, and synapse formation and maturation (Elston & Fujita,
2014; Kalil & Dent, 2014; McAllister, 2007). Rho-GTPases switch between their active
form (bound to GTP) and inactive form (bound to GDP) by other regulatory proteins. RhoGEFs catalyze the reaction between GDP to GTP, activating Rho-GTPases, whereas RhoGAPs stimulate the hydrolysis of GTP to GDP, thus inactivating Rho-GTPases (Cook,
Rossman, & Der, 2014; Moon, Zang, & Zheng, 2003). Many mutations within this pathway
have been identified in ID disorders. For example, mutations in OPHN1, which codes for
a Rho-GAP protein, are linked to mild X-linked ID, cerebellar hypoplasia, and lateral
ventricle enlargement in humans and in animal models (Philip et al., 2003) (Billuart et al.,
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1998; Khelfaoui et al., 2007). Furthermore, deletion of Ophn1 in mice results in spine
immaturity and impaired short-term plasticity (Khelfaoui et al., 2007). Mutations in RAC1,
which codes for a small GTPase, have also been implicated in varying degrees of
developmental delay and brain malformations (Reijnders et al., 2017). In animal models,
Rac1 has been shown to be necessary for spine development and long-term synaptic
plasticity (Bongmba, Martinez, Elhardt, Butler, & Tejada-Simon, 2011), reinforcing the
notion that Rho-GTPases and their regulators are critical for proper cognitive function.
Mutations in epigenetic proteins have also been linked to ID, including writers, erasers,
and readers of the histone code, DNA methyltransferases, and chromatin remodeling
proteins. A 2016 study reported that of 650 genes related to ID, 68 were linked to the
“chromatin” Gene Ontology category, a >2-fold enrichment against genome-wide
background (Kochinke et al., 2016). This suggests that proper regulation of chromatin is
vital to cognitive processes.

1.3 Chromatin dysregulation in ID
Chromatin is made up of DNA wrapped tightly around protein octamers called histones,
allowing for compaction of genetic material within the cell. Epigenetic changes to either
the DNA or histones can affect basic cellular processes such as replication, transcription,
and repair. The most common type of epigenetic change to DNA is methylation, which is
generally associated with transcriptional silencing at CpG islands (Kass, Pruss, & Wolffe,
1997) and is controlled by DNA methyltransferases and demethylation enzymes. However,
this modification has also been shown at non-CpG islands to control expression of tissueand cell-type specific genes (Lister et al., 2013). Histone modifications are more diverse,
and include acetylation, methylation, ubiquitination, phosphorylation, and many others.
These modifications can act to facilitate or repress transcription, depending on the type and
combination. For instance, acetylation almost always results in activation of transcription,
as it results in a net negative charge on the histone, repelling the negatively charged DNA
and opening the chromatin to allow binding of transcriptional machinery (Lee, Hayes,
Pruss, & Wolffe, 1993). Methylation of the histone tails can either be repressive or
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activating, depending on the residue modified and the extent of methylation (mono-, di-,
or tri-). Trimethylation of lysine 4 on histone 3 (H3K4me3) results in activation of
transcription, whereas trimethylation of lysine 27 on histone 3 (H3K27me3) is an indicator
of repressive chromatin, deposited by Enhancer of zeste homolog 2 (EZH2) and usually
found in heterochromatic regions (Barski et al., 2007; Plath et al., 2003). Histones can also
be replaced with variants of different properties – for instance, histone 3 has seven variants
(H3.1, H3.2, H3.3, H3.4, H3.5, H3.X, and H3.Y). For all these DNA and histone epigenetic
modifications, there are proteins that act as writers, erasers, and readers, many of which
are vital for normal cognitive function.
Epigenetic “writers” are proteins that add DNA methylation or histone marks, including
methylation, acetylation, phosphorylation, and ubiquitination. DNA methylation is carried
out by DNA methytransferases (DNMTs), of which there are 3: DNMT1, DNMT3A, and
DNMT3B. DNMT1 and DNMT3B are both highly expressed in the central nervous system
(Feng, Chang, Li, & Fan, 2005), and DNMT3B mutations lead to Immunodeficiency,
Centromere instability and Facial anomalies (ICF) syndrome, symptoms of which can
include ID (Weemaes et al., 2013; Xu et al., 1999). Mutations in histone methyltransferases
(HMTs) and histone acetyltransferases (HATs) can also lead to ID. Rubinstein-Taybi
syndrome arises from mutations in HATs CBP or EP300, and is characterized by moderate
to severe ID and craniofacial and skeletal abnormalities (Roelfsema et al., 2005). Mutations
in NSD1 and EZH2, both HMTs, lead to Sotos syndrome and Weaver syndrome
respectively (Gibson et al., 2012; Kurotaki et al., 2002). These syndromes have a lot of
symptomatic overlap, including intellectual disability and skeletal overgrowth.
Interestingly, mouse models for syndromes arising from these “writer” proteins all result
in impairments in spatial learning and memory, particularly in the Morris water maze and
contextual fear tasks (Feng et al., 2010; Wood et al., 2005; Zhang et al., 2014).
Furthermore, mouse models of ICF syndrome and Rubinstein-Taybi have impaired longterm potentiation in the hippocampus (Feng et al., 2010; Wood et al., 2005), indicating
overlap between clinical features and molecular mechanisms of the syndromes.
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“Erasers” remove the marks that the “writers” deposit, through DNA demethylation, or
removal of histone modifications through processes including deacetylation and
demethylation. The major class of DNA demethylases are the ten-eleven translocation
methylcytosine dioxygenase (TET) family, and while no members have been identified in
human intellectual disability disorders, mouse models have implicated TET1 in learning
and memory. Tet1 expression is induced through neuronal activation and activates
memory-related genes (Kaas et al., 2013), and deletion of Tet1 resulted in impaired
memory extinction and enhanced long-term depression in the hippocampus (Rudenko et
al., 2013). Histone deacetylases (HDACs) can also be mutated in ID. A variant of the
histone deacetylase gene HDAC8 has been identified in a family presenting with
intellectual disability, hypogonadism, short stature, and craniofacial abnormalities
(Harakalova et al., 2012). Additionally, HDACs are often differentially regulated in other
cognitive disorders, such as autism spectrum disorders and Huntington’s (Bardai et al.,
2013; Pinto et al., 2014). Finally, mutations in histone demethylases are tightly linked to
ID disorders. KDM6A mutations lead to Kabuki syndrome, KDM1A mutations result in
KBG syndrome, and Claes-Jensen syndrome arises from mutations in KDM5C. Patients of
these three syndromes all display intellectual disability and have craniofacial
abnormalities, again demonstrating overlap between many of these disorders.
Proteins that act as readers of the histone code function by recognizing specific histone
modifications and either interacting with other proteins to form transcriptionally activating
or repressing complexes, or by modulating the chromatin by changing its structure by
nucleosome remodeling (removing or replacing histone variants or displacing histones on
chromatin). Methyl-CpG-binding protein 2 (MECP2) recognizes and binds methylated
DNA, where it interacts with other proteins to either activate or repress expression of genes,
as well as alter global chromatin organization (Agarwal et al., 2011; Chahrour et al., 2008).
Mutations in MECP2 result in Rett syndrome, an autism spectrum disorder of
developmental regression accompanied by microcephaly, hypotonia, and craniofacial and
skeletal abnormalities (Amir et al., 1999; Neul et al., 2010; Percy et al., 2010), and
duplication of the MECP2 gene in males causes severe ID (Van Esch et al., 2005),
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indicating the importance of gene dosage to proper cognitive function. Nucleosome
remodeling proteins have intrinsic ATPase activity in order to remove or replace histone
variants. There are multiple subfamilies of chromatin remodeling proteins, including the
switching defective / sucrose non-fermenter (SWI/SNF) family (known as the BRG1- or
HBRM-associated factors (BAF) complex family in humans). Several members of this
family have been implicated in ID, including ARID1A, ARID1B, SMARCB1, SMARCA4 in
Coffin-Siris syndrome, SMARCA2 in Nicolaides-Baraitser syndrome, and ARID2 in nonsyndromic ID (Miyake, Tsurusaki, & Matsumoto, 2014; Santen et al., 2012; Shang et al.,
2015). Another member of the SWI/SNF family is the alpha-thalassemia X-linked
intellectual disability protein (ATRX), which has been linked to the eponymous ATR-X
ID syndrome, non-syndromic ID.
A subset of DNA-binding proteins can alter the higher-order architecture of chromatin and
loss-of-function of these proteins can lead to ID. Regulators of chromatin higher order
chromatin architecture, such as CCCTC-binding factor (CTCF) and cohesin-complex
genes, are involved in chromatin looping to bring distal transcriptional start sites and
enhancers or repressors into proximity to control gene expression (Zuin et al., 2014).
Exome

sequencing

of

individuals

with

non-syndromic

intellectual

disability,

microcephaly, and growth retardation revealed de novo mutations in CTCF (Bastaki et al.,
2017; Gregor et al., 2013). Mice lacking CTCF in forebrain excitatory neurons exhibit
impaired learning in the Morris water maze and decreased hippocampal long-term
potentiation (Sams et al., 2016). Cornelia de Lange syndrome, characterized by intellectual
disability and craniofacial abnormalities such as long eyebrows and short nose, arises from
mutations affecting the cohesin complex, mainly NIPBL, SMC1A, and SMC3 (Deardorff et
al., 2007; Krantz et al., 2004). Deletion of Smc3 in mouse neurons led to impaired dendritic
pruning, an increase in immature cortical synapses, and anxiety-like behaviours (Fujita et
al., 2017), demonstrating that maintenance of genomic architecture is critical for cognitive
function.
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1.4 The ATRX ID gene
An association between alpha-thalassemia and intellectual disability was first described in
1988 in three patients (Weatherall et al., 1981) with several more individuals reported eight
years later (Higgs et al., 1989). These patients had severe intellectual disability, facial
dysmorphism, genital abnormalities, and hemoglobin H inclusions stemming from reduced
expression of the of the α-globin gene. A study published in 1991 examined cytogenetics
of 13 patients with both alpha-thalassemia and intellectual disability and found that 8
patients had a deletion of the 16p13.3 band on chromosome 16, which corresponds to the
alpha-globin cluster (Wilkie et al., 1991). However, five of these individuals without this
deletion still displayed low levels of HBA1 and HBA2 mRNA, indicating that this
phenotype resulted from a missing regulatory factor. Due to the absence of male-to-male
inheritance of the non-deletion form of these ID cases, it was named alpha-thalassemia
mental retardation, X-linked syndrome – now, alpha-thalassemia X-linked intellectual
disability syndrome (OMIM #301040) (Wilkie et al., 1991).
ATR-X syndrome is characterized by moderate to profound intellectual disability in 95%
of cases, delay of developmental milestones, facial anomalies (including a flat nasal bridge,
upturned nose, and a tented upper lip), genital abnormalities in 80% of affected children, a
wide range of skeletal abnormalities (including clinodactyly, brachydactyly and kyphosis),
and seizures in a subset of patients (35%) (Gibbons & Higgs, 2000). Magnetic resonance
imaging (MRI) / Computed tomography (CT) scanning revealed gross morphological
abnormalities in ATR-X syndrome patients, including brain atrophy, white matter
abnormalities, and delayed myelination (Wada et al., 2013). Carrier females are generally
unaffected due to extremely skewed inactivation of the affected X chromosome (greater
than 90:10) (Gibbons, Suthers, Wilkie, Buckle, & Higgs, 1992), however in rare cases there
is non-skewed X-inactivation and presence of moderate intellectual disability (Wada,
Sugie, Fukushima, & Saitoh, 2005). The exact cause of the skewed X-inactivation is
unclear; however, there is evidence that ATRX is involved in X-chromosome inactivation
(XCI). In mice with early embryonic Atrx deletion, skewed XCI appears after the earliest
stages of embryogenesis, and ATRX only localizes to the inactive X-chromosome after
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XCI has occurred (Baumann & De La Fuente, 2009; Muers et al., 2007), hinting that
perhaps ATRX is not required for the initiation of XCI, but may be involved in its
maintenance.
There are several other syndromes that arise from mutations in the ATRX gene, including
Chudley-Lowry, Juberg-Marsidi, Carpenter-Waziri, Holmes-Gang, and Smith-FinemanMyers syndromes, which now fall under the term “X-linked mental retardation-hypotonic
facies syndrome” (OMIM#309580) (Abidi et al., 2005; Villard & Fontes, 2002); these
syndromes lack the haematological symptoms of ATR-X syndrome. Additionally, ATRX
has been implicated in non-syndromic ID, where patients display ID without any additional
symptoms (Renieri et al., 2005). Next-generation sequencing of 986 patients with nonsyndromic ID identified variants in ATRX as one of the most common causes, alongside
its interacting partner methyl-CpG binding protein 2 (MeCP2) (Morgan et al., 2015). This
reinforces the idea that ATRX is extremely important for normal cognitive function.

1.4.1

Structural analysis of ATRX

Linkage analysis originally mapped the mutations in ATR-X syndrome to Xq12-q21.31
(Gibbons et al., 1992). Gibbons, Picketts, Villard, and Higgs (1995) further resolved the
location to Xq13.3 and discovered a variety of mutations underlying ATR-X syndrome in
the XH2 gene in patients, later renamed ATRX. Characterization of the full-length cDNA
indicated that ATRX consists of 36 exons spanning 306 kb with two splice variants of 270
kDa and 265 kDa and shows sequence homology to the SWItching defective/Sucrose
NonFermenter (SWI/SNF) subgroup of DNA-dependent ATPases (Picketts et al., 1996).
These complexes regulate gene expression through nucleosome remodeling capabilities
(N. Liu, Balliano, & Hayes, 2011; L. Tang, Nogales, & Ciferri, 2010). Similarly, it was
reported that ATRX was able to disrupt DNA-histone interactions in an ATP-dependent
manner and translocate along double stranded DNA (Y. Xue et al., 2003). ATRX also
exhibits an ability to assemble and mobilize nucleosomes (Lewis, Elsaesser, Noh, Stadler,
& Allis, 2010), further reinforcing the role of ATRX as a chromatin remodeling protein
through its SWI/SNF domain.
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Another important domain within the ATRX protein is the ADD domain, named after its
sequence homology with DNMT3A/B and DNMT3L (Aapola et al., 2000). This domain
confers ATRX with its ability to localize to chromatin. The ADD domain was shown to
mediate binding to naked dsDNA (Cardoso et al., 2000) and heterochromatin by
recognition of the specific histone marks H3K9Me3/H3K4Me0 (Dhayalan et al., 2011;
Eustermann et al., 2011; Iwase et al., 2011). The majority of ATRX patient mutations occur
within the ADD (50%) and SWI/SNF (30%) domains (Gibbons et al., 2008), indicating the
importance of these conserved domains.

1.4.2

ATRX has multiple binding partners

Interactors of ATRX include heterochromatin protein 1 α (HP1 α), methyl CpG binding
protein 2 (MeCP2), cohesin complex (specifically SMC1 and SMC3), death-domain
associated protein (DAXX) with the histone variant H3.3. HP1α is found in areas of dense
heterochromatin, such as the centromeres and telomeres, but can also be found at
euchromatin regions where its binding is associated with gene repression (Eissenberg &
Elgin, 2000). ATRX can directly bind HP1α through its PxVxL binding motif , which aids
its tethering to pericentromeric heterochromatin (PCH) and aids in repression of these
regions (Eustermann et al., 2011; Kourmouli, Sun, van der Sar, Singh, & Brown, 2005;
Lechner, Schultz, Negorev, Maul, & Rauscher, 2005).
ATRX was shown to bind MeCP2 at heterochromatin through its C-terminal domain, and
a subset of mutations that occur in Rett syndrome (caused by MeCP2 mutations) disrupt
the ATRX-MeCP2 interaction (Nan et al., 2007). ATRX and MeCP2 bind imprinting
control regions (ICR) alongside CTCF and cohesin (Kernohan et al., 2010). MeCP2 is
required for ATRX localization at ICRs, where ATRX regulates positioning of
nucleosomes to facilitate CTCF chromatin binding (Kernohan, Vernimmen, Gloor, &
Berube, 2014).
Finally, ATRX also complexes with DAXX, a protein with roles in both suppression and
activation of apoptosis (Salomoni & Khelifi, 2006). This interaction with DAXX serves
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two major purposes: to localize ATRX to promyelocytic nuclear bodies (PML-NBs) (Y.
Xue et al., 2003), and to act as a histone chaperone complex to deposit the histone variant
H3.3 at pericentromeric heterochromatin, telomeres, and a subset of G-rich genes in the
brain (Levy, Kernohan, Jiang, & Berube, 2015; Lewis et al., 2010). The finding that ATRX
and DAXX deposit H3.3 at repressive heterochromatic regions was unexpected, given that
H3.3 is generally a marker of active chromatin (Ahmad & Henikoff, 2002). While ATRX
can bind H3.3 in its tail domain, this interaction is not required for histone deposition
(Wong et al., 2010). Instead, DAXX binds H3.3 in its globular domain while ATRX
recognizes heterochromatic histone signatures and localizes the ATRX-DAXX-H3.3
complex on chromatin (Lewis et al., 2010).

1.4.3

The role of ATRX in cell division

The initial study that investigated the cellular localization of ATRX found that it was
associated with pericentromeric heterochromatin during both interphase and mitosis
(McDowell et al., 1999). Bérubé, Smeenk, and Picketts (2000) demonstrated that ATRX is
phosphorylated in a cell-cycle dependent manner: during interphase, ATRX is mainly
associated with the nuclear matrix, however at the onset of mitosis it is phosphorylated and
associates with condensed chromatin, suggesting different roles for ATRX in interphase
and mitosis. Indeed, ATRX plays a vital role in mitosis, specifically in the proper
congregation and segregation of sister chromatids (Ritchie et al., 2008). ATRX-depleted
HeLa cells exhibited a prolonged prometaphase-to-metaphase transition and defective
sister chromatid cohesion and congression; these mitotic defects were also shown in vivo
in neuroprogenitors of the embryonic mouse forebrain (Ritchie et al., 2008). Similar results
were observed when ATRX was deleted in mouse oocytes, leading to abnormal
chromosome morphology and segregation defects during meiosis II (Baumann, Viveiros,
& De La Fuente, 2010).

1.4.4

ATRX and DNA replication

The role for ATRX in DNA replication is thought to involve notoriously difficult to
replicate regions of chromatin, particularly tandem repeats such as those found at telomeres

11

or pericentromeric heterochromatin. These repetitive regions can form structured DNA
configurations such as G-quadruplexes, which can act as barriers to processes including
replication (Rizzo et al., 2009). ATRX binds to G-quadruplexes in vitro (Law et al., 2010),
and is required to prevent these structures through the deposition of H3.3 (Clynes &
Gibbons, 2013; Clynes et al., 2015). Indeed, loss of ATRX in mouse embryonic stem cells
(ESCs) or embryonic mouse brain results in an increased DNA damage response and
telomere dysfunction which is exacerbated by G-quadruplex stabilization (Clynes et al.,
2014; Watson et al., 2013; Wong et al., 2010). Leung et al. (2013) demonstrated that ATRX
binds to sites of DNA damage, and that loss of ATRX results in defective replication
checkpoints and replication restart. More recently it was discovered that ATRX is required
at heterochromatic regions for protection of the stalled replication fork, where it prevents
MRE11-dependent degradation of stalled forks due to lack of RAD51 protection (Huh et
al., 2016).

1.4.5

Gene regulation by ATRX

Homology to the SWI/SNF family of proteins was the first indicator that ATRX might be
involved in gene regulation (Gibbons et al., 1995). The presence of the ADD domain
provided additional evidence: not only does ATRX contain a PHD zinc finger which
recognizes histone H3 tails (Gibbons et al., 1997; Sanchez & Zhou, 2011), it also has
sequence similarity to DNMT3A/B and DNMT3L, methyltransferases which repress
transcription through DNA methylation (Bachman, Rountree, & Baylin, 2001). While there
is evidence of altered DNA methylation patterns in ATRX patient blood samples (Gibbons
& Higgs, 2000; Schenkel et al., 2017), the direct link between methylation and ATRX has
not yet been identified.
In addition to structural data, there is also evidence of transcriptional control by ATRX
through its binding partners. In Drosophila, the ATRX homologue is made up of two
distinct proteins: dXNP which is similar to the SWI/SNF domain of ATRX, and dADD,
which shares homology with the ADD domain. dXNP is required for HP1α deposition at
PCH, and functions to silence these regions (Bassett, Cooper, Ragab, & Travers, 2008;
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Emelyanov, Konev, Vershilova, & Fyodorov, 2010). However, it appears that dXNP
dosage is vital for this repression, as overexpression of dXNP also causes de-repression at
PCH (Schneiderman, Sakai, Goldstein, & Ahmad, 2009). dATRX and dADD also localize
HP1α at telomeres and loss of either of the ATRX homologues results in increased
expression of transposons found in Drosophila telomeres (Chavez et al., 2017). The
complex formed by ATRX, cohesin, CTCF, and MeCP2 is found at imprinting control
regions (ICR), specifically binding the unmethylated allele to facilitate intra-chromatin
looping and post-natal repression of these genes essential for development (Kernohan et
al., 2010; Kernohan et al., 2014). This three-dimensional structure can either mediate
enhancer-promoter interactions, or isolate a promoter from an enhancer, resulting in
activation or repression of gene expression, respectively (Zuin et al., 2014).
The contribution to gene expression by the ATRX/DAXX/H3.3 complex appears to be
different. ATRX can repress genes by interacting with other transcription factors at
promoter sites, and DAXX can impede this by sequestering ATRX into PML-NBs (J. Tang
et al., 2004; Valadez-Graham et al., 2012). Additionally, there is evidence that the ATRXDAXX complex represses viral gene expression in models of Herpes-Simplex virus,
Epstein-Barr virus, and Adenovirus 5 infection (Lukashchuk & Everett, 2010; Schreiner et
al., 2013; Tsai, Thikmyanova, Wojcechowskyj, Delecluse, & Lieberman, 2011). Goldberg
et al. (2010) demonstrated that ATRX deposits H3.3 at telomeres, and is required for the
suppression of telomeric RNA, which was counterintuitive as H3.3 is normally associated
with active chromatin. Shortly after, it was demonstrated that ATRX occupies G-rich
tandem repeats across the genome (Law et al., 2010). This binding was required for H3.3
deposition to resolve G-quadruplexes and facilitate transcription by RNA polymerase II
(Levy et al., 2015). ATRX was also demonstrated to deposit H3.3 within the plant genome
to affect gene expression (Duc et al., 2017). Similar to its interaction with MeCP2 in postnatal repression of imprinted alleles, ATRX is also required at the constitutively silenced
imprinted allele to deposit H3.3 to maintain repression (Voon et al., 2015).
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In the testes, ATRX binds the androgen receptor at promoters to facilitate expression of
androgen-responsive genes (Bagheri-Fam et al., 2011). Finally, ATRX can also recruit
DNMTs in the mouse brain, resulting in increased DNA methylation and repression of
genes (Shioda et al., 2018). Altogether, evidence supports that ATRX can act as either an
activator or repressor of gene expression through multiple mechanisms.

1.4.6

The role of ATRX in development

We know that mutations in ATRX result in severe developmental abnormalities such as
intellectual disability, craniofacial abnormalities (e.g. microcephaly, wideset eyes),
hypotonia, seizures, and underdeveloped testes (Weatherall et al., 1981), indicating that
ATRX plays a critical role during development. In situ hybridization of the Atrx gene on
mouse embryo sections showed diffuse expression early in development, however
expression becomes more specific - particularly in the olfactory bulb, hippocampus, cortex,
and cerebellum - in late-development and postnatal stages (Gecz et al., 1994; Stayton et
al., 1994), suggesting a role for ATRX in brain development. Transgenic mice that
overexpress ATRX displayed growth retardation, neural tube defects, and increased
prevalence of embryonic lethality, with disorganization of the ventricular zone (Berube et
al., 2002). The mice that survived until birth exhibited perinatal lethality, seizures,
craniofacial abnormalities, and abnormal behaviour. Conditional inactivation of Atrx at the
8-16 cell stage of embryogenesis resulted in defective extraembryonic trophoblast
development at approximately embryonic day 9.5 (E9.5) and termination of the embryo
(Garrick et al., 2006), which may explain why there are no ‘null’ mutations that result in
ATR-X syndrome. This finding also prompted the necessity for conditional knockouts of
ATRX to study its effect in various tissues.
Many studies investigating ATRX in development have focused on the brain, due to the
prevalence of severe-to-profound intellectual disability in ATR-X syndrome patients. In
the first study that characterized loss of ATRX in the embryonic mouse forebrain, it was
discovered that the cortex was significantly smaller due to increased apoptosis of new
neurons, even though proliferation remained normal (Berube et al., 2005). Investigation of
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neuroprogenitors in the ventricular zone displayed increased incidence of chromosomal
abnormalities including micronuclei and misaligned chromosomes (Ritchie et al., 2008),
and increased p53-dependent apoptosis (Seah et al., 2008). Deletion of ATRX in the
forebrain and anterior pituitary caused reduced growth, shortened lifespan, kyphosis of the
spine, loss of trabecular bone content and subcutaneous fat, and decreased circulating
thyroxine and insulin-like growth factor 1 (Watson et al., 2013), highlighting the
importance of ATRX in mouse development.
Conditional deletion of ATRX in testes leads to proliferative defects, delayed
spermatogenesis, and seminiferous tubule defects (Bagheri-Fam et al., 2011). In muscle,
deletion of ATRX delays S phase, resulting in accumulation of p53 and loss of genomic
integrity (Huh et al., 2012). However, the muscles are able to “catch up” in growth by
prolonging myoblast proliferation (Huh, Young, Yan, Price-O'Dea, & Picketts, 2017).
Deletion in the retina results in defective interneuron differentiation and impaired visual
function (Medina et al., 2009). Interestingly, even though ATR-X syndrome patients
typically have short stature and craniofacial abnormalities, deletion of ATRX in
chondrocytes had no effect on growth rate, body size, or bone length (Solomon, Li, Berube,
& Beier, 2009).

1.4.7

ATRX and cancer

Recently it was discovered that somatic mutations in ATRX are linked to cancer, which
has caused the field of ATRX research to explode in popularity. Approximately 90% of
cancer types utilize telomerase reactivation to lengthen telomere ends and evade
programmed cell death, however the remaining cancer types rely on alternative lengthening
of telomeres (ALT), or homologous recombination between telomeres to extend these
sequences. Mutations in ATRX were originally described in pancreatic neuroendocrine
tumors (PanNETs) which utilize ALT in order to achieve replicative immortality (Heaphy
et al., 2011), and

have since been identified in paediatric glioblastomas,

oligodendrogliomas, and medulloblastomas among others (Jiao et al., 2012; Kannan et al.,
2012; X. Y. Liu et al., 2012; Schwartzentruber et al., 2012). The molecular mechanisms
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behind ALT are largely unknown, however, it has been linked to high levels of genomic
instability, likely resulting in homologous recombination and lengthening of the telomeres.
It has been hypothesized that ATRX is required at telomeres in order to resolve Gquadruplexes for proper replication, and loss of ATRX causes stalling of replication forks,
triggering homologous recombination (Clynes et al., 2015; O'Sullivan et al., 2014).
Although deletion of ATRX causes telomere dysfunction, it is not enough on its own to
drive ALT-like phenotypes (Lovejoy et al., 2012). Therefore, other factors must be
required to trigger the ALT pathway after ATRX loss, such as p53. Dual mutations of
Atrx/p53 in mice rescues apoptosis, but results in increased genomic instability (Seah et
al., 2008; Watson et al., 2013); additionally, mutations in ATRX are often concurrent with
mutations in TP53 in human tumours (X. Y. Liu et al., 2012; Schwartzentruber et al., 2012).
These studies reinforce the idea that ATRX is critical for genomic integrity and telomere
maintenance.

1.4.8

Neurological roles of ATRX

Due to the prevalence of ATRX mutations in ID, research has focused on the role of ATRX
in the nervous system. Many of these studies have concentrated on neurodevelopment,
investigating ATRX in neuroprogenitors, and how loss leads to DNA replication stress,
genomic instability, telomere dysfunction, and p53-dependent apoptosis (Ritchie et al.,
2008; Seah et al., 2008; Watson et al., 2013), however the postnatal role of ATRX in the
brain is largely unknown. Mice were generated that lacked exon 2 of the ATRX gene
(ATRXΔE2) (Nogami et al., 2011) to mimic a human variant of ATR-X syndrome called
Chudley-Lowry syndrome, characterized by mild ID (Abidi et al., 2005; Guerrini et al.,
2000). Deletion of exon 2 resulted in a reduction of ATRX protein levels by approximately
80% with no obvious morphological changes to the hippocampus or cortex, though the
overall brain size was decreased proportional to body weight (Nogami et al., 2011; Shioda
et al., 2011). Mutant mice displayed defective working memory, novel object recognition,
and impaired spatial memory in the Barnes maze and contextual fear task but not Morris
water maze when tested 24 hours post training (Nogami et al., 2011; Shioda et al., 2011).
These

behaviours

were

linked

to

decreased

α-amino-3-hydroxy-5-methyl-4-
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isoxazolepropionic acid (AMPA) receptor-mediated long-term potentiation (LTP), with
decreased phosphorylation of α-Ca2+/calmodulin-dependent protein kinase II (CaMKII)
and AMPA receptor subunit glutamate receptor 1 (GluR1) in the hippocampus (Nogami et
al.,

2011).

Conversely,

in

the medial

prefrontal

cortex

(mPFC),

increased

autophosphorylation of αCaMKII was associated with increased phosphorylation of
downstream Rac1-related proteins, resulting in abnormal dendritic spine morphology
(Shioda et al., 2011). These studies highlight that ATRX depletion could potentially result
in different outcomes in different areas of the brain. Moreover, it is not clear from these
studies whether depletion of ATRX protein in neurons or glial cells is responsible for the
observed defects.
Transcriptional profiling of the ATRXΔE2 hippocampus via microarray revealed increased
expression of the imprinted Xlr3b gene. The associated increased XLR3B protein levels
were shown to sequester Camk2a mRNA and thus inhibit its transport to dendritic spines
(Shioda et al., 2018). The Xlr3b gene sequence is extremely GC-rich, and the authors found
that

ATRX

recognizes

G-quadruplexes

upstream

of

the

gene

and

recruits

DNMT1/DNMT3a to repress gene expression. Treatment of the ATRXΔE2 mice with a Gquadruplex stabilizer resulted in repression of the Xlr3b gene and reversal of impairments
seen in the novel object recognition task, passive avoidance task, and Y maze. However,
ATRX can also recognize and prevent G-quadruplex structures through deposition of H3.3
at a subset of G-rich genes in the brain, including the autism-related gene Nlgn4, thereby
activating transcription (Levy et al., 2015). Therefore, ATRX may act as a repressor or
activator of neuronal genes depending on chromatin environment and its binding partners.

1.5 Types of memory
Humans with ID disorders often have varying levels of memory impairments, and in
different types of memory. Mus musculus, the common house mouse, is an excellent model
to study memory due to its largely conserved molecular mechanisms regulating cognition
compared to humans. Many behavioural paradigms have been developed to test different
types of memory in rodents and a description of the tests performed in this dissertation can
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be found in Table 1-1. There are three main types of memory: working memory, short-term
memory, and long-term memory. Working memory involves the storage and manipulation
of information over extremely short periods of time, for example “carrying” digits when
mentally adding numbers together (reviewed in Goldman-Rakic (1995), D'Esposito and
Postle (2015)). In mouse models, working memory is tested using the Y-maze spontaneous
alternation task and is dependent on the prefrontal cortex, hippocampus, and basal
forebrain (Aggleton, Hunt, & Rawlins, 1986; Curtis & D'Esposito, 2003; Givens & Olton,
1994).
Short-term memory is used for storage but not manipulation of information over a short
period of time, although there is controversy on whether this lasts hours, days, or weeks,
whereas long-term memory involves indefinite storage of knowledge (reviewed in Cowan
(2008)). However, there are multiple different subtypes of short- and long-term memory
that depend on different regions of the brain. For example, recognition memory is the
ability to recognize certain objects, people, or events that have been previously
encountered. This type of memory is dependent on the prefrontal cortex and medial
temporal lobe, which includes the hippocampus (Brown & Aggleton, 2001; Slotnick, Moo,
Segal, & Hart, 2003). In mice, recognition memory is tested using the novel object
recognition task, which requires a mouse to discern between an object it has been
previously exposed to and a novel object (Antunes & Biala, 2012). Spatial memory records
information about one’s spatial environment and is typically encoded through the
hippocampus (Bird & Burgess, 2008). In mice, this can be tested using paradigms such as
the Morris water maze, contextual fear conditioning task, and the paired-associate learning
task (Kim, Heath, Kent, Bussey, & Saksida, 2015; McEchron, Bouwmeester, Tseng,
Weiss, & Disterhoft, 1998; Vorhees & Williams, 2006).

1.6 The hippocampus in learning and memory
1.6.1

What do we know from lesion studies?

The ability to learn and remember spatial locations is an essential behaviour for survival.
To study differential contributions to spatial learning and memory by various brain
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Paradigm

Behaviour(s) tested

Open field test

General activity, anxiety

Elevated plus maze

Anxiety

Y maze

Working memory

Novel object recognition

Recognition memory

Morris water maze

Spatial learning and memory

Contextual fear conditioning

Spatial memory, fear memory

Paired-associate learning task

Spatial learning

Table 1-1 Paradigms used to test for cognitive impairment in mice
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structures, lesion studies have been used in both humans and rodents. The first human
lesion study, and possibly one of the most famous psychiatric studies, is patient H.M., who
suffered from tonic-clonic seizures early in life. To remedy this, he underwent a bilateral
medial temporal lobectomy, removing the hippocampus and surrounding structures. While
this was partially successful in controlling seizures, patient H.M. started to suffer from
severe anterograde amnesia, or inability to form new memories (Scoville & Milner, 1957).
However, since almost the entire medial temporal lobe was bilaterally removed, it was not
entirely conclusive as to what structure was responsible for the memory loss. Almost 30
years later, Zola-Morgan, Squire, and Amaral (1986) described the case of patient R.B.,
who had bilateral lesions of the CA1 region of the hippocampus that extended fully rostrocaudal. This patient displayed severe anterograde amnesia (inability to form new
memories), and no other cognitive signs, indicating that the amnesia stems directly from
the hippocampal lesions. Additionally, magnetic resonance imaging (MRI) revealed
shrunken and atrophic hippocampi in four patients with severe, non-syndromic memory
impairment (Squire, Amaral, & Press, 1990). Lesion studies in monkeys determined that
the perirhinal and parahippocampal cortices also result in amnesia-related impairments in
behaviour (Zola-Morgan, Squire, Amaral, & Suzuki, 1989).
Lesion studies in rodents have also linked the hippocampus to spatial learning and memory.
Loss of hippocampal function in rats leads to impairment in the Morris water maze
(Sutherland & McDonald, 1990), spatial alternation task (Aggleton et al., 1986), and radial
arm maze (Becker & Olton, 1980). Therefore, the hippocampus is vital for formation of
memories in humans and is linked to spatial learning and memory in animal models.

20

Figure 1-1 The anatomy of the hippocampus and the CA1 pyramidal neuron.
(A) The hippocampus consists of the Cornu Ammonis (CA) 1, 2, and 3 and dentate gyrus
(DG). The CA regions are formed by densely packed pyramidal neurons (green) and the
main signaling body of the DG is the granule cell (blue). Two main electrophysiological
pathways converge on the hippocampus, both originating from the entorhinal cortex. The
trisynaptic loop (brown) starts in the entorhinal cortex, where it travels through the DG to
the CA3, then to the proximal dendrites of the CA1 for further processing. The
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temporoammonic pathway (yellow) is a direct route from the entorhinal cortex to the distal
dendrites of the CA1. (B) A pyramidal neuron consists of a triangular cell body called the
soma. Dendrites protrude from the base (basal dendrites) or apex (apical dendrites). On
these dendrites are small spinous processes where the synapse occurs. The CA1 is divided
into four regions: stratum oriens, pryamidale, radiatum, and lacunosum/moleculare.
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1.6.2

The hippocampus

The hippocampus is in the medial temporal lobe of the human brain and is a common
structure in both humans and mice. It contains two major subregions: the hippocampus
proper (or Ammon’s horn, Cornu Ammonis) and the dentate gyrus (Figure 1-1A). The
abbreviation “CA” is used for subdividing the hippocampus proper in to CA1, CA2, CA3,
and CA4 (Amaral & Witter, 1989). The CA regions can be visualized in the brain as a
region of densely packed neurons forming a sideways “U” shape. One end of the “U” is
inserted into the dentate gyrus, is called the dentate hilus in rodents (Knowles, 1992). The
CA3 is the curve of the “U”, and the CA1 is the dorsal section of the hippocampus. The
CA2 region is very small and located between the CA1 and CA3. The CA1-CA3 regions
have distinct layers, or strata: oriens (containing the basal dendritic projections), pyramidal
(containing the densely packed cell bodies), radiatum (the layer containing proximal apical
dendrites), and lacunosum-moleculare (the layer containing distal apical dendrites)
(Amaral & Witter, 1989). The CA3 contains an additional layer, the stratum lucidum,
between the pyramidal and radiatum strata, and is composed mainly of mossy fiber axons
and interneurons. The dentate gyrus is one of three areas of the brain responsible for adult
neurogenesis (Kuhn, Dickinson-Anson, & Gage, 1996). It forms a “V”-like structure
around the CA3 and consists of three layers: the molecular layer (receiving axonal input
from other areas such as the entorhinal cortex), the granular layer (containing granule cells
which project to the CA3 neurons), and polymorphic layer (containing mossy cells which
project to the molecular layer) (Amaral, Scharfman, & Lavenex, 2007).
Pyramidal neurons are perhaps the most well-characterized cell type of the hippocampus.
They are the principle excitatory neurons, receiving input from other regions, such as the
CA3 pyramidal neurons from the dentate gyrus, or the CA1 neurons from the CA3. As
their name suggests, the soma of pyramidal neurons is triangular with one long apical
dendrite emerging from the apex, and many smaller basal dendrites emerging from the base
(Figure 1-1B) (DeFelipe & Farinas, 1992). Along these dendrites are the dendritic spines,
which are the main location at which synapses occur (reviewed in Nimchinsky, Sabatini,
and Svoboda (2002)). A subset of pyramidal neurons are known as place cells that only
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fire when an animal enters a specific location (O'Keefe & Dostrovsky, 1971), and the
presence of place cells further reinforces the importance of the hippocampus in spatial
cognition.
Interneurons are also found within the hippocampus and are largely inhibitory, working to
regulate pyramidal cell activity. Non-neuronal cells also reside in the hippocampus and
include astrocytes which aid in clearing neurotransmitters from the synaptic cleft and cross
the blood-brain-barrier to provide nutrients for neurons and remove waste.
Oligodendrocytes are the other major non-neuronal cell in the hippocampus and are
responsible for myelination of pyramidal cell axons. Microglia are also present and act as
the primary immune defense in the central nervous system.

1.6.3

The electrophysiological pathways of the hippocampus

There are two major pathways that have been implicated in the formation of spatial
memories in mice: the trisynaptic loop and the temporoammonic pathway (Figure 1-1A).
The trisynaptic loop is an indirect pathway in which information is passed from the
entorhinal cortex (EC) to the CA1 via the dentate gyrus and CA3, known as the perforant
pathway. The entorhinal cortex consists of 6 layers, of which layer II projects to the dentate
gyrus granule cells (Ruth, Collier, & Routtenberg, 1982; van Groen, Miettinen, & Kadish,
2003), however there is some evidence that layers IV-VI may also project to the DG (van
Groen et al., 2003; Witter & Amaral, 1991). In humans, the EC layer II neurons are
preferentially affected by Alzheimer’s disease, indicating its importance in memory
formation (Hyman, Van Hoesen, Kromer, & Damasio, 1986; Morys, Sadowski,
Barcikowska, Maciejewska, & Narkiewicz, 1994). The entorhinal cortex can be further
subdivided into medial and lateral entorhinal cortex (MEC and LEC, respectively). The
LEC generally processes non-spatial information and projects to the outer 1/3 of the DG,
whereas the MEC processes spatial information and projects to the middle 1/3 of the
dentate gyrus (Hjorth-Simonsen, 1972; Mayeaux & Johnston, 2004; Naber, CaballeroBleda, Jorritsma-Byham, & Witter, 1997; Sargolini et al., 2006).
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The DG, after receiving input from the EC, projects this information to the suprapyramidal
stratum lucidum of the CA3 region through the unmyelinated mossy fibres of the granule
cells (Gaarskjaer, 1978). Unlike the perforant pathway, all granule cells from the DG
generate mossy fibres that extend through the whole CA3 (i.e. no specific area of the DG
projects to a specific area of the CA3). The Schaffer collateral pathway connects the CA3
to the CA1 and is the most often-studied in relation to learning and memory. The distal
CA3 connects the proximal CA1 while the proximal CA3 connects the distal CA1
(Ishizuka, Weber, & Amaral, 1990; Laurberg, 1979), however, all synapses occur within
the stratum radiatum and stratum oriens layers (Raisman, Cowan, & Powell, 1966). These
synapses are largely glutamatergic and dependent on N-methyl-D-aspartic acid (NMDA)
receptor activation indicating the presence of excitatory synapses (Collingridge, Kehl, &
McLennan, 1983). Activation of the Schaffer-collateral pathway induces LTP, a longlasting increase in synapse strength (Larson, Wong, & Lynch, 1986), and loss of LTP along
this pathway results in impaired spatial learning and memory in mice (Brucato et al., 1996;
C. M. Chen et al., 2017; Grant et al., 1992; Wang et al., 2017). Therefore, the Schaffercollateral pathway is very important for proper formation of spatial memories.
The temporoammonic pathway is a direct input to the CA1 stratum lacunosum moleculare
from the entorhinal cortex layer 3 neurons (Steward, 1976). Similar to the Schaffercollaterals, this pathway exhibits NMDA receptor-dependent LTP (Aksoy-Aksel &
Manahan-Vaughan, 2015; Remondes & Schuman, 2003) and is heavily implicated in longterm spatial learning and memory (Brun et al., 2008; Vago & Kesner, 2008). The reason
for this overlap between the trisynaptic loop and temporoammonic pathway is not fully
understood. Brun et al. (2002) cut off input to the CA1 from the CA3 and noted normal
spatial recognition memory but impaired recall or navigation, indicating two functionally
separate circuits.

1.7 Synaptic Plasticity
Synaptic plasticity is based on the idea that synaptic transmission will get stronger
following repetitive stimulation and weaker following decreased activity, and is one of the
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most important correlates of learning and memory (Hughes, 1958). The synaptic changes
can be defined as short-term or long-term depending on how long they persist. Short-term
synaptic plasticity lasts between a few milliseconds to several minutes, and is most often
characterized using paired-pulse facilitation where identical stimuli are delivered within a
short interval (Katz & Miledi, 1968). This results in either enhancement or depression of
the second stimulus response depending on numerous factors including number of docked
vesicles (Dobrunz & Stevens, 1997).
Long-term synaptic plasticity was first proposed in 1949 by a model known as Hebbian
plasticity: that synaptic efficiency increases when a post-synaptic neuron is persistently
stimulated by a pre-synaptic terminal (Hebb, 1949). Long-term synaptic plasticity can
further be classified as either long-term potentiation (LTP) or long-term depression (LTD).
Bliss and Gardner-Medwin (1973) demonstrated that repeated activation of a neuron
resulted in a potentiation of synaptic strength that lasted for hours or even days, and they
named this phenomenon LTP. There are three main properties of LTP: cooperativity,
associativity, and input specificity (Nicoll, Kauer, & Malenka, 1988). Cooperativity is
described as the critical number of activated synapses required to induce LTP.
Associativity dictates that if weak stimulation does not induce LTP at a dendritic spine,
then concurrent strong stimulation of a neighbouring spine on the same post-synaptic
neuron will result in LTP. Finally, input specificity is the finding that LTP is only elicited
at the active synapse, and not other synapses. After activation of LTP, the signal needs to
be maintained. This is achieved through new protein synthesis at dendritic spines
(Reymann & Frey, 2007; Sutton & Schuman, 2006) and transcription in the nucleus (Zhou
et al., 2006).
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Figure 1-2 The structure of an excitatory synapse.
(A) The presynaptic structure. Vesicles are localized in either the reserve pool or readily
releasable pool (RRP). Calcium influx occurs through voltage-dependent calcium
channels, triggering exocytosis of glutamate. Neurexins and cadherins can be found as cell
adhesion molecules. (B) The postsynaptic structure. Glutamate activates the NMDA
receptor which causes autophosphorylation of CaMKII, which triggers mobility of AMPA
receptors to the postsynaptic density in addition to a signaling cascade ultimately ending
in activation of gene expression.
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Long-term depression is less well-studied in comparison to LTP but results in a weakening
of the synapse. The establishment of LTD demonstrated that synaptic signaling can control
synaptic strength in a bidirectional manner (Dudek & Bear, 1992; Mulkey & Malenka,
1992). Unlike LTP, which requires a calcium influx beyond a certain threshold (Malenka
& Nicoll, 1993), LTD requires low-frequency stimulation that results in a small increase
of intracellular calcium (Cummings, Mulkey, Nicoll, & Malenka, 1996), which results in
increased activation of protein phosphatases, exocytosis of neurotransmitter receptors, and
shrinkage of dendritic spines (Heynen, Quinlan, Bae, & Bear, 2000; Morishita et al., 2001;
Nagerl, Eberhorn, Cambridge, & Bonhoeffer, 2004).

1.7.1

The synapse

There are two main types of synapses: asymmetric, where the post-synaptic density (PSD)
is larger than the pre-synaptic density, and symmetric, where the PSD is roughly the same
thickness than the pre-synaptic density (Tao et al., 2018). Excitatory synapses are generally
asymmetric, and are axo-dendritic with round vesicles, whereas inhibitory are usually
symmetric, axo-somatic, and have flat vesicles (Colonnier, 1968; Gray, 1969). Most
excitatory synapses occur on dendritic spines within the stratum radiatum and stratum
oriens of the CA1 hippocampus, while inhibitory synapses are generally found on the
dendritic shaft or cell body in this region (Megias, Emri, Freund, & Gulyas, 2001). Within
the stratum lacunosum, however, asymmetric synapses can also be found on shafts, and
symmetric synapses can be found on spines (Megias et al., 2001). However, while there
are differences in the appearance and location of asymmetric and symmetric synapses, the
structure of their pre-synapse and post-synapse is largely the same (Figure 1-2) (Gray,
1969).

1.7.2

Pre-synaptic structure and function

The pre-synaptic neuron is responsible for neurotransmitter release from the axonal
terminal into the synaptic cleft at the active zone (AZ) (Figure 1-2A). The active zone is
aligned with the PSD of the post-synaptic neuron, with the synaptic cleft spanning
approximately 15-30 nm (Landis, Hall, Weinstein, & Reese, 1988). This alignment is
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possible through many different types of cell adhesion molecules which include cadherins,
protocadherins, and neurexins (Frank & Kemler, 2002; Missler & Sudhof, 1998; Shapiro
& Colman, 1999; Yagi & Takeichi, 2000). All these adhesion molecules have similar
protein motifs: an extracellular domain that binds PSD adhesion molecules or extracellular
matrix, a single transmembrane domain, and an intracellular domain that binds the
cytoskeleton or scaffolding proteins along the AZ (Gottardi & Gumbiner, 2001; Hung &
Sheng, 2002).
The two main functions of the AZ are to allow calcium ion (Ca2+) entry and to release
neurotransmitters within a fraction of a millisecond (Heidelberger, Heinemann, Neher, &
Matthews, 1994). Voltage-dependent calcium channels (VDCC) open in response to an
action potential, allowing for calcium influx (Augustine, Charlton, & Smith, 1987). This
increase in cytoplasmic calcium activates soluble N-ethylmaleimade-sensitive factor
attachment protein receptor (SNARE) complex proteins, facilitating vesicular-membrane
fusion and release of neurotransmitter. Synaptotagmins are a family of calcium-sensitive
proteins that localize to secretory vesicles and membranes, but synaptotagmin-1 (Syt1) is
the main calcium sensor in forebrain neurons (Geppert et al., 1994). Syt1 can bind to
SNAREs through a Ca2+ binding domain; this interaction is functionally important, yet the
significance is still unknown (Bai & Chapman, 2004; Bowen, Weninger, Ernst, Chu, &
Brunger, 2005; Pang, Shin, Meyer, Rosenmund, & Sudhof, 2006). Syt1 induces vesicular
clustering at the synapse (Arac et al., 2006), and reducing the binding affinity of the Syt1
Ca2+ domain decreased the amount of neurotransmitter released (Fernandez-Chacon et al.,
2001), indicating the importance of Syt1 in Ca2+-mediated exocytosis.
The complexin family has also been implicated in Ca2+-dependent neurotransmitter release,
however, studies have shown contrasting roles in vesicular fusion. Loss of complexin-1
(Cplx1) and complexin-2 (Cplx2) in neurons resulted in reduced Ca2+-triggered
neurotransmitter release, however, overexpression of Cplx1 at synaptic terminals also
decreased neurotransmitter release, indicating a requirement for balance in Cplx1
expression (Ono et al., 1998; Reim et al., 2001; Tokumaru et al., 2001). Cplx1 binds
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SNARE proteins and clamps the SNARE/vesicle complex to the pre-synaptic membrane
(Giraudo, Eng, Melia, & Rothman, 2006; M. Xue et al., 2007). Upon Ca2+ influx, Syt1
displaces Cplx1 on the SNARE complex allowing for fusion of the vesicle to the presynaptic membrane and release of neurotransmitter into the synaptic cleft (Schaub, Lu,
Doneske, Shin, & McNew, 2006; J. Tang et al., 2006).
Since long-term memory depends on synthesis of new proteins (Sutton & Schuman, 2006),
microRNAs (miRNA) can provide another layer of regulation of synaptic plasticity. These
non-coding RNA bind to messenger RNA 3’ untranslated regions (UTR) to promote
degradation of the transcript or to block translation (Bagga et al., 2005; Humphreys,
Westman, Martin, & Preiss, 2005). Indeed, LTP causes altered transcription of many
miRNA, which in turn have diverse targets across the transcriptome (Joilin et al., 2014). A
subset of miRNAs have been shown to act within the synaptic terminal to control
neurotransmitter release and regulate presynaptic potential by targeting transporters or
synaptic vesicle machinery (Siegert et al., 2015; Verma, Augustine, Ammar, Tashiro, &
Cohen, 2015). miRNA regulation of synaptic plasticity translates to cognitive effects, as
behaviour in the Morris water maze, novel object recognition, and contextual fear task is
affected in miRNA loss-of-function models(Hansen, Sakamoto, Wayman, Impey, &
Obrietan, 2010; Siegert et al., 2015)

1.7.3

Post-synaptic structure and function

The postsynaptic neuron is responsible for receiving neurotransmitter and turning it into a
signaling cascade. Most of this process occurs within a structure called the post-synaptic
density (PSD), an electron-dense thickening at the postsynaptic membrane (Figure 1-2B)
(Gray, 1959; Palay, 1956). The PSD consists of many scaffolding proteins that anchor
neurotransmitter receptors, cell adhesion molecules, and signaling complexes. The main
scaffolding protein is PSD-95 which comprises approximately 2.3% of the total PSD mass,
and can interact with a variety of proteins through its PDZ motif (X. Chen et al., 2005).
Mice lacking PSD-95 have impaired spatial learning and altered LTP and LTD, indicating
the importance of PSD-95 in NMDAR-dependent signaling (Migaud et al., 1998).
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The postsynaptic membrane shares many cell adhesion molecule classes with the
presynaptic membrane, such as cadherins and protocadherins, however there are some that
are specific to the postsynapse. For example, neuroligins are a class of four proteins
(Neuroligin-1 through -4) only found on post-synaptic membranes and bind to neurexins
to align the synaptic cleft (Ichtchenko et al., 1995; Ichtchenko, Nguyen, & Sudhof, 1996).
Neuroligins are typically synapse specific, with neuroligin-1 found at excitatory,
neuroligin-2 and -4 at inhibitory, and neuroligin-3 at both (Budreck & Scheiffele, 2007;
Hoon et al., 2011; Song, Ichtchenko, Sudhof, & Brose, 1999; Varoqueaux, Jamain, &
Brose, 2004). Their cytoplasmic domain contains a PDZ motif to recruit PSD-95 and other
scaffolding proteins (Kornau, Schenker, Kennedy, & Seeburg, 1995). Other cell adhesion
molecules include synaptic cell adhesion molecules (synCAMs) which act across the cleft
to increase active synapse numbers, and neural cell adhesion molecules (NCAMs) which
promote assembly of cytoskeletal scaffolds (Sytnyk, Leshchyns'ka, Nikonenko, &
Schachner, 2006).
Other proteins anchored to the PSD include neurotransmitter receptors. The two main
classes in excitatory neurons are NMDAR and AMPAR. NMDARs allow calcium influx
in response to synaptic depolarization, and can trigger either LTP or LTD (Sheng & Kim,
2002). They are formed by a tetramer of four subunits GluN1-3. NDMAR require two
GluN1 with either two GluN2 or a GluN2/GluN3 combination (Monyer et al., 1992;
Schorge & Colquhoun, 2003). Intracellular domains of these subunits bind CaMKII and
calmodulin, allowing for fast activation of these proteins upon Ca2+ influx (Ehlers, Zhang,
Bernhadt, & Huganir, 1996; Strack & Colbran, 1998). AMPAR can be found at the
synaptic membrane, but are most often found packaged in vesicles ready to be trafficked
to the membrane upon depolarization (Bredt & Nicoll, 2003; Hayashi et al., 2000). Like
NMDAR, AMPAR are tetrameric and heteromeric complexes and it can contain a
combination of subunits GluR1-4 (or GluRA-D in some nomenclature). GluR2 is usually
found in all conformations of the receptor, as it confers Ca2+ permeability (Isaac, Ashby,
& McBain, 2007), and the majority of AMPAR found in hippocampal pyramidal neurons
contain two GluR1 and two GluR2 (Wenthold, Petralia, Blahos, & Niedzielski, 1996).
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Early LTP (E-LTP) induction requires NMDAR activation and an increase in intracellular
Ca2+ (Huber, Mauk, & Kelly, 1995). Upon Ca2+ influx, CaMKII activates via
autophosphorylation (Fukunaga, Muller, & Miyamoto, 1995). This is a critical step, since
mice expressing mutant CaMKII display a drastic reduction in LTP (Giese, Fedorov,
Filipkowski, & Silva, 1998; Silva et al., 1992). Activation of CaMKII results in
phosphorylation of many downstream proteins and signaling cascades. CaMKII
phosphorylates AMPAR to increase its conductance as well as allow for trafficking of the
receptor to the synaptic membrane (Derkach, Barria, & Soderling, 1999; Hayashi et al.,
2000). Phosphorylation of synGAP, a Ras/Rap GTPase-activating protein, by CaMKII
causes activation of Ras, critical for AMPAR trafficking (Araki, Zeng, Zhang, & Huganir,
2015; Zhu, Qin, Zhao, Van Aelst, & Malinow, 2002). CaMKII also targets Rho guanine
exchange factors (GEFs) which in turn activate Rho GTPases such as Rac1 and RhoA
(Herring & Nicoll, 2016). These GTPases are involved in actin cytoskeletal remodeling in
dendritic spines (Murakoshi, Wang, & Yasuda, 2011; Penzes, Cahill, Jones, & Srivastava,
2008). The roles of CaMKII in E-LTP are summarized in Figure 1-2.
Late LTP (L-LTP) is dependent on gene expression changes and de novo protein synthesis
and requires activation of PKA and its downstream targets CREB and MAPK (Frey,
Huang, & Kandel, 1993; Huang & Kandel, 1994; Nguyen, Abel, & Kandel, 1994).
Adenylate cyclase (AC) is induced by Ca2+ influx and catalyzes adenosine triphosphate
(ATP) into cyclic adenosine monophosphate (cAMP) (Eliot, Dudai, Kandel, & Abrams,
1989). cAMP binds and activates protein kinase A (PKA) which phosphorylates CREbinding protein (CREB), resulting in activation of cAMP-response element (CRE) related
genes (Nguyen & Woo, 2003). PKA also activates the mitogen-activated protein kinase
(MAPK) pathway, causing MAPK to translocate to the nucleus where it is involved in
activating transcription factors including CREB (Boglari, Erhardt, Cooper, & Szeberenyi,
1998; Thomson, Mahadevan, & Clayton, 1999; Vossler et al., 1997).
A large number of genes contain the CRE recognition site, including immediate early genes
(IEGs), which are activated quickly and transiently following post-synaptic stimulation.
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Zif268 (or Egr1) is included in this class as a secondary transcription factor for other genes
involved in synaptic plasticity (James, Conway, & Morris, 2005; Veyrac, Besnard,
Caboche, Davis, & Laroche, 2014). Arc is another IEG where upon transcription, Arc
mRNA is translocated to the active spine for local translation (Moga et al., 2004; Steward,
Wallace, Lyford, & Worley, 1998) where the protein regulates structural changes via actin
polymerization (Bramham et al., 2010). Taken together, evidence indicates that E-LTP
requires modification of existing proteins and L-LTP requires de novo transcription and
translation, but there is still much unknown about the molecular and cellular mechanisms
underlying memory formation.

1.8 Thesis Overview
The overall aim of this work was to identify the role of ATRX in learning and memory and
determine a mechanism by which ATRX regulates cognition. At the beginning of this
study, there had been no models investigating ATRX loss specifically in the adult central
nervous system, and most ATRX research had focused on the role of ATRX in
development, not in adult mice. Since mutations in ATRX cause intellectual disability in
humans, and there is evidence that ATRX regulates gene expression in the brain, I
hypothesized that ATRX is required for learning and memory processes by controlling
expression of genes involved in synaptic transmission. To identify the role of ATRX in
cognition we utilized two different mouse models of ATRX loss in the brain: Atrx-cHet
displayed mosaic expression of ATRX in neural and glial precursors and Atrx-cKO had no
ATRX expression in glutamatergic neurons of the mouse forebrain. Remarkably, we found
the Atrx-cHet had endocrine defects in addition to profound intellectual impairment in
many different paradigms (Tamming et al., 2017). However, due to confounding effects
we opted to use the Atrx-cKO mice for further studies
I found both gross and ultrastructural morphology changes in the Atrx-cKO hippocampus.
The hippocampal CA1 stratum radiatum and stratum lacunosum moleculare were
significantly increased in size. However, these increases could not be explained by
increased dendritic branching of the neurons nor increased glial or microglial cell
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infiltration. At the ultrastructural level, I observed an increased number of docked and total
presynaptic vesicles and an increase in postsynaptic density size which are associated with
hippocampal-dependent impairments in learning and memory in the Morris water maze,
contextual fear conditioning, and paired-associate learning task. However, Atrx-cKO
female mice did not display any behavioural impairments, indicating a sexually-dimorphic
effect of ATRX loss in glutamatergic neurons. RNA sequencing revealed sex-specific
alterations in synaptic transcript expression which were correlated to miR-137 expression.
We propose a model whereby ATRX directly or indirectly regulates miR-137 resulting in
repression of synaptic target genes, altered synaptic ultrastructure, and impaired spatial
learning and memory. Taken together, the findings presented here identify a novel function
for ATRX in the regulation of cognition and provide insight into how defects in ATRX
function lead to intellectual disability.
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Chapter 2

2

Mosaic expression of Atrx in the mouse central nervous
system causes memory deficits

The aim of the work outlined in this chapter was to determine the effects of ATRX loss in
the mouse central nervous system (CNS) on learning and memory. This work has been
published in Disease Models and Mechanisms in 2017 (doi: 10.1242/dmm.027482). My
findings suggest that total loss of ATRX in the CNS in males during development is
perinatal lethal, however mosaic expression of ATRX in females is viable. I found that
mosaic expression of ATRX leads to endocrine effects and has a negative impact on
learning and memory.

2.1 Introduction
Alpha thalassemia mental retardation, X-linked, or ATR-X syndrome, is an intellectual
disability (ID) disorder that arises from mutations in the ATRX gene (OMIM 301040). This
rare syndrome is characterized by severe developmental delay, hypotonia, mild αthalassemia and moderate-to-severe ID (Gibbons et al., 1995). A recent study screened a
cohort of nearly 1000 individuals with ID using targeted next-generation sequencing and
identified ATRX variants as one of the most common causes of ID, reinforcing its
importance in cognition (Grozeva et al., 2015). The ATRX protein is a SWI/SNF-type
chromatin remodeller. The N-terminal region of the protein contains a histone reader
domain that mediates interaction of the protein with histone H3 trimethylated at lysine 9
(H3K9me3) and unmethylated at lysine 4 (H3K4me0) (Dhayalan et al., 2011). A
SWI/SNF2-type helicase domain is located in the C-terminal half of the protein and confers
ATP-dependent chromatin remodelling activity (Aapola et al., 2000; Gibbons et al., 1997;
Picketts et al., 1996). Several proteins have been shown to interact with ATRX, including
MeCP2, HP1α, EZH2 and DAXX (Bérubé, Smeenk, & Picketts, 2000; Cardoso et al.,
1998; Nan et al., 2007; Xue et al., 2003). DAXX is a histone chaperone for histone variant
H3.3. In association with ATRX, DAXX deposits H3.3-containing nucleosomes at
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telomeres and pericentromeric heterochromatin (Drane, Ouararhni, Depaux, Shuaib, &
Hamiche, 2010; Lewis, Elsaesser, Noh, Stadler, & Allis, 2010).
Several studies have previously implicated ATRX in the regulation of gene expression
through a variety of mechanisms. Chromatin immunoprecipitation (ChIP) sequencing for
ATRX in human erythroblasts showed that the protein tends to bind GC-rich regions with
high tendency to form G-quadruplexes. For example, ATRX was found to bind tandem
repeats within the human α-globin gene cluster, and it was suggested that reduced
expression of α- globin might be caused by replication-dependent mechanisms that would
affect the expression of nearby genes (Law et al., 2010). The induction of replication stress
was in fact detected in vivo upon inactivation of Atrx in either muscle or brain (Leung et
al., 2013; Watson et al., 2013). More recently, our group demonstrated that loss of ATRX
corresponds to decreased H3.3 incorporation and increased PolII occupancy in GC-rich
gene bodies, including Neuroligin 4, an autism susceptibility gene (Levy, Kernohan, Jiang,
& Berube, 2015).
Although the mechanisms by which ATRX modulates chromatin and genes is starting to
be resolved, its function in neurons and cognitive processes is still obscure. To address this
question, we generated mice with conditional inactivation of Atrx in the central nervous
system (CNS) starting at early stages of neurogenesis. Although hemizygous male progeny
died shortly after birth, heterozygous female mice (henceforth called Atrx-cHet), which
exhibit mosaic expression of ATRX caused by random X-inactivation, survived to
adulthood, allowing the investigation of neurobehavioural outcomes upon inactivation of
Atrx in the brain.

2.2 Materials and Methods
2.2.1

Animal care and husbandry

Mice were exposed to a 12 h:12 h light–dark cycle and with water and chow ad libitum.
The AtrxloxP mice have been described previously (Bérubé et al., 2005). AtrxloxP mice
(129svj) were mated with mice expressing Cre recombinase under the control of the Nestin
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gene promoter (Bl6) (Tronche et al., 1999). The progeny include hemizygous male mice
that produce no full-length ATRX protein in the CNS (Atrxf/y Cre+) and heterozygous
female mice with approximately half the cells lacking ATRX protein as a result of the
random pattern of X-inactivation (Atrxf/+ Cre+). Male and female littermate floxed mice
lacking the Cre allele were used as controls. Genotyping of tail biopsies for the presence
of the floxed and Cre alleles was performed as described previously (Bérubé et al., 2005;
Seah et al., 2008). All procedures involving animals were conducted in accordance with
the regulations of the Animals for Research Act of the province of Ontario and approved
by the University of Western Ontario Animal Care and Use Committee (2017-048).
Behavioural assessments started with less demanding tasks (grip force, open-field tests),
followed by more demanding ones (Morris water maze). Experimenters followed ARRIVE
guidelines: mouse groups were randomized, they were blind to the genotypes, and
software-based analysis was used to score mouse performance in most of the tasks. All
experiments were performed between 09.00 and 16.00 h.

2.2.2

Immunofluorescence staining

Mice were perfused and the brains fixed for 72 h with 4% paraformaldehyde in PBS and
cryopreserved in 30% sucrose/PBS. Brains were flash frozen in Cryomatrix (Thermo
Fisher Scientific) and sectioned as described previously (Ritchie, Watson, Davidson, Jiang,
& Berube, 2014). For immunostaining, antigen retrieval was performed by incubating
slides in 10 mM sodium citrate at 95°C for 10 min. Cooled slides were washed and
incubated overnight in anti-ATRX rabbit polyclonal antibody (Santa Cruz Biotechnology,
SC-15408; 1:200, H-300) (Watson et al., 2013) diluted in 0.3% Triton-X100 in PBS.
Sections were washed and incubated with goat anti-rabbit Alexa Fluor 594 (Life
Technologies) for 1 h. Sections were counterstained with DAPI and mounted with
SlowFade Gold (Invitrogen). Cell counts were done in three control–KO littermatematched pairs in a blinded manner.
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2.2.3

Microscopy

All images were captured using an inverted microscope (DMI 6000b; Leica) with a digital
camera (ORCA-ER; Hamamatsu). Openlab image software was used for manual image
capture, and images were processed using the Volocity software (PerkinElmer).

2.2.4

Haematoxylin and eosin staining

Brain cryosections (8 μm thick) from 3-month-old mice were rehydrated in 70% ethanol
for 2 min followed by tap water for 5 min. They were then placed in CAT Haematoxylin
(Biocare) for 2 min, placed under running tap water for 1 min, and set in filtered Tasha’s
Bluing Solution (Biocare) for 30 s. The slides were placed under running tap water for 10
min and set in filtered Eosin Y (Fisher Scientific) for 2 min. Immediately afterwards, the
cells were dehydrated in 70% ethanol for 30 s each, then 90% ethanol for 1 min and 100%
ethanol for 2 min each. The slides were placed in xylene 3× for 5 min and mounted with
Permount (Fisher Scientific) immediately after.

2.2.5

RT-qPCR

Total RNA was isolated from control and Atrx-cHet rostral cortex and hippocampus using
the RNeasy Mini Kit (Qiagen) and reverse transcribed to cDNA using 1 μg RNA and
SuperScript II Reverse Transcriptase (Invitrogen). cDNA was amplified in duplicate using
primers in the following conditions: 95°C for 10 s, 55°C for 20 s and 72°C for 30 s for 35
cycles. Primers detected Atrx exons 17 and 18. Standard curves were generated for each
primer pair. Primer efficiency (E) was calculated as E=(10−1/slope−1)×100%, where a
desirable slope is −3.32 and R2>0.990. All data were corrected against β-actin.

2.2.6

ELISAs

Blood was collected from the inferior vena cava of P17 mice. One hundred microlitres of
0.5 M EDTA pH 7.0 per millilitre of blood collected was added to the blood sample and
centrifuged at 21,000 g for 10 min at 4°C. Plasma supernatant was collected and kept frozen
at −80°C. Plasma IGF-1 concentration was measured using a mouse IGF-1 ELISA kit
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(R&D Systems, MG100). Plasma GH (Millipore, EZRMGH-45K) and T4 (Calbiotech,
T4044T) were also measured by ELISA according to the manufacturers’ instructions.

2.2.7

Bone staining and measurements

Skinned and eviscerated P17 mouse carcasses were fixed overnight in 95% ethanol and
transferred to acetone overnight (Ulici et al., 2009). Fixed skeletons were stained in a
0.05% Alizarin Red, 0.015% Alcian Blue, 5% acetic acid in 70% ethanol solution for 7-14
days. Stained skeletons were cleaned in decreasing concentrations of potassium hydroxide
(2, 1 and 0.5%) for several days and stored in 50:50 70% ethanol/glycerol solution. Alcian
Blue and Alizarin Red-stained skeletons were imaged using an Olympus SP-57OUZ digital
camera. The lengths of the tibia, femur and humerus, the width of the skull and the length
of the foot from at least four different littermate pairs from both mouse models were imaged
using the Zeiss Stereo Zoom Microscope Stemi SV6 and measured with a ruler accurate to
0.1 mm.

2.2.8
2.2.8.1

Behaviour analysis
Hindlimb clasping

Hindlimb clasping was measured by lifting mice up by the base of the tail. Clasping was
scored on a scale of 0 (no clasping, limbs splayed) to 2 (clasping, wringing paws).

2.2.8.2

Grip force

Grip force, an indicator of muscular strength, was measured using a Grip Strength Meter
(Columbus Instruments) (Solomon, Russell, Makar, Berube, & Beier, 2013). The meter
was positioned horizontally, and the mice were held by the base of the tail and lowered
towards the triangular pull bar. Once the mice had gripped the bar, the meter was calibrated,
and the mice were gently pulled away from the apparatus. The force applied to the bar as
the mice released it was recorded as peak tension (in Newtons). This test was repeated five
times, with the highest and lowest value being removed for user error, and the remaining
three values were averaged for the final grip strength.
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2.2.8.3

Rotarod

For the Rotarod task, mice were placed on the Rotarod apparatus (San Diego Instruments)
and rotation was increased from 5 to 35 rpm over 5 min. Latency to fall was recorded
automatically. Ten trials were performed on the first day and four were performed on the
second day. There was an inter-trial period of 10 min, during which the mice were placed
in their home cage.

2.2.8.4

Treadmill

Training for the treadmill test occurred over 4 days (3 min day−1). On the first day, the
incline was set to 5° and increased by 5° every day to a maximum of 20°. The initial speed
was 8 m min−1, and the treadmill was accelerated by 1 m min−2. On the subsequent
training days 2, 3 and 4, the initial speed was increased to 10, 11 and 12 m min−1,
respectively, with constant acceleration. During testing on the fifth day, the initial speed
was 12 m min−1 and accelerated to 20 m min−1 over the course of 15 min. Distance to
exhaustion was measured, and the work performed (W, in joules) was calculated using the
formula: W (J)=body weight (kg)×cos20°×9.8 (J kg−1×m)×distance (m).

2.2.8.5

Open field test

In the open-field test, locomotor activity was automatically recorded (AccuScan
Instrument). The mice were placed in an arena with an area of 20 cm×20 cm with 30-cmhigh walls. Mice were acclimated to the locomotor room for 10 min before testing.
Locomotor activity was measured in 5 min intervals over 2 h, as previously described
(Martyn et al., 2012).

2.2.8.6

Elevated plus maze

Animals were placed in the centre of the elevated plus maze (Med Associate) and their
activity was recorded over 5 min. The total time spent in the open and closed arms was
recorded using computer software (AnyMaze). The centre of the mouse body was used as
an indicator of which zone they were in.
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2.2.8.7

Y-maze

Spontaneous Y-maze alternation was measured using a symmetrical three-armed Y-maze
as described (de Castro et al., 2009). Video tracking was performed using computer
software (AnyMaze) and the order and number of entries into each arm recorded. Each
mouse underwent one trial lasting 5 min. Spontaneous alternation was counted when a
mouse entered all three arms in a row without visiting a previous arm.

2.2.8.8

Contextual fear conditioning

To measure contextual fear, mice were placed in a 20 cm×10 cm clear acrylic enclosure
with a metal grid floor and one wall distinct from the others (stripes were drawn on one of
the walls). The chamber was equipped with an electric shock generator. Videos were
recorded using the AnyMaze video tracking software. On Day 1, mice were allowed to
explore the enclosure freely, and at 150 s the mice were given a shock (2 mA, 180 V, 2 s).
Shock sensitivity was confirmed by vocalization of the mice. Thirty seconds later the mice
were returned to their home cage. After 24 h, the mice were placed back into the enclosure
for 6 min and freezing time was measured in 30 s intervals. Freezing was defined as
immobility lasting >0.5 s.

2.2.8.9

Novel object recognition

To test novel object recognition, mice were habituated with no objects in an open arena (40
cm×40 cm) for 5 min on both Day 1 and Day 2. On Day 3, mice were placed in the arena
with two identical objects (A; a red plastic ball attached on top of a yellow cube base) and
allowed to explore for 10 min. Video tracking was used (AnyMaze). To test short-term
memory, 1.5 h after training the mice were placed back in the arena for 5 min with one
previous object (A) and one novel object (B; a blue plastic pyramid attached on top of a
green prism base). To test long-term memory, 24 h after training the mice were placed back
in the arena for 5 min with one previous object (A) and one novel object (B). Recognition
of previous and novel objects was expressed as the percentage of time spent with each
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object compared with the total time interacting. Interaction with the object was defined as
sniffing or touching the object, but not leaning against or standing on the object.

2.2.8.10 Morris water maze
The Morris water-maze test was conducted as described previously (Vorhees & Williams,
2006). Mice were given four trials (90 s) a day for 4 days consecutively, with a 15 min
inter-trial period. The latency to find the platform was recorded using video-tracking
software (AnyMaze). If the mice did not find the platform during the 90 s, they were gently
guided onto the platform. On the 5th and the 12th day, the platform was removed and time
spent in each quadrant of the maze recorded using the video software. The task was
performed in a pool 1.5 m in diameter with 25°C water, and the platform was submerged
1 cm beneath the water surface. Spatial cues (shapes printed in black and white) were
distributed around the pool. For the cued version of the Morris water maze, mice were
subjected to four trials (90 s) per day for 7 days consecutively, with a 30 s inter-trial period.
If the mouse did not find the platform after 90 s, it was gently guided onto the platform.
The visible platform and the mouse starting location changed with each trial, so they were
unique between trials. The platform was made visible by placing a red plastic cube on top
of the platform, which was wiped with ethanol between each trial.

2.2.9

Statistical analyses

All data were analysed using GraphPad Prism software or SPSS, with Student’s t-test
(unpaired, two tailed) or one- or two-way ANOVA with Bonferroni or Benjamini–
Hochburg correction where indicated. All results are depicted as means±s.e.m. unless
indicated otherwise. Values of P≤0.05 were considered to indicate significance.

2.3 Results
2.3.1

Survival to adulthood depends on the extent of Atrx deletion
in the CNS

Conditional inactivation of Atrx is required to elucidate its functions in specific tissues,
because general inactivation of the gene is embryonic lethal (Garrick et al., 2006). We thus
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generated mice with Cre recombinase-mediated deletion of Atrx-floxed alleles in the CNS
using the Nestin-Cre driver line of mice. Hemizygous male mice (Atrx-cKO) died by
postnatal day (P)1 (Figure 2-1A). Owing to random X-inactivation in females, Atrx is
expressed from only one of the alleles in any specific cell, resulting in a mosaic pattern of
expression in the brain of Atrx-cHet mice (e.g. if the floxed allele is the active allele, these
cells are functionally null for Atrx; however, if the floxed allele is the silent one, cells are
functionally wild type for Atrx). This was validated by RT-qPCR with Atrx primers in exon
17 and the excised exon 18, showing ∼50% decreased Atrx expression in the cortex and
hippocampus of Atrx-cHet mice compared with littermate controls (Figure 2-1B).

Moreover, a mosaic pattern of ATRX protein expression was observed by
immunofluorescence staining of the hippocampus and medial prefrontal cortex (Figure 21C,D). This was quantified in the medial prefrontal cortex in three pairs of control and cKO
animals (Figure 2-1E). Haematoxylin and Eosin staining of control and Atrx-cHet brain
sections did not reveal major histological alterations in the CA1, CA3 and mPFC regions
(Figure 2-1F). These results demonstrated that inactivation of Atrx throughout the CNS
was perinatal lethal but that Atrx deletion in approximately half of cells allowed survival
of the female heterozygous mice to adulthood.

2.3.2

Mosaic inactivation of Atrx in the CNS impedes normal body
growth

Atrx-cHet mice were weighed weekly for the first 24 postnatal weeks. The data showed
that the Atrx-cHet mice weighed significantly less than control mice over this time period
(F=17.87, P=0.0003; Figure 2-2A,B). Alcian Blue and Alizarin Red skeletal staining of
P17 mice reveal that the Atrx-cHet skeletons were smaller than those of the control mice
(Figure 2-2C). Tibia, femur and humerus bones were also measured and found to be
significantly shorter in the Atrx-cHet mice compared with littermate controls (Figure 22D).
We previously reported that deletion of Atrx in the developing mouse forebrain and anterior
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Figure 2-1 Mosaic pattern of ATRX expression in the brain of Atrx-cHet mice.
(A) Graph depicting the survival of control male mice (n=20), knockout male mice (n=6),
control female mice (n=14) and heterozygote female mice (n=17) as the percentage
survival at each time point. (B) RT-qPCR of Atrx (normalized to Gapdh expression) in the
hippocampus and cortex of Atrx-cHet mice and littermate-matched controls (mean±s.e.m.
of n=4 pairs, Student’s two-tailed unpaired t-test). *P<0.05. (C)Immunofluorescence
staining of ATRX (red) and DAPI (blue) in the hippocampus of control and Atrx-cHet
mice. Scale bar: 100 μm.CA1, cornus ammoni 1; CA3, cornus ammoni 3; DG, dentate
gyrus. (D) Immunofluorescence staining of ATRX (red) and DAPI (blue) in the medial
prefrontal cortex (mPFC) of control and Atrx-cHet mice. Scale bar: 200 μm. (E) The
percentage of ATRX-positive cells in the mPFC of control and Atrx-cHet mice (mean of
three pairs±s.e.m., Student’s two-tailed unpaired t-test). *P<0.05. (F) Haematoxylin and
Eosin staining in the CA1, CA3 and mPFC of control and Atrx-cHet mice. Scale bar: 200
μm.
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pituitary leads to low circulating concentrations of IGF-1 and thyroxine (T4) (Watson et
al., 2013). Some evidence suggests that T4 regulates the prepubertal concentrations of
insulin growth factor 1 (IGF-1), whereas after puberty this regulation is largely mediated
by growth hormone (GH) (Xing et al., 2012). Given that the Atrx-cHet mice were smaller
than control mice, we examined the concentrations of T4, IGF-1 and GH in the blood by
enzyme-linked immunosorbent assays (ELISAs). We observed no significant difference in
T4 and GH concentrations between P17 Atrx-cHet mice and control littermates. However,
there was a large (80%) and significant decrease in IGF-1 concentrations (Figure 2-2E).
Thus, the reduced body size of the Atrx-cHet mice was correlated with low circulating IGF1 concentrations.

2.3.3

Hindlimb-clasping phenotype in Atrx-cHet mice

The Atrx-cHet mice displayed increased hindlimb clasping compared with control mice,
with >90% exhibiting limb clasping by 3 months of age (F=20.78, P<0.0001; Figure 23A). In the open-field test, the distance travelled was not significantly different between
control and Atrx-cHet mice, indicating that activity and locomotion were normal (F=0.20,
P=0.66; Figure 2-3B). Anxiety levels were also normal, based on the time spent in the
centre of the open-field apparatus (F=0.84, P=0.44; Figure 2-3C). Likewise, their
performance in the elevated plus maze revealed no significant difference in the amount of
time that control and Atrx-cHet mice spent in the open versus closed arms (F=0.68, P=0.41;
Figure 2-3C,D).We concluded that the Atrx-cHet mice were not hyper- or hypo-active and
did not exhibit excessive anxiety, but the increased level of hindlimb clasping behaviour
was suggestive of neurological defects.

2.3.4

Atrx-cHet mice have normal working memory but deficits in
object recognition memory

Given that ATRX mutations are linked to ID, we next evaluated memory in Atrx-cHet mice
using various established paradigms. We first tested short-term working memory in the Ymaze task (de Castro et al., 2009). No difference was detected between control and AtrxcHet mice in the percentage alternation or in the number of entries into the arms, suggesting
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Figure 2-2 Atrx-cHet mice have reduced body weight and low circulating IGF-1.
(A) Atrx-cHet female mice are smaller than littermate-matched controls at P17. (B) Growth
curve of mice from 3 to 24 weeks of age (n=13; *P<0.05). Data are represented as
means±s.e.m., two-way repeated measures ANOVA with Benjamini–Hochburg posthoc
test. (C) Skeletal stains of P21 control and Atrx-cHet mice showing cartilage (blue) and
bone (red). (D) The lengths of long bones of Atrx-cHet mice (n=21) are decreased
compared with control mice (n=19). (E) Circulating concentrations of T4, GH and IGF-1
in Atrx-cHet and control mice (n=3) at P17. Data are represented as means±s.e.m.,
Student’s two-tailed, unpaired t-test. *P<0.05.
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that working memory was normal in Atrx-cHet mice (t=0.05, P=0.96; Figure 2-4A). We
then tested the Atrx-cHet mice in the spontaneous novel object recognition task that mainly
involves the prefrontal cortex and hippocampus (Ennaceur & Delacour, 1988). In rodents,
the natural tendency to seek out and explore novelty leads to a preference for the novel
over the familiar object, indicating recognition memory of the familiar object (Bevins &
Besheer, 2006). During the habituation period, both control and Atrx-cHet mice spent
∼50% of the allotted time with each individual object (Figure 2-4B). In the course of the
short-term memory test (1.5 h), control mice spent ∼70% of their time with the novel

object, whereas Atrx-cHet mice still spent ∼50% of their time with each object, suggesting

an inability to remember the familiar object (Figure 2-4B). Similar results were obtained
in the long-term memory test (24 h). The total amount of time spent interacting with the
objects was unchanged between control and Atrx-cHet mice during all three tests, ruling
out visual or tactile impairment.

2.3.5

Atrx-cHet mice display deficits in contextual fear and spatial
memory

To evaluate contextual fear memory, mice were placed in a box with distinctive black and
white patterns on the sides for 3 min and shocked after 2.5 min. Twenty-four hours later,
they were placed back into the same box with the same contextual cues, and the time spent
freezing was measured at 30 s intervals. The data showed that the Atrx-cHet mice spent
less time freezing than control mice (F=28.57, P<0.0001), and the total percentage of
immobility time was significantly lower for Atrx-cHet mice, indicating impaired fear
memory in these mice (t=5.35, P<0.0001; Figure 2-4C).
The Morris water maze was next used to evaluate hippocampus dependent spatial memory
(Morris, 1984). During the 4 days of training, the Atrx-cHet mice took significantly more
time finding the target platform while swimming a longer distance compared with control
mice (latency F=31.44, P<0.0001; distance F=12.29, P<0.01; Figure 2-5A). The Atrx-cHet
mice also swam more slowly than control mice (F=15.40, P<0.001; Figure 2-5A). During
testing on the fifth day, the platform was removed and the time spent in each quadrant
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Figure 2-3 Atrx-cHet mice exhibit hindlimb clasping but normal activity and anxiety
levels.
(A) Hindlimb clasping was evaluated in control (n=13) and Atrx-cHet (n=12) female mice
and data plotted as the proportion of mice with hindlimb clasping from 3 to 25 weeks of
age. (B,C) The open-field test showed no difference in distance travelled (B) and time spent
in the centre (C) between control (n=11) and Atrx-cHet female mice (n=14). (D) Elevated
plus maze test shows no difference in time spent in the open and closed arms in control
(n=11) and Atrx-cHet (n=13) female mice. The data are represented as means±s.e.m. and
a two-way ANOVA test was performed.
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recorded as a measure of spatial memory. Whereas control mice spent significantly more
time in the target quadrant than the left or opposite quadrant (F=4.70, P<0.01), Atrx-cHet
mice showed no preference for the target quadrant (F=0.75, P=0.53; Figure 2-5B). The
results suggested that spatial learning and memory might be impaired in the Atrx-cHet
mice. The cued Morris water maze was used to determine whether motivational or
sensorimotor defects contributed to the phenotype seen in the noncued version of the test.
Whereas the control mice quickly learned to correlate the cue with the platform, the AtrxcHet mice were unable to do so (F=14.09, P<0.01; Figure 2-5C). We noticed that the mice
failed to show normal signs of aversion to water during this task, with a preference to be
swimming rather than to climb on the platform during training, even jumping back into the
water after being placed on the platform.

2.3.6

Atrx-cHet mice have normal motor endurance and motor
memory

Given that the Atrx-cHet mice swam more slowly than control animals in the Morris watermaze task, we considered that perhaps the test was confounded by deficits in motor skills.
To clarify this issue, we examined endurance and motor skills further in the mutant mice.
We found that motor function and balance measured in the Rotarod task were not
significantly different in Atrx-cHet mice during any of the trials (F=3.02, P=0.09; Fig. 6A).
Atrx-cHet mice also performed similarly to control animals in the treadmill task (t=0.34,
P=0.73; Fig. 6B). By contrast, Atrx-cHet mice exhibited decreased forelimb grip strength,
normalized to body weight (t=2.80, P<0.05; Fig. 6C).

2.4 Discussion
This study demonstrates that deletion of Atrx in the CNS leads to endocrine defects and
behavioural abnormalities. Specifically, we see impairments in spatial learning and
memory in the Morris water maze, in contextual fear conditioning and in novel object
recognition.
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Figure 2-4 Impaired novel object recognition and contextual fear memory in AtrxcHet mice.
(A) Percentage alternation and number of arm entries in the Y-maze test by control (n=14)
and Atrx-cHet (n=15) female mice. (B) Control (n=14) and Atrx-cHet (n=14) mice
displayed similar preference for identical objects in the training session of the novel object
recognition task. The Atrx-cHet mice failed to display a preference for the novel object 1.5
and 24 h later (*P<0.05). (C) Atrx-cHet (n=14) mice spent less time immobile than control
mice (n=14) in the fear-conditioning paradigm. The total percentage of time spent
immobile is shown on the right (*P<0.0001). Statistical analyses made use of Student’s
two tailed, unpaired t-test or two-way ANOVA; data are represented as means±s.e.m. and
*P<0.05.
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We previously reported that mice lacking ATRX expression in the embryonic mouse
forebrain have an average lifespan of 22 days (Watson et al., 2013). It is thus not surprising
that inactivation of Atrx using the Nestin-Cre driver (which mediates deletion in the
majority of CNS cells) is neonatal lethal. By contrast, the Atrx-cHet female mice survived
to adulthood, probably because roughly half of all Nestin-expressing cells and their
progeny are spared. Mosaic loss of ATRX in Atrx-cHet female mice still negatively affects
development, as the mice are smaller compared with littermate controls, and the length of
long bones is decreased. As the Nestin-Cre driver does not promote Cre expression in bone
progenitors (Wiese et al., 2004), this phenotype might result from the low concentration of
circulating IGF-1 in these mice. The reason for low IGF-1 is difficult to pinpoint in our
mice. It has been shown that mice expressing Cre under the control of the Nestin promoter
are smaller as a result of a decrease in mouse GH (Declercq et al., 2015). However, in our
hands, GH concentrations are normal in the Atrx-cHet mice. Given the normal
concentrations of both T4 and GH, there could be unanticipated expression of Cre in the
liver that affects IGF-1 production. Examining the potential off-target expression of Cre
will be required to elucidate the mechanism of IGF-1 downregulation in these mice.
The Atrx-cHet mice displayed a variety of behavioural abnormalities. We initially noticed
that the mice displayed excessive hindlimb clasping, which could indicate neurological
impairment (Guy, Hendrich, Holmes, Martin, & Bird, 2001). This prompted us to perform
additional tests to assess neurobehaviour of the mice. We observed no change in general
activity or anxiety using the open-field test and elevated plus maze, respectively, and no
change in working memory in the Y-maze task. The Atrx-cHet mice exhibited increased
latency to reach the platform in the Morris water-maze task, which might indicate a defect
in spatial memory. However, the findings are difficult to interpret because Atrx-cHet mice
swam at a lower speed, which could indicate a problem with their ability to swim rather
than with memory. It was previously reported that mice lacking MeCP2 protein, an
established interactor with ATRX in the brain, exhibit navigational difficulties in the
Morris water maze (Stearns et al., 2007). Significant differences in swimming ability made
it difficult to conclude whether the increased latency to the platform was attributable to
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Figure 2-5 Atrx-cHet mice perform poorly in the Morris water-maze paradigm.
(A) Atrx-cHet mice (n=13) spent more time finding the platform compared with control
mice (n=11) over the four consecutive days of training (*P<0.05). They swam longer
distances but at a lower speed compared with control mice (*P<0.05). (B) Control mice
spent more time swimming in the target quadrant (T) compared with the left (L) and
opposite (O) quadrants (*P<0.05) on the day 5 probe test, whereas Atrx-cHet mice spent
∼25% of their time in each of the quadrants. (C) In the cued version of the Morris water

maze, Atrx-cHet mice (n=11) were unable to learn the location of the visible platform,
whereas the control mice could effectively learn this task (n=11). Data are represented as
means±s.e.m. and a two-way ANOVA test was done. *P<0.05.
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motor or cognitive deficits, similar to our findings with the Atrx-cHet mice. Although we
did not observe defective motor skills in the Rotarod or treadmill tests or decreased activity
in the open-field test, we noticed that the mice failed to show normal signs of aversion to
water during this task and preferred to be swimming rather than to climb on the platform
during training, even jumping back into the water after being placed on the platform. We
attempted to test the mice in the Barnes maze, another spatial learning and memory test,
but the heterozygote mice tended to jump off the edge of the maze. This could be due to
multiple factors. The mice could have decreased motivation and therefore do not care about
being out of the water, or they may have a reduction in tactile sensitivity and therefore do
not have an aversion to water, although pain sensitivity has been tested in mice with
decreased expression of ATRX and no change was found (Nogami et al., 2011).
Despite these issues, which might require further experimentation for a full understanding,
we obtained supporting evidence that memory is affected in the Atrx-cHet mice in the
contextual fear and the novel object recognition tasks. Additional support comes from a
previous study done in a mouse model of Chudley–Lowry syndrome associated with
reduced expression of ATRX (Nogami et al., 2011). The authors of that study reported an
impairment in contextual fear memory and suggested that ATRX might play a role in
regulation of adult-born neurons. Our results show defects not only in contextual fear
memory, but also in novel object recognition and, potentially, the Morris water-maze task.
This might indicate a role for ATRX not only in adult-born neurons, but perhaps also in
the amygdala, hippocampus and the rest of the medial temporal lobe, structures which are
vital for the tasks impaired in the Atrx-cHet mice (Logue, Paylor, & Wehner, 1997; Phillips
& LeDoux, 1992; Wan, Aggleton, & Brown, 1999).
The DAXX protein is a well-established interactor with ATRX. Although the behaviour of
DAXX knockout mice has not yet been investigated, a study previously demonstrated that
DAXX binds with ATRX to the promoters of several immediate-early genes upon
activation of cortical neuronal cultures (Michod et al., 2012). DAXX was also shown to be
crucial for the incorporation of histone H3.3 at these gene promoters, supporting a potential
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Figure 2-6 Normal motor memory and endurance but decreased grip strength in AtrxcHet mice.
(A) Atrx-cHet (n=18) and control (n=16) female mice performed normally in the Rotarod
test. (B) Atrx-cHet (n=15) and control (n=15) mice exhibited similar performance in the
treadmill test. (C) Atrx-cHet mice (n=13) exhibited a decreased grip strength compared
with control mice (n=11), normalized to body mass. Statistical analyses made use of twoway ANOVA or Student’s two-tailed, unpaired t-test; data are represented as means±s.e.m.
*P<0.05.
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role for DAXX and ATRX the initial steps of memory consolidation. EZH2, a member of
the PRC2 complex that mediates H3K27 trimethylation, is another putative binding partner
of ATRX (Cardoso et al., 1998; Margueron et al., 2009). Inducible deletion of the Ezh2
gene in neural progenitor cells in the adult brain caused impaired spatial learning and
memory and contextual fear memory, suggesting that EZH2 (potentially with ATRX)
provides important cues in adult neural progenitor cells (Zhang et al., 2014). We emphasize
that these mice do not model the ATR-X syndrome, where only males are affected and
females exhibit 100% skewing of X-chromosome inactivation and are therefore largely
unaffected. Rather, the Atrx-cHet mice are a useful tool to probe ATRX function in the
CNS. Overall, our study presents compelling evidence that ATRX is required in the mouse
CNS for normal cognitive processes and sets the stage for additional investigations delving
into the mechanisms by which it regulates chromatin structure and gene expression in
neurons in the context of learning and memory.
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Chapter 3

3

Atrx deletion in neurons leads to sexually-dimorphic
dysregulation of miR-137 and spatial learning and
memory deficits

Mutations in the ATRX chromatin remodeler are associated with syndromic and nonsyndromic intellectual disability. Emerging evidence points to key roles for ATRX in
preserving neuroprogenitor cell genomic stability, whereas ATRX function in
differentiated neurons and memory processes are still unresolved. Here, I show that Atrx
deletion in mouse forebrain glutamatergic neurons causes distinct hippocampal anatomical
defects identified by magnetic resonance imaging. Ultrastructural analysis revealed fewer
presynaptic vesicles and an enlarged postsynaptic area at CA1 apical dendrite-axon
junctions. These synaptic defects are associated with impaired long-term contextual
memory in male, but not female mice. Mechanistically, I identified ATRX-dependent and
sex-specific alterations in synaptic gene expression linked to miR-137 levels, a known
regulator of presynaptic processes and spatial memory. I concluded that ablation of Atrx in
excitatory forebrain neurons leads to sexually dimorphic outcomes on miR-137 and on
spatial memory, identifying a promising therapeutic target for neurological disorders
caused by ATRX dysfunction.

3.1 Introduction
Alpha-thalassemia X-linked intellectual disability syndrome, or ATR-X syndrome, is a rare
congenital X-linked disorder resulting in moderate to severe intellectual disability (ID),
developmental delay, microcephaly, hypomyelination, and a mild form of alphathalassemia [OMIM: 301040] (Gibbons, Picketts, Villard, & Higgs, 1995). In a recent
study of approximately 1000 individuals with ID, ATRX mutations were identified as one
of the most frequent cause of non-syndromic ID (Grozeva et al., 2015), emphasizing a key
requirement for this gene in cognitive processes. ATRX-related ID arises from
hypomorphic mutations in the ATRX gene, most commonly in the highly conserved
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ATRX/DNMT3/DNMT3L (ADD) and Switch/Sucrose non-fermenting (SWI/SNF)
domains (Gibbons et al., 1997; Gibbons et al., 2008). The former targets ATRX to
chromatin by means of a histone reader domain that recognizes specific histone tail
modifications (Eustermann et al., 2011), and the latter confers ATPase activity and is
critical for its chromatin remodeling activity (Lewis, Elsaesser, Noh, Stadler, & Allis,
2010; Picketts et al., 1996).
ATRX, in a complex with the histone chaperone DAXX, promotes the deposition of the
histone variant H3.3 at heterochromatic domains including telomeres and pericentromeres
(Goldberg et al., 2010; Law et al., 2010). However, ATRX is also required for H3.3
deposition within the gene body of a subset of G-rich genes, presumably to reduce Gquadruplex formation and promote transcriptional elongation (Levy, Kernohan, Jiang, &
Berube, 2015). ATRX is also required for the postnatal suppression of a network of
imprinted genes in the neonatal brain by promoting long range chromatin interactions via
CTCF and cohesin (Kernohan et al., 2010).
In mice, germline deletion of Atrx results in embryonic lethality (Garrick et al., 2006) while
conditional deletion of Atrx in neuroprogenitors leads to excessive DNA damage caused
by DNA replication stress and subsequent Tp53-dependent apoptosis (Seah et al., 2008;
Watson et al., 2013). Mice with deletion of exon 2 of Atrx (AtrxΔE2) were generated that
result in global reduction of Atrx expression. These mice are viable and exhibit impaired
novel object recognition memory, spatial memory in the Barnes maze, and contextual fear
memory (Shioda et al., 2011). Some of the molecular defects identified in these mice
included decreased activation of CaMKII and the AMPA receptor in the hippocampus as
well as decreased spine density in the medial prefrontal cortex, and altered DNA
methylation and increased expression of Xlr3b in neurons (Shioda et al., 2018). Our group
also reported similar behavioural impairments in female mice exhibiting mosaic expression
of ATRX in the central nervous system (Tamming et al., 2017). However, the contribution
of different cell types and sex difference to behavioural abnormalities have not yet been
resolved.
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To start addressing these questions, we deleted Atrx specifically in glutamatergic forebrain
neurons in male and female mice. This approach bypasses deleterious effects of ATRX
loss of function that we previously observed during brain development caused by
replication stress in proliferating neuroprogenitors (Garrick et al., 2006; Watson et al.,
2013). A comprehensive analysis of these mice reveals that ATRX promotes long-term
spatial learning and memory associated with morphological and synaptic ultrastructural
changes in the hippocampus. We show that female mice lacking ATRX in neurons are
protected from spatial learning and memory defects and identify sex-specific effects of
ATRX loss on the expression of synaptic genes and miR-137. Overall, we identify a novel
sex-specific function for ATRX in neurons in the regulation of long-term spatial memory
associated with abnormal synapse ultrastructure.

3.2 Methods
3.2.1

Animal care and husbandry

Mice were exposed to a 12-hour-light/12-hour-dark cycle and with water and chow ad
libitum. The AtrxloxP mice have been described previously (Bérubé et al., 2005). AtrxloxP
mice were mated with C57BL/6 mice expressing Cre recombinase under the control of the
αCaMKII gene promoter (Tsien et al., 1996). The progeny includes hemizygous male mice
that produce no ATRX protein in forebrain excitatory neurons (Atrx-cKO). The Atrx-cKO
males were mated to AtrxloxP females to yield homozygous deletion of Atrx in female mice
(Atrx-cKOFem). Male and female littermate floxed mice lacking the Cre allele were used as
controls (Ctrl; CtrlFem). For embryo cultures, AtrxloxP were mated to mice expressing Cre
recombinase under the control of the Nestin promoter (AtrxNestin-cKO) (Tronche et al.,
1999). The progeny includes hemizygous male mice that produce no ATRX protein in all
neural and glial precursors of the central and peripheral nervous system. Male littermate
floxed mice lacking the Cre allele were use as controls (CtrlNestin). Genotyping of tail
biopsies for the presence of the floxed and Cre alleles was performed as described
previously (Bérubé et al., 2005). All procedures involving animals were conducted in
accordance with the regulations of the Animals for Research Act of the province of Ontario
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and approved by the University of Western Ontario Animal Care and Use Committee
(2017-048). Behavioural assessments started with less demanding tasks (open field tests,
elevated plus maze) to more demanding ones (Morris water maze). ARRIVE guidelines
were followed: mouse groups were randomized, experimenters were blind to the
genotypes, and software-based analysis was used to score mouse performance in all the
tasks. All behavioural experiments were performed between 9:00 AM and 4:00 PM.

3.2.2

Cortical cultures

Cortices were removed from E16.5 control and AtrxNestin-cKO embryos and placed in
Hanks balanced salt solution (ThermoFisher). Tissue was dissociated gently using a P1000
pipette by pipetting up and down 10-15 times. Cells were plated in 2 wells of a 6-well plate
at a density of 8x105 cells/mL in neurobasal media (Invitrogen) supplemented with B27
serum, GlutaMAX, and penicillin/streptomycin (all Invitrogen). At 9 DIV cells were
treated with 1 µm tetrodotoxin (Tocris). At 10 DIV one well per sample was activated with
potassium chloride while the other well was left at basal conditions. 1 hour post-stimulation
cells were collected, pelleted, and froze until later use.

3.2.3

Immunofluorescence staining

Mice were perfused with 25mL phosphate buffered saline (PBS) followed by 25mL 4%
paraformaldehyde (PFA) in PBS and the brain fixed for 24 hours in 4% PFA in PBS and
cryopreserved in 30% sucrose/PBS. Brains were flash frozen in Cryomatrix (Thermo
Scientific) and sectioned at 8µm thickness as described previously (Watson et al., 2013).
For immunostaining, antigen retrieval was performed by incubating slides in 10 mM
sodium citrate at 95°C for 10 min. Cooled sections were washed and blocked with 10%
normal goat serum Sigma). The slides were incubated overnight in primary antibody
(ATRX: 1:200, H-300 Santa Cruz Biotechnology Inc; GFAP: 1:200, Agilent Technologies,
Inc; IBA1: 1:500, Wako Pure Chemical Corporation) diluted in 0.3% Triton-X/PBS.
Sections were washed in 0.3% Triton-X/PBS 3x 5 min and incubated with secondary
antibody (goat anti-rabbit-Alexa Fluor 594: 1:800, Life Technologies) for one hour.
Sections were washed again three times for 5 min, counterstained with DAPI and mounted
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with SlowFade Gold (Invitrogen). All images were captured using an inverted microscope
(Leica DMI 6000b) with a digital camera (Hamamatsu ORCA-ER). Openlab image
software was used for manual image capture, and images were processed using the
Volocity software (Demo Version 6.0.1; PerkinElmer) and Adobe Photoshop CS6 (Version
13.0). Cell counts of DAPI, GFAP, and IBA1 were performed in Adobe Photoshop. DAPI
was counted per mm2 and GFAP and IBA1 were counted as percentages of DAPI+ cells.
One section from five pairs of Ctrl/Atrx-cKO was counted. Statistical significance was
determined using an unpaired Student’s T-test.

3.2.4

Reverse transcriptase real-time PCR (qRT-PCR)

Total RNA was isolated from control and Atrx-cKO frontal cortex and hippocampus using
the miRVANA total RNA isolation kit (ThermoFisher) and reverse transcribed to cDNA
using 1 μg RNA and SuperScript II Reverse Transcriptase (Invitrogen). RNA was isolated
from cortical cultures using the RNeasy Mini Kit (Qiagen) and reverse transcribed to
cDNA as above.
Real-time PCR was performed in duplicate using gene-specific primers under the following
conditions: 95°C for 10 s, 58°C for 20 s, 72°C for 30 s for 35 cycles. All data were
normalized against β-actin expression levels. Primers used were as follows:
Gene
β-actin
Atrx
c-Fos
Junb
Egr1
Arc
Npas4
Gadd45g

Forward Primer
CTGTCGAGTCGCGTCCACCC
AGAAATTGAGGATGCTTCACC
ATGGGCTCTCCTGTCAACAC
CGGAGATCATCGCTTTTAGC
GAGCGAACAACCCTATGAGC
GAAGTGGTGGGAGTTCAAGC
GTGGCAGCACTACCTGGATT
TCTACGAGTCCGCCAAAGTC

Reverse Primer
ˍ
ACATGCCGGAGCCGTTGTCG
TGAACCTGGGGACTTCTTTG
GACACGGTCTTCACCATTCC
TCATTTTTCAACACGCCGTA
GAGTCGTTTGGCTGGGATAA
CTCCTCAGCGTCCACATAGA
AGATGGTCAGCAGGGTCAAT
AATGAGGATGCAATGCAGGT

Total RNA was also used for reverse transcription of miRNA using the TaqMan Advanced
MicroRNA reverse transcription kit (ThermoFisher). qRT-PCR was performed using the
TaqMan Universal PCR Master Mix, no AmpErase (ThermoFisher) using advanced probes
for miR-137-3p (mmu480924_mir), miR-34a-5p (mmu481304_mir), miR-27b-3p
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(mmu478270_mir), miR-485-5p (mmu482774_mir), and normalized to miR-191-5p
(mmu481584_mir) under the following protocol: 95 °C for 10 min, 45 cycles of 95 °C for
15 s and 60 °C for 1 min.

3.2.5

Western blot analysis

Whole cell lysates were collected in standard RIPA buffer and quantified using a Bradford
assay (BioRad). Protein lysates (50µg) were loaded on a 6% SDS-PAGE gel and
transferred to nitrocellulose membrane (BioRad) using a wet electroblotting system
(BioRad). The membrane was blocked in 5% milk in Tris-buffered saline with 0.1%
Tween-20 (SigmaAldrich) for 1 hour and incubated overnight at 4°C with primary antibody
(ATRX: 1:500, H-300 Santa Cruz Biotechnology Inc.; INCENP: 1:3000, Sigma). The
following day the membrane was washed and incubated in the appropriate horseradish
peroxidase-conjugated

secondary

antibody

(1:4000,

Jackson

ImmunoResearch

Laboratories, Inc.). The membrane was rinsed briefly in enhanced chemiluminescence
substrate (BioRad) before exposure on a ChemiDoc Gel Imaging System (BioRad).

3.2.6

Magnetic resonance imaging

Mice were perfused with 30mL of PBS supplemented with 1µL/mL heparin (Sandoz) and
2mM ProHance (Bracco Imaging Canada) followed by 30mL 4% paraformaldehyde
supplemented with 2mM ProHance. After perfusion, mice were decapitated, and the skin,
cartilaginous nose tip, and lower jaw were removed. The remaining brain and skull
structures were incubated in PBS supplemented with 2mM ProHance and 0.02% sodium
azide for at least one month before MRI scanning (de Guzman, Wong, Gleave, & Nieman,
2016). A multi-channel 7.0 Tesla MRI scanner (Agilent Inc., Palo Alto, CA) was used to
image the brains within their skulls. Sixteen custom-built solenoid coils were used to image
the brains in parallel (Nieman et al., 2018). In order to detect volumetric changes, we used
the following parameters for the MRI scan: T2- weighted, 3-D fast spin-echo sequence,
with a cylindrical acquisition of k-space, a TR of 350 ms, and TEs of 12 ms per echo for 6
echoes, field-of-view equaled to 20 x 20 x 25 mm3 and matrix size equaled to 504 x 504 x
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630. Our parameters output an image with 0.040 mm isotropic voxels. The total imaging
time was 14 hours (Spencer Noakes, Henkelman, & Nieman, 2017).

3.2.7

MRI Registration and Analysis

To visualize and compare any changes in the mouse brains, the images are linearly (6
followed by 12 parameter) and non-linearly registered together. Registrations were
performed with a combination of mni_autoreg tools (Collins, Neelin, Peters, & Evans,
1994) and ANTS (advanced normalization tools) (Avants, Tustison, Wu, Cook, & Gee,
2011). All scans are then resampled with the appropriate transform and averaged to create
a population atlas representing the average anatomy of the study sample. The result of the
registration is to have all images deformed into alignment with each other in an unbiased
fashion. For the volume measurements, this allows for the analysis of the deformations
needed to take each individual mouse's anatomy into this final atlas space, the goal being
to model how the deformation fields relate to genotype (Lerch et al., 2008; Nieman,
Flenniken, Adamson, Henkelman, & Sled, 2006). The jacobian determinants of the
deformation fields are then calculated as measures of volume at each voxel. Significant
volume differences can then be calculated by warping a pre-existing classified MRI atlas
onto the population atlas, which allows for the volume of 182 different segmented
structures encompassing cortical lobes, large white matter structures (i.e. corpus callosum),
ventricles, cerebellum, brain stem, and olfactory bulbs (Dorr, Lerch, Spring, Kabani, &
Henkelman, 2008; Qiu et al., 2018; Richards et al., 2011; Steadman et al., 2014; Ullmann
et al., 2014) to be assessed in all brains. Further, these measurements can be examined on
a voxel-wise basis to localize the differences found within regions or across the brain.
Multiple comparisons in this study were controlled for using the False Discovery Rate
(Genovese, Lazar, & Nichols, 2002).

3.2.8

Golgi staining and analysis

Brains from 3-month-old mice were stained using the FD Rapid GolgiStain Kit (FD
Neurotechnologies, Inc). They were then flash frozen and sectioned on a cryostat at 100µm
thickness and further processed as per kit instructions. Hippocampal CA1 pyramidal
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neurons were imaged on a laser scanning confocal microscope (Leica SP5). z-Stacks were
obtained of whole neurons (10-15 z-intervals per neuron). 65 Ctrl and 51 Atrx-cKO neurons
were traced from 3 Ctrl/Atrx-cKO pairs. Dendrites were analyzed in ImageJ (FIJI) using
the Simple Neurite Tracer plugin; the traces were analyzed using the Sholl plugin in ImageJ
(FIJI) at a radius step size of 4µm (Ferreira et al., 2014; Longair, Baker, & Armstrong,
2011). Statistics were calculated by two-way repeated measures ANOVA with Sidak’s
multiple comparison test or unpaired Student’s T-tests where applicable.

3.2.9

Open field test

In the open field test, locomotor activity was automatically recorded (AccuScan
Instrument). The mice were placed in an arena with an area of 20 cm x 20 cm with 30 cm
high walls. Mice were acclimated to the room for ten minutes prior to testing. Locomotor
activity was measured in 5 min intervals over 2 hours as previously described (Tamming
et al., 2017). Distance travelled and time spent in the center were recorded. Statistics were
calculated by two-way repeated measures ANOVA with Sidak’s multiple comparison test
or unpaired Student’s T-tests where applicable.

3.2.10

Elevated plus maze

Animals were placed in the center of the elevated plus maze (Med Associate Inc) and their
activity was recorded over 5 min. Total time spent in the open and closed arms was
recorded using computer software (AnyMaze). The center of the mouse body was used as
an indicator of which zone they were in. Statistics were calculated by unpaired Student’s
T-tests.

3.2.11

Y maze

Animals were placed in the center of a symmetrical three-armed Y maze as described (de
Castro et al., 2009; Tamming et al., 2017). Each mouse underwent one trial of 5 minutes.
Order of arm entry was recorded using computer software (AnyMaze) and spontaneous
alternation was counted when a mouse entered all three arms in a row without visiting a
previous arm.
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3.2.12

Novel object recognition

Mice were habituated in an open arena with no objects for 5 minutes on Day 1 and Day 2,
as described (Tamming et al., 2017). On Day 3, mice were exposed to two identical objects
for ten minutes (A; a red plastic ball attached on top of a yellow cube base). Video tracking
(AnyMaze) was used to record time spent with each object. To test short-term memory,
mice were exposed to the original object (A) and a novel object (B; a blue plastic pyramid
attached on top of a green prism base) 1.5 hours after training. To test long-term memory,
mice were exposed to (A) and (B) 24 hours after training. Novel object recognition was
expressed as the percentage of time spent with the novel object as a fraction of the total
time spent interacting. Interaction was defined as sniffing or touching the object, but not
leaning against or climbing on the object.

3.2.13

Morris water maze

The Morris water maze was conducted as described previously (Vorhees & Williams,
2006). The task was performed in a 1.5 m diameter pool with 25°C water and the platform
was submerged 1 cm beneath the water surface. Spatial cues (shapes printed in black &
white) were distributed around the pool. Mice were given four trials (90 s) a day for 4
consecutive days with a 15 min intertrial period. The latency, distance, and swim speed to
find the platform was recorded using video tracking software (AnyMaze). If the mice did
not find the platform within 90 s, they were gently guided onto the platform. On the fifth
and the twelfth days the platform was removed and time spent in each quadrant of the maze
was recorded using the video software. Statistics were calculated by one- or two-way
repeated measures ANOVA with Sidak’s multiple comparison test, where applicable.

3.2.14

Contextual fear conditioning

To measure contextual fear memory, mice were placed in a 20 cm x 10 cm clear acrylic
enclosure with a metal grid floor and one wall distinct from the others (stripes were drawn
on one of the walls). The chamber was equipped with an electric shock generator. Videos
were recorded using the AnyMaze video tracking software. On Day 1, mice could explore
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the enclosure freely and at 150 s the mice were given a shock (2 mA, 180 V, 2 s). After 30
s, the mice were returned to their home cage. The next day (24 h), the mice were placed
back into the enclosure for 6 min and freezing time was measured in 30 s intervals. Freezing
was defined as immobility lasting more than 0.5 s. Statistics were calculated by two-way
repeated measures ANOVA with Sidak’s multiple comparison test or unpaired Student’s
T-tests where applicable.

3.2.15

Touchscreen assays

The paired associate learning (dPAL) and visual paired discrimination (VPD) and reversal
tasks were performed as previously described (Bussey et al., 2008; Delotterie et al., 2015;
Talpos, Winters, Dias, Saksida, & Bussey, 2009). Animals were food-restricted to 85%
starting body weight. Animals were separated into two counter-balanced subgroups to
control for time of day of testing, and equipment variation. Mice were tested in BusseySaksida mouse touch screen chambers (Lafayette Neuroscience) with strawberry
milkshake given as a reward.
For the dPAL acquisition phase, animals were tested for their ability to associate objects
with locations. Mice were presented with two images in two of three windows; one image
was in its correct location (S+) and one was in one of its two incorrect locations (S-). The
third window was blank. A correct response triggered reward presentation and start of an
inter-trial period. The pre-training was repeated until mice reached criterion (completion
of 36 trials within 60 minutes). The dPAL evaluation phase was performed for 45 sessions
over 9 weeks. A correct response triggered reward presentation, whereas an incorrect
response caused a 5 s time out and the house lights to turn on. An incorrect response also
resulted in a correction trial, where the same S+/S- images were presented in the same two
locations until the mouse responded correctly. The mouse was given 36 trials over 60
minutes per day. Percent correct, number of correction trials, latency to a correct or
incorrect response, and latency to retrieve reward were recorded for each week.
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VPD acquisition required the animal to touch the same image (S+) no matter which
window it appeared in. The other screen had an incorrect image (S-). A correct response
triggered reward presentation, whereas an incorrect response triggered the house lights to
turn on, a time out of 5 s, and a correction trial to begin (previous trial repeated until a
correct choice is made). This was repeated until mice reached criterion of 24/30 trials
correct within 60 minutes over 2 consecutive days, after which baseline measurements
were done for two sessions. Parameters for baseline were identical to the acquisition steps.
Immediately following baseline measurements, the VPD task reversal began, where most
parameters were the same as the acquisition, but the correct image associated with the
reward was S-, and the incorrect response that triggers house lights was S+. The mouse
was given 30 trials per day over 10 days. Percent correct, number of correction trials
needed, latency to a correct or incorrect response, and latency to retrieve reward on each
day were recorded. Statistics were calculated by two-way repeated measures ANOVA with
Sidak’s multiple comparison test or unpaired Student’s T-tests where applicable.

3.2.16

RNA sequencing and analysis

Hippocampal total RNA was isolated using the miRVANA RNA isolation kit
(ThermoFisher) from three pairs of 3-month-old control and Atrx-cKO male and female
mice (12 samples total). RNA was quantified using the Qubit 2.0 Fluorometer (Thermo
Fisher Scientific, Waltham, MA) and quality was assessed using the Agilent 2100
Bioanalyzer (Agilent Technologies Inc., Palo Alto, CA) with the RNA 6000 Nano kit
(Caliper Life Sciences, Mountain View, CA). Libraries were prepared, including rRNA
reduction, using the ScriptSeq Complete Gold Kit (H/M/R) (Illumina Inc., San Diego, CA).
Samples were fragmented, cDNA was synthesized, tagged, cleaned-up and subjected to
PCR with barcoded reverse primers (ScriptSeq Index PCR Primers) to permit equimolar
pooling of samples into one library. The pooled library size distribution was assessed on
an Agilent High Sensitivity DNA Bioanalyzer chip and quantitated using the Qubit 2.0
Fluorometer. All samples were sequenced at the London Regional Genomics Centre
(Robarts Research Institute, London, Ontario, Canada; http://www.lrgc.ca) using the
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Illumina NextSeq 500 (Illumina Inc., San Diego, CA). The libraries were sequenced as a
paired end run, 2 x76 bp, using a High Output v2 kit (150 cycles). Fastq data files were
downloaded from BaseSpace. At least 60 million fragments were obtained for each sample.
Raw reads were pre-processed with the sequence-grooming tool cutadapt (Zerbino et al.,
2018) version 0.4.1 with the following quality trimming and filtering parameters (`-phred33 --length36 -q 5 --stringency 1 -e 0.1`). Each set of paired-end reads was mapped
against the Mus Musculus GRCm38.p6 primary assembly downloaded from Ensembl
(Pertea et al., 2015) release 94 (https://useast.ensembl.org/Mus_musculus/Info/
Annotation) using HISAT2 version 2.0.4. SAMtools was then used to sort and convert
SAM files. The read alignments and Mus Musculus GRCm38 genome annotation were
provided as input into StringTie v1.3.3 (Soneson, Love, & Robinson, 2015) which returned
gene and transcript abundances for each sample. We imported coverage and abundances
for transcripts into R using the tximport (Love, Huber, & Anders, 2014) R package and
conducted differential analysis of transcript count data stratified or not on sex using the
DESeq2 R package. For the unstratified analysis, an interaction term was added to the
model in order to test if the effect of ATRX deletion differs across sex. We used the
independent hypothesis weighting (IHW) Bioconductor package (Ignatiadis, Klaus, Zaugg,
& Huber, 2016) to weight p-values and adjust for multiple testing using the procedure of
Benjamini Hochberg (BH) (Benjamini & Hochberg, 1995). Functional enrichment of
significant genes with aggregated p-value <0.05 was evaluated by the ‘weight01’ algorithm
implemented in the R topGO package (Alexa, Rahnenfuhrer, & Lengauer, 2006) that
assesses, prunes and weighs for local dependencies of gene ontology (GO) terms, and
Fisher exact test.

3.2.17

Transmission electron microscopy

Mice were perfused with 4% paraformaldehyde (VWR) dissolved in phosphate buffer and
sectioned at 500µm on a Vibratome Series 1000 Sectioning System. Sections were postfixed overnight in 4% paraformaldehyde for 24h and in 1% glutaraldehyde for 1 hour, then
washed and left in phosphate buffer until preparation of ultra-thin sections. Slices were
transferred to the Biotron facility at Western University for the remaining steps. Coronal
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slices from the hippocampal layer were rinsed in distilled water, post-fixed for one hour at
room temperature in 1% osmium tetroxide (Electron Microscopy Sciences Warrington,
PA) and 1.5% potassium ferrocyanide and post-fixed for a second hour in 1% osmium
tetroxide (Harris, Jensen, & Tsao, 1992). The slices were quickly dehydrated through a
graded series of ethanol, rinsed in 100% acetone and then infiltrated with inversion for one
hour in 50% epon-araldite resin and placed overnight in 100% resin on a rotator. The slices
were polymerized overnight at 60°C in a vented oven, sandwiched between two sheets of
Aclar film covered with a light weight (Bisht, El Hajj, Savage, Sanchez, & Tremblay,
2016). The hippocampal region was cut from the resin-embedded slice using a razor blade
and mounted on a blank epoxy block using cyanoacrylate glue. Semi-thin sections were
made with a Reichert Ultracut ultramicrotome and stained with toluidine blue and used to
select the CA1 neuropil region for ultrathin sectioning. Thin sections (100nm) were
collected on 200 mesh nickel grids (EMS), post-stained with lead citrate and images were
collected with a Philips 420 transmission electron microscope equipped with an AMT 4K
megapixel XR41S-B camera (Woburn, MA). Images were captured within the stratum
radiatum / stratum lacunosum moleculare at 9200X in a semi-random manner to obtain at
least 50 synapses containing a distinct synaptic cleft without regard to the length of the
cleft. Image analysis was performed in ImageJ. A total of 104 Ctrl and 84 Atrx-cKO
synapses were quantified from 3 Ctrl/Atrx-cKO pairs. Synapses were binned in 50nm
increments from the active zone and the number of docked vesicles and vesicles in each
bin were counted; this also determined total number of vesicles per synapse. Vesicle cluster
size was measured to calculate vesicle density. The area of the post-synaptic density was
also quantified. Statistics were calculated by two-way repeated measures ANOVA with
Sidak’s multiple comparison test or unpaired Student’s T-tests where applicable.

3.2.18

Statistical analyses

All data were analyzed using GraphPad Prism software with Student’s T test (unpaired,
two-tailed) or one or two-way repeated measures ANOVA with Sidak’s post-test where
applicable. All results are depicted as mean +/- SEM unless indicated otherwise. P values
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of less than 0.05 were considered to indicate significance. For neuron branching and
transmission electron microscopy analyses, individual neurons or synapses were counted
as a single n value, based on previous literature (de Vivo et al., 2017; Molnar et al., 2016).

3.1 Results
3.1.1

Generation and validation of mice with neuron-specific Atrx
deletion

We generated mice lacking ATRX in postnatal forebrain excitatory neurons by Cre/loxP
mediated recombination of the mouse Atrx gene with the CaMKII-Cre driver line of mice
(Tronche et al., 1999). To confirm loss of ATRX, we performed immunofluorescence
staining of control and conditional knockout (Atrx-cKO) brain cryosections obtained from
3-month-old mice (Figure 3-1A,B). ATRX is highly expressed in excitatory neurons of the
hippocampus of control mice, including the cortex and hippocampal CA1, CA2/3, and
dentate gyrus neurons, but is absent in these cells in the Atrx-cKO mice. Additional
validation of Atrx inactivation in Atrx-cKO mice was achieved by qRT-PCR (Figure 3-1C),
showing that Atrx expression is decreased by 78% (+/- 9.4%) and 81% (+/- 1.7%) in the
cortex and the hippocampus, respectively, which is expected from a neuron-specific
deletion. The brain sub-region specificity of ATRX loss was demonstrated by western blot
analysis, showing reduced protein levels in the rostral and caudal cortices and
hippocampus, but not in the cerebellum (Figure 3-1D). The mice survived to adulthood and
had normal general appearance and behaviour. However, body weight measurements
revealed a small but significant reduction in Atrx-cKO compared to control mice (Figure
3-1E). These findings demonstrate that we achieved specific deletion of Atrx in excitatory
neurons and while the mice were slightly smaller, they survived to adulthood, allowing
further analyses in the adult brain.

3.1.2

MRI analysis reveals anatomical abnormalities in the
hippocampus of Atrx-cKO mice
We first examined control and Atrx-cKO mouse brains for neuroanatomical

anomalies by magnetic resonance imaging (MRI). Using a T2-weighted MRI sequence, we
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Figure 3-1 Validation of Atrx inactivation in pyramidal neurons of the forebrain.
Immunofluorescence in cortex of control (Ctrl) and knockout (Atrx-cKO) male mice.
ATRX: red; DAPI: blue. Scale bar: 100 µm. (B) Immunofluorescence in hippocampus of
control (Ctrl) and knockout (Atrx-cKO) male mice. ATRX: red; DAPI: blue. Scale bar: 200
µm. (C) Atrx RNA transcripts measured by qRT-PCR in the rostral cortex (Ctx) (p<0.005)
and hippocampus (HI) (p<0.001) (n=4). (D) Western blot of ATRX and INCENP using
protein extracts from rostral cortex (RC), caudal cortex (CC), hippocampus (Hip) and
cerebellum (Ceb). (E) Body weight of control and Atrx-cKO male mice at 3 months of age
(n=10) (p<0.05). Statistics by unpaired Student’s T-test.
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Figure 3-2 MRI reveals altered morphology of Atrx-cKO hippocampi.
(A) Absolute volumes of Ctrl and Atrx-cKO mouse brains in mm3 (p<0.0001). (B)
Cumulative images of Ctrl and Atrx-cKO brains displaying changes in density of absolute
volume. (C) Cumulative 3D image from Ctrl and Atrx-cKO mouse brains displaying
changes in density of hippocampus volume relative to brain size. Hippocampus is colored
yellow, areas of increased volume in Atrx-KO are colored orange and areas of decreased
volume in green. (D) Relative size of CA1 stratum radiatum and lacunosum moleculare in
Ctrl and Atrx-cKO mouse brains (p<0.05), with MRI image showing cumulative changes
in Atrx-cKO compared to control. (E) Relative size of CA3 pyramidal layer in Ctrl and
Atrx-cKO mouse brains (p<0.005), with MRI image showing cumulative changes in AtrxcKO compared to control. (F) Relative volumes of all hippocampal structures, including
mean and standard deviation (SD) of Ctrl and Atrx-cKO, percent difference (%Diff), effect
size, P-value, and false discovery rate (FDR). Asterisks indicate p<0.05. All data is derived
from 16 Ctrl and 13 Atrx-cKO mouse brains.
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were able to analyze and compare the entire brain as well as independent brain regions
from 16 control and 13 Atrx-cKO male animals. The data obtained showed that the overall
volume of the Atrx-cKO brain is significantly smaller compared to controls (92.8% of
control volume, P<0.0001), as indicated by whole volume in mm3 and cumulative serial
slices of control and Atrx-cKO brains (Figure 3-2A,B), which correlates with the smaller
body size of the mice. Due to the reduction in body size and absolute total brain and
hippocampal volumes of the Atrx-cKO mice, we next examined hippocampal
neuroanatomy relative to total brain volume (Figure 3-2C). The relative volume of the CA1
stratum radiatum (SR) and stratum lacunosum moleculare (SLM) was significantly
increased in the Atrx-cKO mice compared to controls (Figure 3-2D) whereas the CA3
pyramidal layer was significantly decreased in size (Figure 3-2E). Relative volumes of all
hippocampal regions are tabulated in Figure 3-2F.
We postulated that the increase in relative volume of the CA1 SR/SLM may be due to
increased length or branching of CA1 apical dendrites. To investigate this possibility, Golgi
staining was used to sporadically label neurons (Figure 3-3A) and Sholl analysis was
performed on confocal microscopy images to evaluate apical dendrite branching of CA1
hippocampal neurons. However, no significant difference in dendritic branching or length
was observed between control and Atrx-cKO mice, whether analyzed separately for apical
or basal dendrites (Figure 3-3B-G). Increased relative volume might also be caused by an
increased number of cells, but immunofluorescence staining and quantification of
astrocytes (GFAP+) and microglia (IBA1+) and total number of cells (inferred from
DAPI+ staining) revealed no differences in Atrx-cKO hippocampi (Figure 3-3H-J).
Overall, the increased relative volume of the CA1 SR/SLM cannot be explained by
increased length or complexity of dendritic trees or by an increased number of glial cells.

3.1.3

Pre- and post-synaptic structural defects in Atrx-cKO male
mice

Based on the hippocampal structural alterations we detected by MRI, we looked more
closely at potential ultrastructural changes in the CA1 SR/SLM area using transmission
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Figure 3-3 CA1 dendritic length and branching and the number of non-neuronal
cells are not affected in Atrx-cKO mouse hippocampi.
(A) Representative Golgi traces from Ctrl and Atrx-cKO hippocampal CA1 pyramidal
neurons. (B) Sholl analysis of Ctrl (n=73) and Atrx-cKO (n=53) CA1 pyramidal neurons
(p=0.0842). (C) Total length of Ctrl and Atrx-cKO CA1 dendrites (p=0.2994). (D) Sholl
analysis of Ctrl and Atrx-cKO CA1 apical dendrites (p=0.3858). (E) Total length of Ctrl
and Atrx-cKO CA1 apical dendrites (p=0.7832). (F) Sholl analysis of Ctrl and Atrx-cKO
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CA1 basal dendrites (p=0.7339). (G) Total length of Ctrl and Atrx-cKO CA1 basal
dendrites (p=0.2237). (H) Immunofluorescence staining of GFAP or IBA1 in Ctrl and
Atrx-cKO hippocampi. DAPI was used as a counterstain. Scale bar indicates 400 µm. (I)
Quantification of the proportion of GFAP+ (p=0.2151) and IBA1+ (p=0.7903) cells in
stratum radiatum/stratum lucidem moleculare of Ctrl and Atrx-cKO hippocampi (n=5). (J)
Quantification of DAPI+ cells per mm2 in n stratum radiatum/stratum lucidem moleculare
of Ctrl and Atrx-cKO hippocampi (n=10, p=0.2904). Data was analyzed by unpaired
Student’s T-Test or two-way repeated measures ANOVA with Sidak’s multiple
comparisons test where applicable, and asterisks indicate p<0.05. Data is displayed as mean
+/-SEM.
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Figure 3-4 Ultrastructural analysis of Atrx-cKO CA1 apical synapses reveals a
reduced number of total or docked presynaptic vesicles, wider synaptic cleft and
larger post-synaptic density.
(A) Representative images of Ctrl and Atrx-cKO CA1 synapses imaged by transmission
electron microscopy. Red shading indicates presynaptic neuron, blue shading indicates
postsynaptic neuron. Scale bar = 200 nm. (B) Number of vesicles in 50nm bins from the
active zone (p=0.9504) (Ctrl n=60, Atrx-cKO n=63). (C) Number of total vesicles (p<0.01).
(D) Density of vesicles per cluster (p<0001). (E) Number of docked vesicles (p<0.05). (F)
Post-synaptic density (PSD) area (p<0.005). (G) Synaptic cleft width (p< 0.0001). (H)
Length of the pre-synaptic active zone (p=0.7039). (I) Synaptic vesicle cluster size
(p=0.9917). (J) Vesicle diameter (p=0.1895). Data was analyzed by unpaired Student’s Ttest or two-way repeated measures ANOVA with Sidak’s multiple comparisons test where
applicable, and asterisks indicate p<0.05. Data is displayed as mean +/- SEM.
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electron microscopy (TEM) (Figure 3-4A). The presynaptic boutons were divided in 50nm
bins from the active zone, and the number of vesicles in each bin was counted. The spatial
distribution of vesicles in relation to the cleft was unchanged between the Atrx-cKO mice
and controls (Figure 3-4B). However, we found that the total number of vesicles, the
density of the vesicles, and the number of docked vesicles was significantly decreased at
Atrx-cKO compared to control synapses (Figure 3-4C-E).

We also analysed other

structural aspects of synapses and found that the size of the post-synaptic density and the
width of the synaptic cleft were both increased in Atrx-cKO compared to controls (Figure
3-4F,G). The length of the active zone, cluster size, or diameter of the vesicles did not vary
significantly between control and Atrx-cKO samples (Figure 3-4H-J). These results suggest
that ATRX is required for structural integrity of the pre- and post-synapse, including
maintenance of the synaptic vesicle pool at pre-synaptic termini and potential defects in
postsynaptic protein clustering.

3.1.4

Loss of ATRX in neurons leads to long-term spatial learning
and memory deficits

We next performed a battery of behaviour tests on male Atrx-cKO mice. Locomotor
activity in the open field test was not significantly different between Atrx-cKO mice
compared to controls, either over time (F=0.1722, P=0.6803) or if considering total
distance travelled (T=0.6691, P=0.5072; Figure3-5A,B). The Atrx-cKO mice did not spend
significantly more time in the centre of the chamber over time (F=2.960, P=0.0927; Figure
3-5C). However, they spent significantly more total time in the centre of the chamber when
compared to controls (T=2.262, P=0.0291; Figure 3-5D), suggesting that loss of ATRX in
neurons has an anxiolytic effect. This was confirmed by the behaviour of the Atrx-cKO
mice in the elevated plus maze, as they spent significantly more time in the open arm of
the maze compared to controls (T=2.158, P=0.0403; Figure 3-5E,F). We observed no
difference in percent alternation in the Y-maze (T=0.9431, P=0.3543 Figure 3-5G), nor in
the training phase of the novel object recognition task (Ctrl T=1.128, P=0.2697; cKO
T=1.657, P=0.1096; Figure 3-5H) or memory tests at 1.5 hours (Ctrl T=4.277, P<0.001;
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Figure 3-5 The Atrx-cKO males displayed decreased anxiety in the open field test
and elevated plus maze.
(A) Distance travelled over 120 minutes in the open field test (p=0.6803) (n=22). (B) Total
distance travelled (p=0.5072). (C) Time spent in the centre over 120 minutes in the open
field test (p=0.0927) (n=22). (D) Total time spent in the centre (p<0.05). (E) Time spent in
the closed (p=0.1308) and open (p<0.05) arm of the elevated plus maze (n=14). Statistics
by two-way repeated measures ANOVA with Sidak’s multiple comparisons test or
Student’s T-test where applicable, asterisks indicate p<0.05.
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cKO T=3.545, P<0.005) or 24 hours (Ctrl T=1.645, P=0.112; cKO T=2.459, P<0.05;
Figure 3-5I).
To investigate the effects of neuronal-specific ATRX ablation on spatial learning and
memory, we tested the mice in the Morris water maze task. The Atrx-cKO mice showed a
significant delay in latency to find the platform on day 3 of the learning portion of the task;
however, by day 4 they were able to find the platform as quickly as the control mice
(F=4.622, P=0.0404; Figure 3-6A). This finding was reflected in the distance traveled to
find the platform (F=4.829, P=0.0364; Figure 3-6B). Swim speed was comparable to
controls over the four days of learning the task (F=0.04238, P=0.8384; Figure 3-6C),
confirming the findings of the open field test which showed similar activity levels between
control and Atrx-cKO mice. Memory was tested on day 5 (24h after last training day) and
day 12 (7 days after last training day). Both controls (F=29.36, P<0.0001) and the AtrxcKO male mice (F=18.97, P<0.0001) spent significantly more time in the target quadrant
than the left, opposite, or right quadrants (Figure 3-6D). However, on day 12, Atrx-cKO
male mice failed to spend significantly more time in the target quadrant (F=1.420,
P=0.2594) whereas controls were still able to remember (F=6.785, P<0.01), suggesting a
long-term spatial memory deficit (Figure 3-6E). Moreover, Atrx-cKO male mice froze
significantly less in the contextual fear memory task in comparison to their control
counterparts 24h after a foot shock (over time F=5.392, P=0.0251; total time T=2.322;
P=0.0251; Figure 3-6F,G). These behavioural analyses suggest that ATRX in required in
excitatory neurons for long-term hippocampal-dependent spatial learning and memory.

3.1.5

Neuron-specific deletion of Atrx in female mice does not
cause memory deficits

To determine whether loss of ATRX in female mice would exhibit similar behavioural
defects as seen in male mice, we generated Atrx-cKO female mice (Atrx-cKOFem) and
validated loss of ATRX in forebrain excitatory neurons by immunofluorescence staining
and qRT-PCR (Figure 3-7A-C). Atrx-cKOFem mice displayed normal locomotion over time
(F=1.239, P=0.2796) or in total distance travelled in the open field test (T=1.113,

109

Figure 3-6 The Atrx-cKO mice exhibit impaired long-term spatial memory in the
Morris water maze paradigm and in the contextual fear conditioning task.
(A,B,C) Latency to reach the platform (p<0.05), distance travelled (p<0.05), and
swimming speed (p=0.8384) over four days (four trials per day) in the Morris water maze
(n=15). (D) Percent time spent in each quadrant after removal of the platform on day 5.
Dotted line indicates chance at 25%. (E) Percent time spent in each quadrant after removal
of the platform on day 12. Dotted line indicates chance at 25%. (F) Percent of time freezing
over 360s during the contextual fear conditioning task (p<0.05) (n=22). (G) Total time
freezing (p<0.05). Statistics by two-way repeated measures ANOVA with Sidak’s multiple
comparisons test or Student’s T-test where applicable, asterisks indicate p<0.05.
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P=0.2796). Furthermore, we observed no changes in anxiety in the open field test over time
(F=0.009, P=0.9254), total time spent in centre (T=0.095, P=0.9254; Figure 3-8A-D) nor
in the time spent in the open arm (T=0.4947, P=0.6250) and closed arm (T=0.4907,
P=0.6277; Figure 3-8E) in the elevated plus maze in the Atrx-cKOFem mice compared to
control, indicating that the decreased anxiety levels are sex-specific.
Conversely to what was observed in the Atrx-cKO male mice we failed to observe
differences between Atrx-cKOFem and control mice in latency in the Morris water maze
training sessions (latency F=3.631, P=0.0683; distance F=1.385, P=0.2503; speed
F=1.243, P=0.2754; Figure 3-9A-C). Memory of the platform location remained equivalent
to that of controls when tested on day 5 or day 12 (Ctrl day 5 F=12.80, P<0.0001; cKO day
5 F=11.63, P=0.0006; Ctrl day 12 F=16.47, P<0.0001; Atrx-cKOFem day 12 F=12.97,
P<0.0001; Figure 3-9D,E). Finally, there was no difference in freezing between control
and Atrx-cKOFem 24h after foot shock in the contextual fear conditioning task (over time
F=0.02257, P=0.8818; total time T=0.1502, P=0.8818; Figure 3-9F,G). We conclude that
learning and memory is not impaired by ATRX loss in forebrain excitatory neurons of the
Atrx-cKOFem mice.

3.1.6

Impaired object location associative memory in the rodent
version of the paired associate learning (dPAL) task.

Given the observed male-specific defects in spatial memory, we performed additional
translational cognitive tasks on the Atrx-cKO male mice. The dPAL touchscreen task in
mice is analogous to cognitive testing done in humans by the Cambridge
Neuropsychological Test Automated Battery (CANTAB) (Nithianantharajah et al., 2015;
Sahakian et al., 1988) and normal performance in this task is thought to partly depend on
the hippocampus (Delotterie et al., 2015; C. H. Kim, Heath, Kent, Bussey, & Saksida,
2015).
Control and Atrx-cKO mice were trained to identify the position of three images as depicted
in Figure 3-10A, undergoing 36 trials per day for 10 weeks. The results demonstrate that
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Figure 3-7 Expression of Atrx in Atrx-cKO females.
Immunofluorescence in cortex of control (CtrlFem) and knockout (Atrx-cKOFem) female
mice. ATRX: red; DAPI: blue. Scale bar: 50 µm. (B) Immunofluorescence in hippocampus
of control (CtrlFem) and knockout (Atrx-cKOFem) female mice. ATRX: red; DAPI: blue.
Scale bar: 200 µm. (C) Expression of Atrx in the hippocampus by qRT-PCR (n=4)
(p<0.005). Statistics by unpaired Student’s T-test.
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the Atrx-cKO mice exhibit a profound deficit in this task, indicated by both the percent
correct (F=10.53, P=0.0031; Figure 3-10B) and the number of correction trials required
(F=30.64, P<0.0001; Figure 3-10C). These defects were not due to an inability to perform
within the chamber or to attentional deficits, as latency to a correct answer (F=0.4802,
P=0.4943), to an incorrect answer (F=0.1259, P=0.7255), and to retrieve the reward
(F=0.9840, P=0.3300) was not significantly different between control and Atrx-cKO mice
(Figure 3-10D-F). To determine if the impairment in the dPAL task is caused by a vision
problem rather than a learning defect, the mice were also tested in the visual paired
discrimination (VPD) touchscreen task which requires the mice to discriminate between
two images regardless of position on the screen. While the Atrx-cKO mice took
significantly longer to reach the criterion pre-testing (T=2.945, P=0.0067; Figure 3-10G),
there was no difference in the percent correct during baseline tests or after reversal
compared to controls, suggesting that vision is intact in the Atrx-cKO mice (F=1.388,
P=0.2490; Figure 3-10H). They did however require an increased number of correction
trials, indicating that their cognitive flexibility may be marginally impaired compared to
controls (F=11.84, P=0.0019; Figure 3-10I). The results of these touchscreen tests reinforce
the findings that the Atrx-cKO male mice have impaired learning and memory.

3.1.7

RNA sequencing of the hippocampus reveals sex-specific
transcriptional changes

Immediate early genes (IEGs) are activated rapidly and transiently upon neuronal
stimulation (Cole, Saffen, Baraban, & Worley, 1989; Minatohara, Akiyoshi, & Okuno,
2015). In cultured neurons, ATRX is localized to a subset of IEG regulatory elements, and
its protein binding partner DAXX is required for transcriptional activation of IEGs upon
neuronal activation. Therefore, we investigated whether this was true for ATRX. In
cultured E16.5 cortical neurons upon neuronal activation we found no significant changes
in expression of a variety of immediate early genes (Appendix A), indicating that ATRX
is not required in cortical neurons for activity-dependent regulation of IEG expression.
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Figure 3-8 Atrx-cKO females have no change in anxiety.
(A) Distance travelled over 120 minutes in the open field test (p=0.2796) (CtrlFem n=12,
Atrx-cKOFem n=9). (B) Total distance travelled (p=0.2796). (C) Time spent in the centre
over 120 minutes in the open field test (p=0.9254) (CtrlFem n=12, Atrx-cKOFem n=9). (D)
Total time spent in the centre (p=0.9254). (E) Time spent in the closed (p=0.6277) and
open (p=0.6250) arm of the elevated plus maze (CtrlFem n=15, Atrx-cKOFem n=12).
Statistics by two-way repeated measures ANOVA with Sidak’s multiple comparisons test
or Student’s T-test where applicable.
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To identify the molecular mechanism(s) leading to spatial memory impairment, we
performed RNA-sequencing in both male and female hippocampi obtained from three pairs
of littermate-matched Ctrl/Atrx-cKO and CtrlFem/Atrx-cKOFem mice. There were 1520
transcripts differentially expressed in the Atrx-cKO males compared to control counterparts
and 9068 transcripts in Atrx-cKOFem compared to the female controls (FDR < 0.20). To
isolate transcripts that were likely to be causative to the impaired learning and memory
phenotype in the male mice which was not found in the female mice, we focused on
transcripts whose changes in expression with the Atrx-cKO were differential between male
and female mice (n = 1054 transcripts, interaction term FDR < 0.05, Supplementary Table
1). The expression heat map of these transcripts illustrates that their expression levels are
similar in control males and females but are differentially expressed when ATRX is lost
depending on sex (Figure 3-11A). We then utilized PANTHER (Mi et al., 2017), a tool for
gene enrichment analysis based on functional annotations to examine Gene Ontology
biological processes for which our list of transcripts was enriched (Figure 3-11B). The top
five pathways included neurotransmitter receptor transport to postsynaptic membrane,
protein localization to postsynaptic membrane, non-motile cilium assembly, and vesiclemediated transport to the membrane. Therefore, the RNA sequencing revealed many
transcripts related to synapses, supporting the TEM data.
Certain miRNA are enriched within presynaptic terminals and have been implicated in
neurotransmitter release by controlling expression of SNARE and other synaptic vesicle
proteins (Ryan, Joilin, & Williams, 2015). These miRNA include miR-485, miR-34a, miR137, and miR-27b. miR-485 targets a vesicular glycoprotein SV2A and overexpression
results in decreased neurotransmitter release (Cohen, Lee, Chen, Li, & Fields, 2011), while
miR-34a also targets vesicular proteins SYT1 and SYN1, affecting miniature excitatory
postsynaptic currents (Agostini et al., 2011). miR-27b regulates two-thirds of the
presynaptic transcriptome by silencing expression of the negative transcriptional regulator
Bmi1 (Poon, Gu, Ji, VanDongen, & Fivaz, 2016), and miR-137 overexpression affects
synaptic vesicle localization and LTP (Siegert et al., 2015). To determine whether any of
these miRNAs might be regulated by ATRX, with differential effects in male and female
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Figure 3-9 No change in spatial learning or memory in Atrx-cKO females in the
Morris water maze or contextual fear conditioning tasks.
(A,B,C) Latency (p=0.0683), distance (p=0.2503), and speed (p=0.2754) over four days
(four trials per day) in the Morris water maze (CtrlFem n=15, Atrx-cKOFem n=12). (D)
Percent time spent in each quadrant after removal of the platform on day 5. Dotted line
indicates chance at 25%. (E) Percent time spent in each quadrant after removal of the
platform on day 12. Dotted line indicates chance at 25%. (F) Percent of time freezing over
360s during the contextual fear conditioning task (p=0.8818) (CtrlFem n=15, Atrx-cKOFem
n=12. (G) Total time freezing (p=0.8818). Statistics by two-way repeated measures
ANOVA with Sidak’s multiple comparisons test or Student’s T-test where applicable,
asterisks indicate p<0.05.
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cKO hippocampi, we assessed their expression by qRT-PCR. This analysis revealed no
significant changes in the expression the miR-485, miR-34a, and miR-27b (Figure 3-11CE). Conversely, we observed a striking and significant sex-specific effect of ATRX loss
on the expression of miR-137 in Atrx-cKO hippocampi, with an upregulation of expression
in the male hippocampi and a downregulation in the female hippocampi (Figure 3-11f). To
further confirm this finding, we mined previous microarray data of neonatal forebrain
tissue of mice lacking ATRX in the forebrain (Atrxfl/fl x FoxG1-Cre cross) (Levy,
Fernandes, Tremblay, Seah, & Berube, 2008). Analysis of this data through the gene
enrichment analysis tool TOPPGENE (Chen, Bardes, Aronow, & Jegga, 2009) revealed
enrichment of downregulated genes in Gene Ontology categories including synaptic
signalling and regulation of excitatory potential (Figure 3-12A) as well as an enrichment
for targets of miR-137 (Figure 3-12B). We compared the list of genes downregulated in
the Atrx-cKO male hippocampi to those predicted to be regulated by miR-137 through
miRNA.org. We found Shank2, Cadps2, Glrb, and Sgip1 expression to be inversely related
to miR-137, with expression decreased in Atrx-cKO and increased in Atrx-cKOFem. Shank2
and Glrb are both postsynaptic proteins, with Shank2 (SH3 and multiple ankyrin repeat
domains 2) acting as a scaffolding protein within the PSD (Sheng & Kim, 2000) and GlrB
(Glycine receptor beta), is the beta subunit of the glycine receptor (Rajendra, Lynch, &
Schofield, 1997). Cadps2 and Sgip1 are found at the presynaptic terminal, where Cadps2
(Ca2+-dependent activator protein for secretion 2) regulates exocytosis of vesicles
(Cisternas, Vincent, Scherer, & Ray, 2003) and Sgip1 (Src homology 3-domain growth
factor receptor-bound 2-like interacting protein 1) is involved in clathrin-mediated
endocytosis (Dergai et al., 2010). This data provides additional evidence that loss of ATRX
in the cortex and hippocampus of male mice leads to increased miR-137 expression and
consequent downregulation of its target genes, starting at early stages of forebrain
development.

3.2 Discussion
This study presents evidence that ATRX is required in a sex-specific manner in excitatory
forebrain neurons for normal spatial learning and memory. We found that loss
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Figure 3-10 Atrx-cKO mice display deficits in spatial learning in the PairedAssociate Learning operant task.
(A) Representative images used in the paired-associate learning task, where touching the
(+) stimuli on the screen results in reward and the (-) stimuli results in negative
reinforcement (Talpos et al., 2009). (B) Percent correct over 10 weeks (p<0.005). Dotted
line indicates % correct by chance. (C) Number of correction trials required over ten weeks
(p<0.0001). (D) Latency to choose a correct answer (p=0.49). (E) Latency to choose an
incorrect answer (p=0.72). (F) Latency to retrieve the reward (p=0.33). (G) Number of days
to reach criterion in the Visual Paired Discrimination task (p<0.01). (H) Percent correct
during baseline (two days) and reversal (10 days) (p=0.25). (I) Number of correction trials
required during baseline and reversal trials (p<0.005). Statistics by two-way repeated
measures ANOVA with Sidak’s multiple comparisons test or Student’s T-test where
applicable, asterisks indicate p<0.05.
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of ATRX in these neurons resulted in impaired long-term memory in the Morris water
maze, contextual fear conditioning task, and impaired learning in the dPAL touchscreen
assay. Magnetic resonance imaging revealed a higher relative volume of hippocampal CA1
SR/SLM and decreased relative volume of the CA3 pyramidal cell layer. There are two
hippocampal pathways implicated in spatial learning and memory, the Schaffer collateral
pathway and the temporoammonic pathway. The Schaffer collateral pathway involves the
CA3 axons projecting to the CA1 medial apical dendrites (Vago & Kesner, 2008), whereas
the temporoammonic pathway initiates in layer III of the entorhinal cortex and projects to
the CA1 middle apical dendritic layer (Nguyen & Kandel, 1996).

We originally

hypothesized that the increased volume of the CA1 SR/SLM may be due to increased
branching of pyramidal neurons, particularly the apical dendrites that project to this region.
However, analysis of Golgi stained CA1 neurons failed to show abnormalities in dendritic
branching that would explain the MRI data. Astrocyte and microglia infiltration have been
linked with defects in learning and memory in various mouse models (Bian et al., 2012;
McGill et al., 2018; Tanaka et al., 2006). Yet after examination of these cell types by
immunofluorescence staining, we saw no change in either astrocyte or microglia cell
number. The reason for volume increase thus remains undetermined, but might be caused
by other cell types infiltrating the hippocampus such as T cells or to increased volume of
the perineuronal net (changes to the extracellular matrix), which has been shown in mouse
models to help regulate learning and memory (Bukalo, Schachner, & Dityatev, 2001;
Hylin, Orsi, Moore, & Dash, 2013). An alternative explanation is that volumetric
measurements are normal in these areas but decreased elsewhere in the hippocampus.
Loss of ATRX in the Atrx-cKO male mice resulted in various hippocampal-dependent
memory impairments including contextual fear memory, and spatial learning and memory
in the Morris water maze and paired-associate touchscreen task. The results from the
touchscreen task were especially interesting considering the translational aspect of these
tests (Bussey et al., 2012), and comparable results to humans are achieved using mouse
models of cognitive impairments (Nithianantharajah et al., 2013; Nithianantharajah et al.,
2015). Unexpectedly, Atrx-cKOFem mice displayed normal memory in several
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Figure 3-11 Transcriptional profiling reveals dysregulation of presynaptic vesicular
genes possibly resulting from miR-137 overexpression.
(A) Heat map analysis of differentially expressed transcripts according to sex (FDR < 0.05)
by RNA sequencing from Ctrl, Atrx-cKO, CtrlFem, and Atrx-cKOFem hippocampi. (B)
Unique transcripts that were regulated in a sex-specific manner upon loss of ATRX were
used for Gene Ontology analysis and top 25 Biological Processes were listed by
Enrichment value (p<0.001, FDR<0.05). Those related to synapses were noted with a red
asterisk. (C) Expression of miR-485 in Ctrl and Atrx-cKO (p=0.1284), CtrlFem and AtrxcKOFem (p=0.3787) hippocampi normalized to miR-191. (D) Expression of miR-34a in Ctrl
and Atrx-cKO (p=0.3072), CtrlFem and Atrx-cKOFem (p=0.7193) hippocampi normalized to
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miR-191. (E) Expression of miR-27b in Ctrl and Atrx-cKO (p=0.3953), CtrlFem and AtrxcKOFem (p=0.4968) hippocampi normalized to miR-191. (F) Expression of miR-137 in Ctrl
and Atrx-cKO (p<0.05), CtrlFem and Atrx-cKOFem (p<0.01) hippocampi normalized to miR191. (G) Transcript expression of Shank2, Cadsp2, Glrb, and Sgip1 in Ctrl, Atrx-cKO,
CtrlFem and Atrx-cKOFem hippocampi. Data was analyzed by unpaired Student’s T-test
where applicable, and asterisks indicate p<0.05. Data is displayed as mean +/- SEM.
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paradigms, indicating a sex-specific phenomenon upon ATRX inactivation. In humans,
females harbouring ATRX mutations are protected from the disease by complete skewing
of X-inactivation (Gibbons, Suthers, Wilkie, Buckle, & Higgs, 1992); however this cannot
be the case here since the mice were homozygous for the “floxed” allele and we confirmed
by immunofluorescence staining that ATRX is indeed absent from hippocampal excitatory
neurons. We did not sync estrous cycles of the Atrx-cKOFem mice (except those housed
together), which has been shown to influence some behaviours (Meziane, Ouagazzal,
Aubert, Wietrzych, & Krezel, 2007), however we did not see a difference in variability
compared to the male mice. Sexual dimorphism has been reported in other mouse models
with mutations in chromatin remodeling proteins, including CHD8 and MeCP2, where
females are unaffected by loss of the protein of interest or are affected differently (Jung et
al., 2018; K. C. Kim et al., 2016; Kurian, Bychowski, Forbes-Lorman, Auger, & Auger,
2008). In humans, neurological disorders such as autism-spectrum disorders tend to
preferentially affect males rather than females, possibly due to combinatorial contributions
of hormonal and genetic factors in a phenomenon known as the female protective effect
(Fombonne, 2009; Jacquemont et al., 2014; Voineagu et al., 2011), and this is regularly
supported with mouse models (Hu, Sarachana, Sherrard, & Kocher, 2015; Sato et al., 2012;
Tsutiya et al., 2017). The presence of estrogen and estrogen receptor in the female brain
has been shown to be neuroprotective and leads to enhanced Schaffer-collateral LTP
(Wang et al., 2018). In addition, certain X-linked genes involved in chromatin regulation
(e.g. Utx, a histone demethylase) are able to escape X-inactivation and so are expressed
two-fold in females compared to males (Xu, Deng, Watkins, & Disteche, 2008). These
mechanisms could lead to protective gene regulation in the Atrx-cKOFem, causing the
sexually dimorphic defects in learning and memory. We previously reported impairment
of spatial learning and memory in a female mouse model with mosaic expression of ATRX
in all cells of the central nervous system (Tamming et al., 2017). This suggests the
intriguing possibility that female-specific protective factors originate from cell types other
than the excitatory neurons targeted in the present study. Female-specific glial factors, for
example might provide important protection against the loss of ATRX in neurons.
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MicroRNAs (miRNAs) are critical for the regulation of transcriptional programs in the
brain. Excitation of whole neuronal networks results in drastic changes to miRNA levels,
such as in seizures or traumatic brain injury (Jimenez-Mateos et al., 2011; Lei, Li, Chen,
Yang, & Zhang, 2009). miRNA levels can also change after exposure to certain
behavioural tasks including contextual fear conditioning or novel object recognition (Lin
et al., 2011; Woldemichael et al., 2016). At the molecular level, miRNAs can target 100s
to 1000s of genes thereby altering expression of proteins at the presynaptic terminal,
postsynaptic membrane, or both. The TEM and RNA-sequencing data obtained in the
current study identified impaired presynaptic vesicular function, with decreased number of
docked and total vesicles, prompting us to focus on miRNAs previously implicated in these
functions: miR-485, miR-34a, miR-27b, and miR-137. Of the four miRNA tested, only
miR-137 was significantly increased in Atrx-cKO male hippocampi while decreased in
expression in the Atrx-cKOFem hippocampi, identifying another mechanism by which the
females may be protected by ATRX loss. miR-137 overexpression has previously been
linked to impaired hippocampal-dependent learning and memory in mice through the
Morris water maze and contextual fear conditioning task, similar to the Atrx-cKO mice
(Siegert et al., 2015). Additionally, miR-137 overexpression results in altered vesicular
trafficking and reduced LTP in vivo and a reduction in the number of docked and total
vesicles in vitro (He et al., 2018; Siegert et al., 2015), again paralleling our findings in the
Atrx-cKO mice. miR-137 is also known to regulate expression of genes involved in
postsynaptic function, including NMDA and AMPA receptor synthesis (Olde Loohuis et
al., 2015; Zhao et al., 2013) and multiple targets in the PI3K-Akt-mTOR pathway (Thomas
et al., 2017). Therefore, increased expression of miR-137 could explain the presynaptic
defects seen in the Atrx-cKO male mice and may have other effects within the post-synaptic
density and downstream signalling that should be examined in more detail in the future.
The previously reported ATRXΔE2 mice had impaired contextual fear memory, working
memory, novel object recognition memory, and spatial memory in the Barnes maze
(Nogami et al., 2011; Shioda et al., 2011). Molecular analyses revealed decreased levels of
CaMKII protein at synapses and increased expression of the Xlr3b gene, which is proposed
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Figure 3-12 Transcriptional profiling reveals dysregulation of presynaptic genes in
Atrx-FoxG1 mice.
(A) Differentially expressed genes between Control and Atrx-FoxG1 P0.5 forebrain were
used for Gene Ontology analysis and top 25 Biological Processes were listed by P-value.
(B) Top miRNA predicted to regulate differentially expressed genes from Control and
Atrx-FoxG1 mice.
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to bind synaptic mRNAs and inhibit transport to dendritic spines (Shioda et al., 2018). In
comparison, the Atrx-cKO male mice had no defects in working memory (Y-maze) or in
novel object recognition. These differences point to potential cell-type specific effects,
where ATRX downregulation or loss contributes to spatial memory, while loss in other cell
types affects working and recognition memory. The timing of inactivation might also
explain differences in behavioural outcomes. The ATRXΔE2 mice may display a greater
number of defects because ATRX depletion is present from the beginning of brain
development, while Atrx inactivation occurs postnatally in the CamKII-Cre conditional
approach taken here. Future investigations should discern the effects of inactivating ATRX
in various cell types on cognitive output.
In conclusion, our study presents strong evidence that ATRX is required in forebrain
excitatory neurons for spatial learning and long-term memory and regulation of genes
required for efficient synaptic transmission.

3.3 References
Agostini, M., Tucci, P., Steinert, J. R., Shalom-Feuerstein, R., Rouleau, M., Aberdam, D.,
. . . Melino, G. (2011). microRNA-34a regulates neurite outgrowth, spinal
morphology, and function. Proc Natl Acad Sci U S A, 108(52), 21099-21104. doi:
10.1073/pnas.1112063108
Alexa, A., Rahnenfuhrer, J., & Lengauer, T. (2006). Improved scoring of functional groups
from gene expression data by decorrelating GO graph structure. Bioinformatics,
22(13), 1600-1607. doi: 10.1093/bioinformatics/btl140
Avants, B. B., Tustison, N. J., Wu, J., Cook, P. A., & Gee, J. C. (2011). An open source
multivariate framework for n-tissue segmentation with evaluation on public data.
Neuroinformatics, 9(4), 381-400. doi: 10.1007/s12021-011-9109-y
Benjamini, Yoav, & Hochberg, Yosef. (1995). Controlling the false discovery rate: a
practical and powerful approach to multiple testing. Journal of the Royal statistical
society: series B (Methodological), 57(1), 289-300.
Bérubé, N. G., Mangelsdorf, M., Jagla, M., Vanderluit, J., Garrick, D., Gibbons, R. J., . . .
Picketts, D. J. (2005). The chromatin-remodeling protein ATRX is critical for
neuronal survival during corticogenesis. J Clin Invest, 115(2), 258-267. doi:
10.1172/JCI22329

125

Bian, Y., Pan, Z., Hou, Z., Huang, C., Li, W., & Zhao, B. (2012). Learning, memory, and
glial cell changes following recovery from chronic unpredictable stress. Brain Res
Bull, 88(5), 471-476. doi: 10.1016/j.brainresbull.2012.04.008
Bisht, K., El Hajj, H., Savage, J. C., Sanchez, M. G., & Tremblay, M. E. (2016). Correlative
Light and Electron Microscopy to Study Microglial Interactions with beta-Amyloid
Plaques. J Vis Exp(112). doi: 10.3791/54060
Bukalo, O., Schachner, M., & Dityatev, A. (2001). Modification of extracellular matrix by
enzymatic removal of chondroitin sulfate and by lack of tenascin-R differentially
affects several forms of synaptic plasticity in the hippocampus. Neuroscience,
104(2), 359-369.
Bussey, T. J., Holmes, A., Lyon, L., Mar, A. C., McAllister, K. A., Nithianantharajah, J., .
. . Saksida, L. M. (2012). New translational assays for preclinical modelling of
cognition in schizophrenia: the touchscreen testing method for mice and rats.
Neuropharmacology, 62(3), 1191-1203. doi: 10.1016/j.neuropharm.2011.04.011
Bussey, T. J., Padain, T. L., Skillings, E. A., Winters, B. D., Morton, A. J., & Saksida, L.
M. (2008). The touchscreen cognitive testing method for rodents: how to get the
best out of your rat. Learn Mem, 15(7), 516-523. doi: 10.1101/lm.987808
Chen, J., Bardes, E. E., Aronow, B. J., & Jegga, A. G. (2009). ToppGene Suite for gene
list enrichment analysis and candidate gene prioritization. Nucleic Acids Res,
37(Web Server issue), W305-311. doi: 10.1093/nar/gkp427
Cisternas, F. A., Vincent, J. B., Scherer, S. W., & Ray, P. N. (2003). Cloning and
characterization of human CADPS and CADPS2, new members of the Ca2+dependent activator for secretion protein family. Genomics, 81(3), 279-291.
Cohen, J. E., Lee, P. R., Chen, S., Li, W., & Fields, R. D. (2011). MicroRNA regulation of
homeostatic synaptic plasticity. Proc Natl Acad Sci U S A, 108(28), 11650-11655.
doi: 10.1073/pnas.1017576108
Cole, A. J., Saffen, D. W., Baraban, J. M., & Worley, P. F. (1989). Rapid increase of an
immediate early gene messenger RNA in hippocampal neurons by synaptic NMDA
receptor activation. Nature, 340(6233), 474-476. doi: 10.1038/340474a0
Collins, D. L., Neelin, P., Peters, T. M., & Evans, A. C. (1994). Automatic 3D intersubject
registration of MR volumetric data in standardized Talairach space. J Comput
Assist Tomogr, 18(2), 192-205.
de Castro, B. M., Pereira, G. S., Magalhaes, V., Rossato, J. I., De Jaeger, X., Martins-Silva,
C., . . . Prado, M. A. (2009). Reduced expression of the vesicular acetylcholine

126

transporter causes learning deficits in mice. Genes Brain Behav, 8(1), 23-35. doi:
10.1111/j.1601-183X.2008.00439.x
de Guzman, A. E., Wong, M. D., Gleave, J. A., & Nieman, B. J. (2016). Variations in postperfusion immersion fixation and storage alter MRI measurements of mouse brain
morphometry. Neuroimage, 142, 687-695. doi: 10.1016/j.neuroimage.2016.06.028
de Vivo, L., Bellesi, M., Marshall, W., Bushong, E. A., Ellisman, M. H., Tononi, G., &
Cirelli, C. (2017). Ultrastructural evidence for synaptic scaling across the
wake/sleep cycle. Science, 355(6324), 507-510. doi: 10.1126/science.aah5982
Delotterie, D. F., Mathis, C., Cassel, J. C., Rosenbrock, H., Dorner-Ciossek, C., & Marti,
A. (2015). Touchscreen tasks in mice to demonstrate differences between
hippocampal and striatal functions. Neurobiol Learn Mem, 120, 16-27. doi:
10.1016/j.nlm.2015.02.007
Dergai, O., Novokhatska, O., Dergai, M., Skrypkina, I., Tsyba, L., Moreau, J., & Rynditch,
A. (2010). Intersectin 1 forms complexes with SGIP1 and Reps1 in clathrin-coated
pits.
Biochem
Biophys
Res
Commun,
402(2),
408-413.
doi:
10.1016/j.bbrc.2010.10.045
Dorr, A. E., Lerch, J. P., Spring, S., Kabani, N., & Henkelman, R. M. (2008). High
resolution three-dimensional brain atlas using an average magnetic resonance
image of 40 adult C57Bl/6J mice. Neuroimage, 42(1), 60-69. doi:
10.1016/j.neuroimage.2008.03.037
Eustermann, S., Yang, J. C., Law, M. J., Amos, R., Chapman, L. M., Jelinska, C., . . .
Neuhaus, D. (2011). Combinatorial readout of histone H3 modifications specifies
localization of ATRX to heterochromatin. Nat Struct Mol Biol, 18(7), 777-782. doi:
10.1038/nsmb.2070
Ferreira, T. A., Blackman, A. V., Oyrer, J., Jayabal, S., Chung, A. J., Watt, A. J., . . . van
Meyel, D. J. (2014). Neuronal morphometry directly from bitmap images. Nat
Methods, 11(10), 982-984. doi: 10.1038/nmeth.3125
Fombonne, E. (2009). Epidemiology of pervasive developmental disorders. Pediatr Res,
65(6), 591-598. doi: 10.1203/PDR.0b013e31819e7203
Garrick, D., Sharpe, J. A., Arkell, R., Dobbie, L., Smith, A. J., Wood, W. G., . . . Gibbons,
R. J. (2006). Loss of Atrx affects trophoblast development and the pattern of Xinactivation in extraembryonic tissues. PLoS Genet, 2(4), e58. doi:
10.1371/journal.pgen.0020058

127

Genovese, C. R., Lazar, N. A., & Nichols, T. (2002). Thresholding of statistical maps in
functional neuroimaging using the false discovery rate. Neuroimage, 15(4), 870878. doi: 10.1006/nimg.2001.1037
Gibbons, R. J., Bachoo, S., Picketts, D. J., Aftimos, S., Asenbauer, B., Bergoffen, J., . . .
Higgs, D. R. (1997). Mutations in transcriptional regulator ATRX establish the
functional significance of a PHD-like domain. Nat Genet, 17(2), 146-148. doi:
10.1038/ng1097-146
Gibbons, R. J., Picketts, D. J., Villard, L., & Higgs, D. R. (1995). Mutations in a putative
global transcriptional regulator cause X-linked mental retardation with alphathalassemia (ATR-X syndrome). Cell, 80(6), 837-845.
Gibbons, R. J., Suthers, G. K., Wilkie, A. O., Buckle, V. J., & Higgs, D. R. (1992). Xlinked alpha-thalassemia/mental retardation (ATR-X) syndrome: localization to
Xq12-q21.31 by X inactivation and linkage analysis. Am J Hum Genet, 51(5), 11361149.
Gibbons, R. J., Wada, T., Fisher, C. A., Malik, N., Mitson, M. J., Steensma, D. P., . . .
Traeger-Synodinos, J. (2008). Mutations in the chromatin-associated protein
ATRX. Hum Mutat, 29(6), 796-802. doi: 10.1002/humu.20734
Goldberg, A. D., Banaszynski, L. A., Noh, K. M., Lewis, P. W., Elsaesser, S. J., Stadler,
S., . . . Allis, C. D. (2010). Distinct factors control histone variant H3.3 localization
at specific genomic regions. Cell, 140(5), 678-691. doi: 10.1016/j.cell.2010.01.003
Grozeva, D., Carss, K., Spasic-Boskovic, O., Tejada, M. I., Gecz, J., Shaw, M., . . .
Raymond, F. L. (2015). Targeted Next-Generation Sequencing Analysis of 1,000
Individuals with Intellectual Disability. Hum Mutat, 36(12), 1197-1204. doi:
10.1002/humu.22901
Harris, K. M., Jensen, F. E., & Tsao, B. (1992). Three-dimensional structure of dendritic
spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages:
implications for the maturation of synaptic physiology and long-term potentiation.
J Neurosci, 12(7), 2685-2705.
He, E., Lozano, M. A. G., Stringer, S., Watanabe, K., Sakamoto, K., den Oudsten, F., . . .
Verhage, M. (2018). MIR137 schizophrenia-associated locus controls synaptic
function by regulating synaptogenesis, synapse maturation and synaptic
transmission. Hum Mol Genet, 27(11), 1879-1891. doi: 10.1093/hmg/ddy089
Hu, V. W., Sarachana, T., Sherrard, R. M., & Kocher, K. M. (2015). Investigation of sex
differences in the expression of RORA and its transcriptional targets in the brain as
a potential contributor to the sex bias in autism. Mol Autism, 6, 7. doi:
10.1186/2040-2392-6-7

128

Hylin, M. J., Orsi, S. A., Moore, A. N., & Dash, P. K. (2013). Disruption of the
perineuronal net in the hippocampus or medial prefrontal cortex impairs fear
conditioning. Learn Mem, 20(5), 267-273. doi: 10.1101/lm.030197.112
Ignatiadis, N., Klaus, B., Zaugg, J. B., & Huber, W. (2016). Data-driven hypothesis
weighting increases detection power in genome-scale multiple testing. Nat
Methods, 13(7), 577-580. doi: 10.1038/nmeth.3885
Jacquemont, S., Coe, B. P., Hersch, M., Duyzend, M. H., Krumm, N., Bergmann, S., . . .
Eichler, E. E. (2014). A higher mutational burden in females supports a "female
protective model" in neurodevelopmental disorders. Am J Hum Genet, 94(3), 415425. doi: 10.1016/j.ajhg.2014.02.001
Jimenez-Mateos, E. M., Bray, I., Sanz-Rodriguez, A., Engel, T., McKiernan, R. C., Mouri,
G., . . . Henshall, D. C. (2011). miRNA Expression profile after status epilepticus
and hippocampal neuroprotection by targeting miR-132. Am J Pathol, 179(5),
2519-2532. doi: 10.1016/j.ajpath.2011.07.036
Jung, H., Park, H., Choi, Y., Kang, H., Lee, E., Kweon, H., . . . Kim, E. (2018). Sexually
dimorphic behavior, neuronal activity, and gene expression in Chd8-mutant mice.
Nat Neurosci, 21(9), 1218-1228. doi: 10.1038/s41593-018-0208-z
Kernohan, K. D., Jiang, Y., Tremblay, D. C., Bonvissuto, A. C., Eubanks, J. H., Mann, M.
R., & Berube, N. G. (2010). ATRX partners with cohesin and MeCP2 and
contributes to developmental silencing of imprinted genes in the brain. Dev Cell,
18(2), 191-202. doi: 10.1016/j.devcel.2009.12.017
Kim, C. H., Heath, C. J., Kent, B. A., Bussey, T. J., & Saksida, L. M. (2015). The role of
the dorsal hippocampus in two versions of the touchscreen automated paired
associates learning (PAL) task for mice. Psychopharmacology (Berl), 232(21-22),
3899-3910. doi: 10.1007/s00213-015-3949-3
Kim, K. C., Choi, C. S., Kim, J. W., Han, S. H., Cheong, J. H., Ryu, J. H., & Shin, C. Y.
(2016). MeCP2 Modulates Sex Differences in the Postsynaptic Development of the
Valproate Animal Model of Autism. Mol Neurobiol, 53(1), 40-56. doi:
10.1007/s12035-014-8987-z
Kurian, J. R., Bychowski, M. E., Forbes-Lorman, R. M., Auger, C. J., & Auger, A. P.
(2008). Mecp2 organizes juvenile social behavior in a sex-specific manner. J
Neurosci, 28(28), 7137-7142. doi: 10.1523/JNEUROSCI.1345-08.2008
Law, M. J., Lower, K. M., Voon, H. P., Hughes, J. R., Garrick, D., Viprakasit, V., . . .
Gibbons, R. J. (2010). ATR-X syndrome protein targets tandem repeats and
influences allele-specific expression in a size-dependent manner. Cell, 143(3), 367378. doi: 10.1016/j.cell.2010.09.023

129

Lei, P., Li, Y., Chen, X., Yang, S., & Zhang, J. (2009). Microarray based analysis of
microRNA expression in rat cerebral cortex after traumatic brain injury. Brain Res,
1284, 191-201. doi: 10.1016/j.brainres.2009.05.074
Lerch, J. P., Carroll, J. B., Dorr, A., Spring, S., Evans, A. C., Hayden, M. R., . . .
Henkelman, R. M. (2008). Cortical thickness measured from MRI in the YAC128
mouse model of Huntington's disease. Neuroimage, 41(2), 243-251. doi:
10.1016/j.neuroimage.2008.02.019
Levy, M. A., Fernandes, A. D., Tremblay, D. C., Seah, C., & Berube, N. G. (2008). The
SWI/SNF protein ATRX co-regulates pseudoautosomal genes that have
translocated to autosomes in the mouse genome. BMC Genomics, 9, 468. doi:
10.1186/1471-2164-9-468
Levy, M. A., Kernohan, K. D., Jiang, Y., & Berube, N. G. (2015). ATRX promotes gene
expression by facilitating transcriptional elongation through guanine-rich coding
regions. Hum Mol Genet, 24(7), 1824-1835. doi: 10.1093/hmg/ddu596
Lewis, P. W., Elsaesser, S. J., Noh, K. M., Stadler, S. C., & Allis, C. D. (2010). Daxx is an
H3.3-specific histone chaperone and cooperates with ATRX in replicationindependent chromatin assembly at telomeres. Proc Natl Acad Sci U S A, 107(32),
14075-14080. doi: 10.1073/pnas.1008850107
Lin, Q., Wei, W., Coelho, C. M., Li, X., Baker-Andresen, D., Dudley, K., . . . Bredy, T. W.
(2011). The brain-specific microRNA miR-128b regulates the formation of fearextinction memory. Nat Neurosci, 14(9), 1115-1117. doi: 10.1038/nn.2891
Longair, M. H., Baker, D. A., & Armstrong, J. D. (2011). Simple Neurite Tracer: open
source software for reconstruction, visualization and analysis of neuronal
processes. Bioinformatics, 27(17), 2453-2454. doi: 10.1093/bioinformatics/btr390
Love, M. I., Huber, W., & Anders, S. (2014). Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol, 15(12), 550. doi:
10.1186/s13059-014-0550-8
McGill, B. E., Barve, R. A., Maloney, S. E., Strickland, A., Rensing, N., Wang, P. L., . . .
Milbrandt, J. (2018). Abnormal Microglia and Enhanced Inflammation-Related
Gene Transcription in Mice with Conditional Deletion of Ctcf in Camk2a-CreExpressing Neurons. J Neurosci, 38(1), 200-219. doi: 10.1523/JNEUROSCI.093617.2017
Meziane, H., Ouagazzal, A. M., Aubert, L., Wietrzych, M., & Krezel, W. (2007). Estrous
cycle effects on behavior of C57BL/6J and BALB/cByJ female mice: implications
for phenotyping strategies. Genes Brain Behav, 6(2), 192-200. doi: 10.1111/j.1601183X.2006.00249.x

130

Mi, H., Huang, X., Muruganujan, A., Tang, H., Mills, C., Kang, D., & Thomas, P. D.
(2017). PANTHER version 11: expanded annotation data from Gene Ontology and
Reactome pathways, and data analysis tool enhancements. Nucleic Acids Res,
45(D1), D183-D189. doi: 10.1093/nar/gkw1138
Minatohara, K., Akiyoshi, M., & Okuno, H. (2015). Role of Immediate-Early Genes in
Synaptic Plasticity and Neuronal Ensembles Underlying the Memory Trace. Front
Mol Neurosci, 8, 78. doi: 10.3389/fnmol.2015.00078
Molnar, G., Rozsa, M., Baka, J., Holderith, N., Barzo, P., Nusser, Z., & Tamas, G. (2016).
Human pyramidal to interneuron synapses are mediated by multi-vesicular release
and multiple docked vesicles. Elife, 5. doi: 10.7554/eLife.18167
Nguyen, P. V., & Kandel, E. R. (1996). A macromolecular synthesis-dependent late phase
of long-term potentiation requiring cAMP in the medial perforant pathway of rat
hippocampal slices. J Neurosci, 16(10), 3189-3198.
Nieman, B. J., Flenniken, A. M., Adamson, S. L., Henkelman, R. M., & Sled, J. G. (2006).
Anatomical phenotyping in the brain and skull of a mutant mouse by magnetic
resonance imaging and computed tomography. Physiol Genomics, 24(2), 154-162.
doi: 10.1152/physiolgenomics.00217.2005
Nieman, B. J., van Eede, M. C., Spring, S., Dazai, J., Henkelman, R. M., & Lerch, J. P.
(2018). MRI to Assess Neurological Function. Curr Protoc Mouse Biol, 8(2), e44.
doi: 10.1002/cpmo.44
Nithianantharajah, J., Komiyama, N. H., McKechanie, A., Johnstone, M., Blackwood, D.
H., St Clair, D., . . . Grant, S. G. (2013). Synaptic scaffold evolution generated
components of vertebrate cognitive complexity. Nat Neurosci, 16(1), 16-24. doi:
10.1038/nn.3276
Nithianantharajah, J., McKechanie, A. G., Stewart, T. J., Johnstone, M., Blackwood, D.
H., St Clair, D., . . . Saksida, L. M. (2015). Bridging the translational divide:
identical cognitive touchscreen testing in mice and humans carrying mutations in a
disease-relevant homologous gene. Sci Rep, 5, 14613. doi: 10.1038/srep14613
Nogami, T., Beppu, H., Tokoro, T., Moriguchi, S., Shioda, N., Fukunaga, K., . . . Kitajima,
I. (2011). Reduced expression of the ATRX gene, a chromatin-remodeling factor,
causes hippocampal dysfunction in mice. Hippocampus, 21(6), 678-687. doi:
10.1002/hipo.20782
Olde Loohuis, N. F., Ba, W., Stoerchel, P. H., Kos, A., Jager, A., Schratt, G., . . . Aschrafi,
A. (2015). MicroRNA-137 Controls AMPA-Receptor-Mediated Transmission and
mGluR-Dependent
LTD.
Cell
Rep,
11(12),
1876-1884.
doi:
10.1016/j.celrep.2015.05.040

131

Pertea, M., Pertea, G. M., Antonescu, C. M., Chang, T. C., Mendell, J. T., & Salzberg, S.
L. (2015). StringTie enables improved reconstruction of a transcriptome from
RNA-seq reads. Nat Biotechnol, 33(3), 290-295. doi: 10.1038/nbt.3122
Picketts, D. J., Higgs, D. R., Bachoo, S., Blake, D. J., Quarrell, O. W., & Gibbons, R. J.
(1996). ATRX encodes a novel member of the SNF2 family of proteins: mutations
point to a common mechanism underlying the ATR-X syndrome. Hum Mol Genet,
5(12), 1899-1907.
Poon, V. Y., Gu, M., Ji, F., VanDongen, A. M., & Fivaz, M. (2016). miR-27b shapes the
presynaptic transcriptome and influences neurotransmission by silencing the
polycomb group protein Bmi1. BMC Genomics, 17(1), 777. doi: 10.1186/s12864016-3139-7
Qiu, L. R., Fernandes, D. J., Szulc-Lerch, K. U., Dazai, J., Nieman, B. J., Turnbull, D. H.,
. . . Lerch, J. P. (2018). Mouse MRI shows brain areas relatively larger in males
emerge before those larger in females. Nat Commun, 9(1), 2615. doi:
10.1038/s41467-018-04921-2
Rajendra, S., Lynch, J. W., & Schofield, P. R. (1997). The glycine receptor. Pharmacol
Ther, 73(2), 121-146.
Richards, K., Watson, C., Buckley, R. F., Kurniawan, N. D., Yang, Z., Keller, M. D., . . .
Reutens, D. C. (2011). Segmentation of the mouse hippocampal formation in
magnetic
resonance
images.
Neuroimage,
58(3),
732-740.
doi:
10.1016/j.neuroimage.2011.06.025
Ryan, B., Joilin, G., & Williams, J. M. (2015). Plasticity-related microRNA and their
potential contribution to the maintenance of long-term potentiation. Front Mol
Neurosci, 8, 4. doi: 10.3389/fnmol.2015.00004
Sahakian, B. J., Morris, R. G., Evenden, J. L., Heald, A., Levy, R., Philpot, M., & Robbins,
T. W. (1988). A comparative study of visuospatial memory and learning in
Alzheimer-type dementia and Parkinson's disease. Brain, 111 ( Pt 3), 695-718.
Sato, D., Lionel, A. C., Leblond, C. S., Prasad, A., Pinto, D., Walker, S., . . . Scherer, S.
W. (2012). SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J
Hum Genet, 90(5), 879-887. doi: 10.1016/j.ajhg.2012.03.017
Seah, C., Levy, M. A., Jiang, Y., Mokhtarzada, S., Higgs, D. R., Gibbons, R. J., & Berube,
N. G. (2008). Neuronal death resulting from targeted disruption of the Snf2 protein
ATRX is mediated by p53. J Neurosci, 28(47), 12570-12580. doi:
10.1523/JNEUROSCI.4048-08.2008

132

Sheng, M., & Kim, E. (2000). The Shank family of scaffold proteins. J Cell Sci, 113 ( Pt
11), 1851-1856.
Shioda, N., Beppu, H., Fukuda, T., Li, E., Kitajima, I., & Fukunaga, K. (2011). Aberrant
calcium/calmodulin-dependent protein kinase II (CaMKII) activity is associated
with abnormal dendritic spine morphology in the ATRX mutant mouse brain. J
Neurosci, 31(1), 346-358. doi: 10.1523/JNEUROSCI.4816-10.2011
Shioda, N., Yabuki, Y., Yamaguchi, K., Onozato, M., Li, Y., Kurosawa, K., . . . Fukunaga,
K. (2018). Targeting G-quadruplex DNA as cognitive function therapy for ATR-X
syndrome. Nat Med, 24(6), 802-813. doi: 10.1038/s41591-018-0018-6
Siegert, S., Seo, J., Kwon, E. J., Rudenko, A., Cho, S., Wang, W., . . . Tsai, L. H. (2015).
The schizophrenia risk gene product miR-137 alters presynaptic plasticity. Nat
Neurosci, 18(7), 1008-1016. doi: 10.1038/nn.4023
Soneson, C., Love, M. I., & Robinson, M. D. (2015). Differential analyses for RNA-seq:
transcript-level estimates improve gene-level inferences. F1000Res, 4, 1521. doi:
10.12688/f1000research.7563.2
Spencer Noakes, T. L., Henkelman, R. M., & Nieman, B. J. (2017). Partitioning k-space
for cylindrical three-dimensional rapid acquisition with relaxation enhancement
imaging in the mouse brain. NMR Biomed, 30(11). doi: 10.1002/nbm.3802
Steadman, P. E., Ellegood, J., Szulc, K. U., Turnbull, D. H., Joyner, A. L., Henkelman, R.
M., & Lerch, J. P. (2014). Genetic effects on cerebellar structure across mouse
models of autism using a magnetic resonance imaging atlas. Autism Res, 7(1), 124137. doi: 10.1002/aur.1344
Talpos, J. C., Winters, B. D., Dias, R., Saksida, L. M., & Bussey, T. J. (2009). A novel
touchscreen-automated paired-associate learning (PAL) task sensitive to
pharmacological manipulation of the hippocampus: a translational rodent model of
cognitive impairments in neurodegenerative disease. Psychopharmacology (Berl),
205(1), 157-168. doi: 10.1007/s00213-009-1526-3
Tamming, R. J., Siu, J. R., Jiang, Y., Prado, M. A., Beier, F., & Berube, N. G. (2017).
Mosaic expression of Atrx in the mouse central nervous system causes memory
deficits. Dis Model Mech, 10(2), 119-126. doi: 10.1242/dmm.027482
Tanaka, S., Ide, M., Shibutani, T., Ohtaki, H., Numazawa, S., Shioda, S., & Yoshida, T.
(2006). Lipopolysaccharide-induced microglial activation induces learning and
memory deficits without neuronal cell death in rats. J Neurosci Res, 83(4), 557566. doi: 10.1002/jnr.20752

133

Thomas, K. T., Anderson, B. R., Shah, N., Zimmer, S. E., Hawkins, D., Valdez, A. N., . .
. Bassell, G. J. (2017). Inhibition of the Schizophrenia-Associated MicroRNA miR137 Disrupts Nrg1alpha Neurodevelopmental Signal Transduction. Cell Rep, 20(1),
1-12. doi: 10.1016/j.celrep.2017.06.038
Tronche, F., Kellendonk, C., Kretz, O., Gass, P., Anlag, K., Orban, P. C., . . . Schutz, G.
(1999). Disruption of the glucocorticoid receptor gene in the nervous system results
in reduced anxiety. Nat Genet, 23(1), 99-103. doi: 10.1038/12703
Tsien, J. Z., Chen, D. F., Gerber, D., Tom, C., Mercer, E. H., Anderson, D. J., . . .
Tonegawa, S. (1996). Subregion- and cell type-restricted gene knockout in mouse
brain. Cell, 87(7), 1317-1326.
Tsutiya, A., Nakano, Y., Hansen-Kiss, E., Kelly, B., Nishihara, M., Goshima, Y., . . .
Ohtani-Kaneko, R. (2017). Human CRMP4 mutation and disrupted Crmp4
expression in mice are associated with ASD characteristics and sexual dimorphism.
Sci Rep, 7(1), 16812. doi: 10.1038/s41598-017-16782-8
Ullmann, J. F., Watson, C., Janke, A. L., Kurniawan, N. D., Paxinos, G., & Reutens, D. C.
(2014). An MRI atlas of the mouse basal ganglia. Brain Struct Funct, 219(4), 13431353. doi: 10.1007/s00429-013-0572-0
Vago, D. R., & Kesner, R. P. (2008). Disruption of the direct perforant path input to the
CA1 subregion of the dorsal hippocampus interferes with spatial working memory
and novelty detection. Behav Brain Res, 189(2), 273-283. doi:
10.1016/j.bbr.2008.01.002
Voineagu, I., Wang, X., Johnston, P., Lowe, J. K., Tian, Y., Horvath, S., . . . Geschwind,
D. H. (2011). Transcriptomic analysis of autistic brain reveals convergent
molecular pathology. Nature, 474(7351), 380-384. doi: 10.1038/nature10110
Vorhees, C. V., & Williams, M. T. (2006). Morris water maze: procedures for assessing
spatial and related forms of learning and memory. Nat Protoc, 1(2), 848-858. doi:
10.1038/nprot.2006.116
Wang, W., Le, A. A., Hou, B., Lauterborn, J. C., Cox, C. D., Levin, E. R., . . . Gall, C. M.
(2018). Memory-Related Synaptic Plasticity Is Sexually Dimorphic in Rodent
Hippocampus. J Neurosci, 38(37), 7935-7951. doi: 10.1523/JNEUROSCI.080118.2018
Watson, L. A., Solomon, L. A., Li, J. R., Jiang, Y., Edwards, M., Shin-ya, K., . . . Berube,
N. G. (2013). Atrx deficiency induces telomere dysfunction, endocrine defects, and
reduced life span. J Clin Invest, 123(5), 2049-2063. doi: 10.1172/JCI65634

134

Woldemichael, B. T., Jawaid, A., Kremer, E. A., Gaur, N., Krol, J., Marchais, A., &
Mansuy, I. M. (2016). The microRNA cluster miR-183/96/182 contributes to longterm memory in a protein phosphatase 1-dependent manner. Nat Commun, 7,
12594. doi: 10.1038/ncomms12594
Xu, J., Deng, X., Watkins, R., & Disteche, C. M. (2008). Sex-specific differences in
expression of histone demethylases Utx and Uty in mouse brain and neurons. J
Neurosci, 28(17), 4521-4527. doi: 10.1523/JNEUROSCI.5382-07.2008
Zerbino, D. R., Achuthan, P., Akanni, W., Amode, M. R., Barrell, D., Bhai, J., . . . Flicek,
P. (2018). Ensembl 2018. Nucleic Acids Res, 46(D1), D754-D761. doi:
10.1093/nar/gkx1098
Zhao, L., Li, H., Guo, R., Ma, T., Hou, R., Ma, X., & Du, Y. (2013). miR-137, a new target
for post-stroke depression? Neural Regen Res, 8(26), 2441-2448. doi:
10.3969/j.issn.1673-5374.2013.26.005

135

Chapter 4

4

General Discussion and Future Directions

4.1 Thesis Summary
The overall goal of my thesis was to explore how ATRX regulates cognition in the adult
brain. To achieve this, I used two mouse models of ATRX loss: one resulting in mosaic
expression of ATRX in different cell types of the mouse brain (Atrx-cHet), and another
with ATRX loss specifically in adult glutamatergic neurons (Atrx-cKO and Atrx-cKOFem)
and used these animals to examine the effect of ATRX loss on learning, memory, and the
molecular mechanisms of cognition.
The first part of my thesis, presented in chapter two, attempted to uncover the role of ATRX
in the brain in relation to learning and memory. I created a novel mouse model, deleting
ATRX in neuronal and glial cell precursors of the mouse central nervous system starting
at embryonic day 11.5. The males with complete loss of ATRX died perinatally, but the
females which were mosaic for ATRX expression survived to adulthood.
The female mosaics (Atrx-cHet) were smaller than the control counterparts, correlating
with low circulating IGF-1. We found many behavioural impairments in this model,
including recognition memory, contextual fear, and impaired spatial learning in the Morris
water maze. Unfortunately, we were unable to test the Barnes maze due to a tendency of
the mice to run off the platform edge. Additionally, the Atrx-cHet results in the Morris
water maze had confounding factors: the mice had a slower swim speed, though not due to
motor abnormalities as tested in the treadmill task, and many of the Atrx-cHet mice showed
no aversion to the water. These factors made it difficult to conclusively state that
impairments in the water maze were due to spatial learning.
To reduce confounding behaviours, I developed a model where ATRX is only inactivated
after birth, at postnatal day 20, in glutamatergic neurons of the forebrain (Atrx-cKO).
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Besides an increased CA1 stratum radiatum / lacunosum moleculare there were no obvious
gross morphological differences in the brain, nor neuronal morphology differences in the
CA1 layer of the hippocampus of these mice. Similar to the Atrx-cHet mice, the Atrx-cKO
males displayed impaired spatial learning and memory in the contextual fear task and
Morris water maze, in addition to the touchscreen paired-associate learning task. There
were no behaviour differences between control and Atrx-cKOFem mice. The changes in the
male knockouts correlated to altered ultrastructural changes in the proximal-apical CA1
dendritic synapses: decreased number of total and docked vesicles and increased cleft and
post-synaptic density width. Transcriptional profiling revealed decreased expression of
many genes related to synaptic vesicle release corresponding to an increase in the
presynaptic plasticity microRNA miR-137. Therefore, I believe we have identified a
potential mechanism by which loss of ATRX causes an increase in miR-137 and
deregulation of target genes resulting in presynaptic impairment.

4.2 The role of ATRX in cognition
Previously, only one other group had investigated ATRX in the context of learning and
memory using mice lacking exon 2 of ATRX (ATRXΔE2), resulting in decreased ATRX
protein expression throughout the body (Nogami et al., 2011). They found no impairments
in the Morris water maze, however, decreased memory in the contextual fear task, which
correlated to impaired hippocampal long-term potentiation within the Schaffer-collateral
pathway. Additionally, the ATRXΔE2 mice displayed impaired working memory,
recognition memory, and spatial learning in the Barnes maze test (Shioda et al., 2011).
Neither the Atrx-cHet or Atrx-cKO mice behaviour completely match with the ATRXΔE2
results. The Atrx-cHet mice had similar behaviour impairments, the only exceptions being
normal working memory, and impaired Morris water maze. As stated above, the Barnes
maze gave unreliable results due to the tendency of the mice to run off the edge, possibly
due to decreased fear as identified in the contextual fear task. However, the Barnes maze
and Morris water maze both test spatial learning and memory, with the only difference
being the Morris water maze is more stressful to the animals resulting in increased stresshormone corticosterone (Harrison, Hosseini, & McDonald, 2009). The Atrx-cHet mice
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performed poorly in the Morris water maze but the test is inconclusive because they tended
to jump off the platform to continue swimming. Even when tasked with the cued Morris
water maze, which removes spatial dependency, the Atrx-cHet mice were unable to find
the platform, and the swim speed of the animals was considerably lower than control mice.
Undoubtedly, the mice did have impaired spatial memory in the contextual fear task. The
Atrx-cHet mice also had normal working memory, compared to the impaired ATRXΔE2. It
is possible that retained expression of ATRX in half of all cells in the brain has a protective
effect.
Since the Atrx-cKO model results in loss of ATRX in only adult forebrain glutamatergic
neurons, I expected to see fewer behavioural impairments compared to the Atrx-cHet mice.
Differences in learning and memory between the Atrx-cHet and Atrx-cKO mice are
outlined in Table 4-1. Spatial memory in the contextual fear task was impaired in this
model, similar to the Atrx-cHet mice. The Atrx-cHet mice could not be trained in the Morris
water maze, indicating severe learning and memory problems, while the Atrx-cKO merely
had a delay in learning. The Atrx-cKO mice also displayed impaired long-term memory in
this task, tested at 12 days (7 days after training). The Atrx-cKO mice did not display
impaired novel object recognition, unlike the Atrx-cHet. This may be due to expression of
ATRX in other cell types in the Atrx-cKO model, such as astrocytes and oligodendrocytes.
Indeed, it has been shown that impairment of astrocyte function reduces gamma
oscillations and novel object recognition behaviour, while having no effect on contextual
fear conditioning (Lee et al., 2014). Therefore, the impairments in object recognition
memory might be due to the mosaic expression of ATRX in the Atrx-cHet model, instead
of in glutamatergic neurons.
Another impairment observed in the Atrx-cKO males but not the Atrx-cHet mice was a
decrease in anxiety. Again, this may be due to the complete loss of ATRX in forebrain
glutamatergic neurons of the Atrx-cKO mice while the Atrx-cHet have mosaic expression
of ATRX. Indeed, anxiolytic behaviour results mainly from impairments in the mPFC, in
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Behavioural test

Atrx-cHet

Atrx-cKO

Open field test (general activity)

 Normal

 Normal

Open field test (anxiety)

 Normal

 Impaired

Elevated plus maze (anxiety)

 Normal

 Impaired

 Impaired

 Normal

 Normal

 Normal

Morris water maze (spatial learning)

 Impaired

 Impaired

Morris water maze (spatial memory)

Not tested

 Impaired

 Impaired

 Impaired

Not tested

 Impaired

Novel object recognition (recognition memory)
Y-maze (working memory)

Contextual fear conditioning (spatial fear memory)
Paired-associate learning task (spatial learning)

Table 4-1 Behaviour impairments in Atrx-cHet and Atrx-cKO mice
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addition to the hippocampus and amygdala (Adhikari, Topiwala, & Gordon, 2010;
Davidson, 2002). The main neurotransmitter responsible for anxiety-related behaviours is
serotonin, derived from tryptophan and produced in the Raphe nuclei of the brainstem
(Moore, Halaris, & Jones, 1978). In the Atrx-cKO model, production of serotonin should
be normal as ATRX is still expressed in the brainstem. However, defects in serotonin
receptors in glutamatergic neurons in the cortex and hippocampus could be causing
decreased anxiety in this mouse model.
One of the more advanced behavioural techniques performed on the Atrx-cKO mice was
the touchscreen methods for assessing cognitive ability in mice. Tests performed using
these chambers are superior to conventional behaviour paradigms for multiple reasons.
First, they are automated, which not only allows multiple animals to be tested at once, but
also reduces variability related to handling of the animals (Wahlsten et al., 2003). Second,
they are low-stress, unlike other paradigms such as the Morris water maze which relies on
aversive stimuli (in this case water) to learn (Harrison et al., 2009). Stress responses in the
animal can interfere with normal behaviour (Joels & Baram, 2009), and so the touchscreen
assays are reward-based to avoid confounding effects. Third, the touchscreen chambers can
be used to test multiple types of cognition, in our case the paired-associate learning and
visual-paired discrimination tests. This allows for uniformity over the tests – same
apparatus, same reward, and same types of stimuli – and allows for better comparison
between tasks. Finally, the touchscreen tests are translational from mouse to clinic. When
mice lacking the Discs large homolog 2 (Dlg2) gene and humans with a copy number
variation (CNV) deletion in the DLG2 gene are tested in the exact same paired-association
task, by the end of training both mouse knockouts and human patients still performed at
chance levels (Nithianantharajah et al., 2015). The dPAL test in the Atrx-cKO mouse
revealed profound impairments in learning, but we could not test memory as the mice were
never able to learn to the same extent as control. The Morris water maze did reveal a slight
impairment to learning, as there was a delay in latency and distance travelled to the
platform on day 3 of the learning trials, but by day 4 were performing similar to control.
This could be due to the less stressful nature of the test, or that the touchscreen tests give a
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more precise result so that slight deficits in another paradigm may be exacerbated in the
dPAL task. It would be interesting to test the mildly-intellectually disabled patients of
ATRX syndrome in the human dPAL task to see if similar results are achieved.
Many other chromatin modifying proteins have been implicated in spatial learning and
memory, much like ATRX, and spine density is a common defect across several mouse
models. They include the insulator protein CTCF, MeCP2 which binds methylated DNA,
the chromatin organizer SATB1, and the histone deacetylase HDAC2 (Balamotis et al.,
2012; Chapleau et al., 2009; Guan et al., 2009; McGill et al., 2018; Zhou et al., 2006).
Overexpression of miR-137, which is increased in expression in the Atrx-cKO
hippocampus, led to decreased dendritic spine density but no changes to neuronal
morphology (Smrt et al., 2010) while sequestration of miR-137 increases dendritic spine
density (Olde Loohuis et al., 2015). Therefore, it may be informative to examine dendritic
spine density and maturation in the Atrx-cHet and Atrx-cKO mouse models to determine
whether synapse number is changed as spine density is directly correlated to synaptic
contacts (Woolley & McEwen, 1992).

4.3 Synaptic plasticity and ATRX
In chapter three, I found that loss of ATRX in forebrain glutamatergic neurons resulted in
ultrastructural changes at the synapse through transmission electron microscopy. This
included a presynaptic decrease in the number of total and docked vesicles, as well as a
decrease in vesicle density. It’s been known for almost 30 years that vesicle number is
directly related to presynaptic excitatory potential (Koenig, Kosaka, & Ikeda, 1989). There
are two main electrophysiological tests that directly relate to presynaptic function: pairedpulse facilitation (PPF), and post-tetanus plasticity (PTP). Paired-pulse facilitation is the
observation that when a second impulse follows immediately after a first impulse, it results
in a greater potentiation, which is correlated to the size of the readily releasable pool of
vesicles (Dobrunz & Stevens, 1997). There are many rodent models in which vesicle
number, localization, or density are decreased which results in a reduction in PPF
(Klemmer et al., 2011; Walters et al., 2014). Conversely, an increase in the number of
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docked vesicles causes enhanced PPF (Kushner et al., 2005). MiRNAs have also been
shown to regulate PPF, with loss of miR-132 enhancing PPF, although the molecular
mechanism is still unknown (Lambert, Storm, & Sullivan, 2010). Of relevance to the
present study, it has been shown that miR-137 gain-of-function causes impaired vesicle
release and changes in vesicle pool distribution (Siegert et al., 2015).
The other electrophysiological test related to presynaptic function, PTP, records the
transient increase in neurotransmitter release due to calcium ion accumulation in the axon
terminal post-tetanus (Kamiya & Zucker, 1994; Wang, Ferguson, Pineda, Cundiff, &
Storm, 2004). PTP has also been shown to correlate to a decreased number of docked and
reserve pool vesicles (Xiao et al., 2007). Considering the reduction in both docked and total
vesicle number in the Atrx-cKO CA1 stratum radiatum / stratum lacunosum layers of the
hippocampus, we would expect to see impairments in both paired-pulse facilitation and
post-tetanus potentiation in this area.
A reduction in total and docked vesicles have been previously linked to impaired
hippocampal-dependent learning and memory. Gain-of-function mutations of the mouse
HDAC4 histone deacetylase in cultured hippocampal neurons resulted in a reduction in the
docked vesicle pool, and mice with the same mutation displayed impaired spatial learning
and memory in the Barnes maze (Sando et al., 2012). Similarly, deficiency of lipoprotein
lipase, involved in triglyceride hydrolysis, decreases docked and total vesicle numbers as
well as vesicle density in CA1 hippocampal neurons and mice displayed altered learning
in both the Morris water maze and the passive avoidance tasks (Mead, Irvine, & Ramji,
2002; Xian et al., 2009), indicating that proper regulation of the vesicle cycle is critical for
learning and memory.
A reduction in long-term potentiation (LTP) is another type of electrophysiological
impairment commonly found in mouse models of intellectual disability disorders.
Specifically, attenuation in both the Schaffer collateral pathway, which involves signal
from the CA3 to the stratum radiatum region of the CA1, and in the temporoammonic
pathway, which signals from the entorhinal cortex to the stratum lacunosum moleculare of
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the CA1, have been identified in mouse models of impaired spatial memory (Andersen,
Bliss, Lomo, Olsen, & Skrede, 1969; Aou et al., 2003; Hjorth-Simonsen & Jeune, 1972;
Kallarackal et al., 2013). Similar to short-term plasticity, the inverse is also true: enhanced
LTP often correlates to improved spatial memory over controls (Li, Zhong, Chau,
Williams, & Chang, 2011), although there are examples where enhanced LTP is found in
mouse models with impaired hippocampal-dependent memory (Kaksonen et al., 2002;
Meng et al., 2002). In the Atrx-cKO male mice, we not only see impaired spatial memory
through the Morris water maze, contextual fear task, and paired-associate learning, but we
also observed an increase in the size of the CA1 stratum radiatum / stratum lacunosum
regions, which receive input from the Schaffer collateral and temporammonic pathways,
respectively (Andersen et al., 1969; Hjorth-Simonsen & Jeune, 1972). Additionally, the
TEM images were taken in this area, revealing ultrastructural changes at both the pre- and
post-synapse. Taking these observations into account, I would expect that either the
Schaffer collateral pathway or temporoammonic pathway to be impaired in this mouse
model, and current electrophysiological experiments are being conducted to address the
effects of ATRX loss on LTP in several hippocampal synaptic pathways (Gugustea et al,
unpublished).

4.4 ATRX in gene regulation
Ever since the sequence discovery of ATRX revealed its similarity to the SWI/SNF family
of proteins, it has been hypothesized that ATRX regulates transcription in some manner
(Stayton et al., 1994; Winston & Carlson, 1992). Due to the importance of ATRX in
cognition, it was not surprising that this chromatin remodeler regulates transcription in the
brain. Previous research has shown that ATRX localizes to G-rich sequences to regulate
the expression of pseudoautosomal genes, including Neuroligin 4, an autism-associated
gene (Levy, Kernohan, Jiang, & Berube, 2015). ATRX can also regulate the expression of
imprinted genes in the brain, by altering nucleosome density allowing for CTCF and
cohesin binding, resulting in chromatin looping (Kernohan et al., 2010; Kernohan,
Vernimmen, Gloor, & Berube, 2014). Additionally, ATRX can regulate DNA methylation
in neurons, resulting in overexpression of X-linked lymphocyte-regulated 3B (Xlr3b) which
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binds dendritic mRNA an inhibits its translocation to the spines (Shioda et al., 2018).
Therefore, I was interested in the effect that ATRX loss has on transcription in the AtrxcKO mice.
Immediate early genes (IEGs) are a group of genes that are activated quickly and transiently
upon neuronal stimulation (Cole, Saffen, Baraban, & Worley, 1989; Minatohara, Akiyoshi,
& Okuno, 2015). It has been shown that ATRX is localized to a subset of these genes in
basal conditions, and that DAXX, the binding partner of ATRX, is required for expression
of some of these genes upon neuronal stimulation (Michod et al., 2012). We hypothesized
then, that ATRX may also be required to regulate the expression of these same genes.
However, we did not find this to be the case, with IEG expression increasing upon
stimulation to the same extent in ATRX-null cortical neuron cultures as control. However,
while DAXX was shown to be required for IEG in cortical cultures, the impairments in
spatial learning and memory are largely hippocampal-dependent, and so perhaps repeating
the experiments in hippocampal cultures would have a different outcome.
RNA sequencing of the male and female hippocampi identified transcripts decreased in the
males and increased in the females that are predicted targets of Mir-137. These included
SH3 And Multiple Ankyrin Repeat Domains 2 (Shank2), Calcium Dependent Secretion
Activator 2 (Cadps2), Glycine Receptor Beta (Glrb), and SH3-containing GRB2-like
protein 3-interacting protein 1 (Sgip1). SHANK2 functions as a molecular scaffold in the
PSD, where it mediates receptor localization in the post-synaptic membrane (Brandstatter,
Dick, & Boeckers, 2004; Sheng & Kim, 2000). GLRB is also found in the PSD, as the beta
subunit for the glycine receptor, an inhibitory neurotransmitter (Langosch, Becker, & Betz,
1990; Xu & Gong, 2010). CADSP2 and SGIP1 are both found in the presynaptic terminal,
with CADPS2 mediating vesicle exocytosis and SGIP1 involved in the formation of
clathrin-coated pits, including vesicles (Dergai et al., 2010; Grishanin et al., 2004; Schmid,
1997). The decreased expression of these pre- and post-synaptic genes in the Atrx-cKO
model might cause the reduction in number of docked and total vesicles observed, and in
turn, the behaviour changes in these animals.
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There are many miRNA that are enriched in the presynaptic terminal and postsynaptic
spine and have been implicated in proper synaptic plasticity (Lagos-Quintana et al., 2002;
Ryan, Joilin, & Williams, 2015; Schratt, 2009). Due to the obvious vesicle-related
phenotype in the Atrx-cKO male hippocampi, we decided to focus on miRNA that have
been identified in the regulation of presynaptic plasticity: miR-27b, miR-34a, miR-485,
and miR-137 (Agostini et al., 2011; Cohen, Lee, Chen, Li, & Fields, 2011; Poon, Gu, Ji,
VanDongen, & Fivaz, 2016; Siegert et al., 2015). Of these, we were interested in miRNA
that were increased in expression in the Atrx-cKO males (resulting in a decrease of target
genes) and decreased in the Atrx-cKOFem (resulting in increase of target genes). From the
four miRNA tested, only miR-137 fit this pattern. Additionally, miR-137 was identified
to target many genes decreased in the Atrx-cKO RNA sequencing, including Shank2,
Sgip1, Cadsp2, and Glrb. Previously, ATRX has been shown to regulate expression of the
non-coding RNA Xist, by promoting binding of the Polycomb repressive complex 2 (Sarma
et al., 2014), but this is the first evidence for the involvement of ATRX in regulating
miRNA expression, but whether this regulation is direct or indirect is still unknown.
For analysis of the RNA-sequencing, we decided to focus on transcript instead of gene
counts. The use of gene counts for statistical analysis can mask what is occurring at the
transcript level. For instance, if a gene has 10 transcripts and only one is changed, this
would not present as statistically significant. However, changes to single or few transcripts
could have drastic effects on biological function due to the presence of splice variants and
non-coding sequences. When examining gene expression compared to transcript
expression in the Atrx-cKO hippocampi, there are 146 genes that are differentially
expressed, compared to 1520 transcripts. Therefore, we decided to use transcript analysis
for further tests such as Gene Ontology.

4.5 ATRX and miR-137
The discovery that ATRX regulates miR-137 was particularly interesting as it is the first
ever evidence of miRNA regulation by ATRX. Genome-wide association studies had
previously linked single nucleotide polymorphisms in miR-137 to schizophrenia and
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autism-related disorders (Cross-Disorder Group of the Psychiatric Genomics, 2013; Ripke
et al., 2013). Enriched within the synaptosome of mature neurons in the hippocampal
formation, miR-137 has numerous targets – over 4,000 identified by the microRNA.org
database (Betel, Wilson, Gabow, Marks, & Sander, 2008; Siegel et al., 2009; Smrt et al.,
2010). Additionally, miR-137 gain-of-function results in downregulation of presynaptic
target genes and impaired vesicle release, vesicle pool distribution, impaired LTP, and
defective contextual fear memory (Siegert et al., 2015). Therefore, it may be the increase
in miR-137 expression that is causing the presynaptic phenotype in the Atrx-cKO
hippocampi and resultant impaired spatial learning and memory. miR-137 overexpression
is also implicated in autistic-like features in mice, including repetitive behaviours and
social learning (Cheng et al., 2018). Taken together with the finding that ATRX regulates
Nlgn4 expression from Levy et al. (2015), this may indicate that the Atrx-cKO mice might
also display autistic-like features and this is currently being tested.
It is still unknown how ATRX regulates the expression of miR-137. In adult neural stem
cells, chromatin immunoprecipitation of MeCP2 revealed binding of this epigenetic
regulator upstream of miR-137, and deletion of MeCP2 resulted in an increase in miR-137
expression (Szulwach et al., 2010). Additionally, MeCP2 silences miR-137 expression in
human colorectal adenoma and carcinoma (Chen et al., 2017). Previously, it has been
demonstrated that ATRX and MeCP2 form a complex with cohesin to regulate gene
expression at imprinted genes in the brain by controlling nucleosome density and CTCF
binding (Kernohan et al., 2010; Kernohan et al., 2014; Nan et al., 2007). Therefore, it is
possible that MeCP2 and ATRX are working as a complex to regulate miR-137, and loss
of this complex, whether through MeCP2 deletion or ATRX loss, causes derepression of
miR-137. However, the experiments demonstrating regulation of miR-137 expression by
MeCP2 were performed in adult neural stem cells and colorectal cancer, not differentiated
neurons. In a different cell type, such as CA1 pyramidal neurons, ATRX may be regulating
miR-137 expression in a different manner, such as through other identified mechanisms of
transcriptional control including G-quadruplex resolution or controlling promoter
methylation (Levy et al., 2015; Shioda et al., 2018).
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The Atrx-cKO males displayed significant behavioural impairments whereas the AtrxcKOFem exhibited normal learning and memory. This sex-specific phenomenon is similar
to ATR-X syndrome where females are protected from severe ID, however in humans this
is due to preferential inactivation of the X-chromosome (Gibbons, Suthers, Wilkie, Buckle,
& Higgs, 1992). However, it is known that many developmental disorders including autism
spectrum disorders and intellectual disability can affect males more frequently than
females, likely due to a combination of genetic and hormonal factors (Fombonne, 2009;
Jacquemont et al., 2014). I sought to uncover a mechanism by which the Atrx-cKOFem is
protected by ATRX loss, and differential expression of miR-137 might be partially causing
this phenomenon. miR-137 was significantly increased in expression in the Atrx-cKO mice,
which has been demonstrated to cause behavioural and ultrastructural impairments in the
mouse hippocampus (Siegert et al., 2015), yet miR-137 expression was significantly
decreased in the Atrx-cKOFem, causing increased expression of target genes and possibly
enhancing synaptic transmission and protecting against ATRX loss. Several sex hormones
including estrogen and progesterone regulate miRNA biogenesis and in the embryonic
mouse brain there is a distinct, sex-specific pattern of miRNA expression, indicating that
miRNA can be regulated in a sexually-dimorphic manner (Bhat-Nakshatri et al., 2009;
Kuokkanen et al., 2010; Morgan & Bale, 2011). It is possible that the Atrx-cKOFem are
protected from the behavioural impairments in the Atrx-cKO males due to sex hormone
regulation of miRNA expression. Therefore, we are the first to describe the sexually
dimorphic regulation of miRNA to protect females from intellectual disability.

4.6 Proposed model of ATRX function in the hippocampus
By integrating the results of my work with previously published research on ATRX, miR137, gene regulation, and cognition, I propose a model where ATRX regulates learning
and memory (Figure 4-1). Upon deletion of Atrx in forebrain glutamatergic neurons,
hippocampal miR-137 expression is altered in a sex-specific manner, leading to the inverse
expression of its target synaptic genes, such as Shank2 and Glrb. In the male hippocampi,
increased miR-137 levels cause presynaptic defects including decrease in vesicle number,
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Figure 4-1 Proposed model of ATRX function in the hippocampus
(A) When present at normal levels, ATRX limits the expression of hippocampal miR-137
and alters target synaptic gene expression, thus preserving synaptic ultrastructural
morphology and spatial learning and memory. (B) Loss of ATRX in forebrain
glutamatergic neurons leads to increased hippocampal miR-137 expression in male mice,
accompanied by ultrastructural synaptic defects, leading to sexually dimorphic defects in
spatial learning and memory.
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density, and number of docked vesicles in addition to a widened synaptic cleft and
increased postsynaptic density size, leading to impaired hippocampal-dependent learning
and memory.

4.7 Concluding remarks
The identification of ATRX as a sex-specific regulator of miRNA expression was an
unexpected finding but investigating this phenomenon has uncovered a model by which
ATRX may be able to regulate hippocampal-dependent learning and memory. Through its
regulation of miR-137, ATRX loss affects many synaptic transcripts, which could explain
the ultrastructural changes to the hippocampal synapses. However, ATRX loss appears to
have a protective effect in females by reducing the levels of miR-137. We also identified
gross morphological changes within the male hippocampal stratum radiatum/stratum
lacunosum, which may have dire consequences for synaptic signaling. Certainly, a number
of other details remain to be addressed before we fully understand how ATRX regulates
miRNA expression and the resulting changes to synaptic signaling, but it is clear now that
ATRX has many functions within the nervous system, during development and in the
mature brain, and other biological roles may still be discovered in the future. By
understanding these molecular mechanisms, we will better understand how ATRX
mutations lead to disease and help to develop potential treatments to aid in patients with
ATR-X syndrome and non-syndromic ID.
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Appendices

Appendix A ATRX loss does not affect expression of major immediate early genes.
(A) Expression of ATRX in Ctrl and AtrxNestin-cKO 10 DIV cultured E16.5 neurons before
and after stimulation. (B) Expression of c-Fos, Junb, Egr1, Arc, Npas4, and Gadd45g in
Ctrl and AtrxNestin-cKO cultured neurons before and after stimulation by potassium chloride
(KCl).
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Appendix B Permission to reproduce previously published work
The data and associated text in Chapter 2, sections 2.3.1-2.3.6 represent previously
published data:
i
Tamming, R.J., Siu, J.R., Jiang, Y., Prado, M.A.M., Beier, F., and Berube, N.G. (2017)
Mosaic inactivation of Atrx in the central nervous system causes memory deficits.
Disease Models & Mechanisms: doi: 10.1242/dmm.027482.
The material is re-used here in accordance with the policy of Disease Models and
Mechanisms CC-BY copyright provided that the source is attributed by citing doi.
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